CA2502986A1 - Cosmetic and pharmaceutical foam - Google Patents

Cosmetic and pharmaceutical foam Download PDF

Info

Publication number
CA2502986A1
CA2502986A1 CA002502986A CA2502986A CA2502986A1 CA 2502986 A1 CA2502986 A1 CA 2502986A1 CA 002502986 A CA002502986 A CA 002502986A CA 2502986 A CA2502986 A CA 2502986A CA 2502986 A1 CA2502986 A1 CA 2502986A1
Authority
CA
Canada
Prior art keywords
composition
agent
active agent
weight
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002502986A
Other languages
French (fr)
Other versions
CA2502986C (en
Inventor
Dov Tamarkin
Doron Friedman
Meir Eini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vyne Pharmaceuticals Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32178937&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2502986(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from IL15248602A external-priority patent/IL152486A0/en
Application filed by Individual filed Critical Individual
Publication of CA2502986A1 publication Critical patent/CA2502986A1/en
Application granted granted Critical
Publication of CA2502986C publication Critical patent/CA2502986C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/16—Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/046—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/362—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4993—Derivatives containing from 2 to 10 oxyalkylene groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/736—Chitin; Chitosan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8158—Homopolymers or copolymers of amides or imides, e.g. (meth) acrylamide; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/87—Polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/02—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings containing insect repellants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/24—Thermal properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/24—Thermal properties
    • A61K2800/242—Exothermic; Self-heating; Heating sensation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/24—Thermal properties
    • A61K2800/244—Endothermic; Cooling; Cooling sensation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30—Characterized by the absence of a particular group of ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Toxicology (AREA)
  • Inorganic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Botany (AREA)

Abstract

The invention relates to an alcohol-free cosmetic or pharmaceutical foam carrier comprising water, a hydrophobic solvent, a foam adjuvant agent, a surface-active agent and a water gelling agent. The cosmetic or pharmaceutical foam carrier does not contain aliphatic alcohols, making it non-irritating and non-drying. The alcohol-free foam carrier is suitable for inclusion of both water-soluble and oil soluble pharmaceutical and cosmetic agents.

Claims (87)

1. An alcohol-free foamable pharmaceutical or cosmetic carrier, comprising:
(a) a foamable composition comprising:
about 2-75% by weight of composition of a liquid, non-volatile hydrophobic solvent;
about 80-98% by weight of composition of water;
about 0.1% to 5% by weight of composition of a foam adjuvant agent selected from the group consisting of fatty alcohols, fatty acids, hydroxyl-substituted fatty alcohols, hydroxyl-substituted fatty acids, and fatty acids and fatty alcohols including at least one double bond in its carbon atom chain;
about 0.1% to 5% by weight of composition of a surface-active agent; and about 0.1% to 5% by weight of composition of a water gelling agent.
and (b) a liquefied or compressed gas propellant in a container, which upon release provides a breakable foam suitable for topical or muscosal administration.
2. The foamable carrier of claim 1, wherein the hydrophobic solvent comprises about 5-10% by weight of composition.
3. The foamable carrier of claim 1, wherein the hydrophobic solvent comprises about 10-20% by weight of composition.
4. The foamable carrier of claim 1, wherein the hydrophobic solvent comprises about 20-75% by weight of composition.
5. The foamable carrier of claim 1, wherein the hydrophobic solvent comprises a mixture of mineral oil and an emollient in a ratio between 2:8 and 8:2 on a weight basis.
6. The foamable carrier of claim 1, wherein at least 2% of the foamable composition is a silicone oil.
7. The foamable carrier of claim 1, wherein the surface-active agent is selected from the groups of non ionic surfactants, cationic surfactants, amphoteric and zwitterionic surfactants.
8. The foamable carrier of claim 1, wherein the surface-active agent is a mixture of a non ionic surfactant and an anionic surfactant in a 20:1 to 1:1 ratio.
9. The foamable carrier of claim 1, wherein the surface-active agent is a mixture of a non-ionic surfactant and an ionic surfactant in a 100:1 to 6:1 ratio.
10. The foamable carrier of claim 1, wherein the surface-active agent consists essentially of one or more non-ionic surfactants.
11. The foamable carrier of claim 1, wherein the surface-active agent has HLB
value of more than 9.
12. The foamable carrier of claims 7, 8, 9, or 10, wherein the non-ionic surfactant comprises a sucrose ester.
13. The foamable carrier of claim 1, wherein the hydrophobic solvent is selected from the group comprising vegetable oils, marine oils, mineral oils, emollients, silicone oils, plant-derived therapeutic oils and mixture thereof.
14. The foamable carrier of claim 1, wherein the combined amount of foam adjuvant agent, surface-active agent and water gelling agent is less than about 8% (w/w).
15. The foamable carrier of claim 1, wherein the combined amount of foam adjuvant agent, surface-active agent and water gelling agent is less than about 5% (w/w) of the foamable composition.
16. A pharmaceutical or cosmetic composition, comprising:
(a) a foamable composition comprising:
about 2-75% by weight of composition of a liquid, non-volatile hydrophobic solvent;
about 80-98% by weight of composition of water;
about 0.1% to 5% by weight of composition of a foam adjuvant agent selected from the group consisting of fatty alcohols, fatty acids, hydroxyl-substituted fatty alcohols, hydroxyl-substituted fatty acids, and fatty acids and fatty alcohols including at least one double bond in its carbon atom chain;
about 0.1% to 5% by weight of composition surface-active agent; and about 0.1% to 5% by weight of composition water gelling agent;
(b) a therapeutically effective amount of an active agent;
and (c) a liquefied or compressed gas propellant in a container, which upon release provides a breakable foam suitable for topical or muscasol administration.
17. The pharmaceutical or cosmetic composition of claim 16, wherein the hydrophobic solvent comprises about 5-10% by weight of composition.
18. The pharmaceutical or cosmetic composition of claim 16, wherein the hydrophobic solvent comprises about 10-20% by weight of composition.
19. The pharmaceutical or cosmetic composition of claim 16, wherein the hydrophobic solvent comprises about 20-75% by weight of composition.
20. The pharmaceutical or cosmetic composition of claim 16, wherein the active agent is a drug.
21. The pharmaceutical or cosmetic composition of claim 16, wherein the active agent is a cosmetically effective agent.
22. The pharmaceutical or cosmetic composition of claim 16, wherein the hydrophobic solvent is selected from the group comprising vegetable oils, marine oils, mineral oils, emollient, silicone oils, plant-derived therapeutic oils and mixture thereof at any proportion.
23. The pharmaceutical or cosmetic composition of claim 16, further comprising excipients selected from the group consisting of antioxidants, humectants, flavoring, colorant and odorant agents.
24. The pharmaceutical or cosmetic composition of claim 16, wherein the hydrophobic solvent comprises a mixture of mineral oil and an emollient in a ratio between 2:8 and 8:2 on a weight basis.
25. The pharmaceutical or cosmetic composition of claim 16, wherein at least 2% of the composition is a silicone oil.
26. The pharmaceutical or cosmetic composition of claim 16, wherein the surface-active agent is a mixture of a non ionic surfactant and an anionic surfactant in a 20:1 to 1:1 ratio.
27. The pharmaceutical or cosmetic composition of claim 16, wherein the surface-active agent consists essentially of one or more non-ionic surfactants.
28. The pharmaceutical or cosmetic composition of claim 16, wherein the surface-active agent is a mixture of a non-ionic surfactant and an ionic surfactant in a 100:1 to 6:1 ratio.
29. The pharmaceutical or cosmetic composition of claim 16, wherein the combined amount of foam adjuvant agent, surface active agent and water gelling agent is less than about 8% (w/w).
30. The composition of claim 16, further comprising an effective concentration of a penetration enhancer.
31. The pharmaceutical or cosmetic composition of claim 16, wherein the combined amount of foam adjuvant agent, surface active agent and water gelling agent is less than about 5% (w/w).
32. The pharmaceutical or cosmetic composition of claim 20 wherein the drug is selected for the treatment of a disease, the etiology of which is bacterial, fungal, viral, parasitic, inflammatory, autoimmune, allergic, hormonal, malignant and combinations thereof.
33. The pharmaceutical or cosmetic composition of claim 20, wherein the drug is selected for the treatment of a superficial condition.
34. The composition of claim 20, wherein the drug is selected for the treatment of a disorder of the skin, mucosal membrane, vagina and rectum.
35. The composition of claim 20, wherein the drug is selected for the treatment of a disorder, selected from the group of dermatosis, dermatitis, bacterial Infections, fungal Infections, parasitic infections, viral infections, disorders of hair follicles and sebaceous glands, acne, rosacea, scaling papular diseases, benign tumors, malignant tumors, reactions to sunlight, bullous diseases, pigmentation disorders, disorders of cornification, pressure sores, disorders of sweating, inflammatory reactions, xerosis, ichthyosis, allergy, burn, wound, cut, and non-dermatological disorders, which respond to transdermal delivery of said drug.
36. The composition of claim 20 wherein the drug is selected for the treatment of wounds, burns, cuts and ulcers.
37. The composition of claim 20 wherein the drug is antibacterial.
38. The composition of claim 20 wherein the drug is antifungal.
39. The composition of claim 20 wherein the drug is antiviral.
40. The composition of claim 20 wherein the active agent is an insecticide.
41. The composition of claim 20 wherein the active agent is an insect repellent.
42. The composition of claim 20, wherein the drug is an anti-inflammatory or antiallergic agent.
43. The composition of claim 20, wherein the drug is an anticancer agent.
44. The composition of claim 20, wherein the drug is a photodynamic therapy agent.
45. The composition of claim 20 wherein the drug is a local anesthetic.
46. The composition of claim 20 wherein the drug is a nonsteroidal anti-inflammatory drug (NSAID)
47. The composition of claim 21, wherein the active agent is a retinoid.
48. The composition of claim 21, wherein the active agent is an anti-wrinkle agent.
49. The composition of claim 20 or 21, wherein the active agent is a skin-whitening agent.
50. The composition of claim 20 or 21, wherein said active agent is selected from the group comprising sulfur-containing amino acids, thiol compounds, alpha hydroxy acids, lactic acid and its derivatives and salts, glycolic acid and its derivatives and salts, beta-hydroxy acids, salicylic acid and salicylic acid salts and derivatives, phytic acid, lipoic acid, lysophosphatidic acid, skin peel agents, phenol, resorcinol, vitamin B3 compounds, niacinamide, nicotinic acid and nicotinic acid salts and esters, tocopheryl nicotinate, nicotinyl amino acids, nicotinyl alcohol esters of carboxylic acids, nicotinic acid N-oxide and niacinamide N-oxide, retinoids, retinol, retinal, retinoic acid, retinyl acetate, retinyl palmitate ,retinyl ascorbate, caffeine, theophiline, pentoxyphilline, dihydroxy acetone kojic acid, arbutin, nicotinic acid and its precursors, salts and derivatives, arbutin, ascorbic acid and salts and derivatives thereof.
51. The composition of claim 20 or 21, wherein the active agent is an herbal extract.
52. The composition of claim 20 or 21, wherein the active agent is a radical scavenger.
53. The composition of claim 21, wherein the active agent is a self-tanning agent.
54. The composition of claim 20 or 21, wherein the active agent is an anti-acne active agent.
55. The composition of claim 20 or 21, wherein the active agent is a skin whitening agent.
56. The composition of claim 20 or 21 wherein the active agent is a figure forming agent.
57. The composition of claim 21, wherein the active agent is an agent that influences hair growth.
58. The composition of claim 21, wherein the active agent is a hair growth stimulating agent.
59. The composition of claim 21, wherein the active agent is a hair growth inhibiting agent.
60. The composition of claim 16, further comprising a sunscreen agent.
61. The composition of claim 16, further comprising an inorganic sunscreen agent.
62. The composition of claim 16, wherein the active agent is a combination of a skin whitening agent and a sunscreen agent.
63. The composition of claim 16, wherein the active agent is a combination of a skin whitening agent and an inorganic sunscreen agent.
64. The composition of claim 20 wherein the drug is intended for transdermal delivery.
65. The composition of claim 16, further comprising a decontaminating agent selected from the group comprising an oxidizing agent, iodine and iodine compounds, chlorohexidine, bleaching agents and surface-active agents.
66. A method of treating, alleviating or preventing a dermatological disorder, comprising:

administering topically to a subject having said dermatological disorder a therapeutically effective amount of a breakable foam composition comprising:
(a) a foamable composition comprising:
about 2-75% by weight of composition of a liquid, non-volatile hydrophobic solvent;
about 80-98% by weight of composition of water;
about 0.1% to 5% by weight of composition of a foam adjuvant agent selected from the group consisting of fatty alcohols, fatty acids, hydroxyl-substituted fatty alcohols, hydroxyl-substituted fatty acids, and fatty acids and fatty alcohols including at least one double bond in its carbon atom chain;
about 0.1% to 5% by weight of composition of a surface-active agent; and about 0.1% to 5% by weight of composition of a water gelling agent.
(b) at least one active agent, which is intended to prevent, alleviate or cure said disorder; and (c) a liquefied or compressed gas propellant.
67. The method of claim 66, wherein at least 2% of the composition is a silicone oil.
68. The method of claim 66, wherein the hydrophobic solvent comprises a mixture of mineral oil and an emollient in a ratio between 2:8 and 8:2 on a weight basis.
69. The method of claim 66, wherein the surface-active agent is selected from the groups of non-ionic surfactants, cationic surfactants, amphoteric and zwitterionic surfactants.
70. The method of claim 66, wherein the surface-active agent is a mixture of a non-ionic surfactant and an anionic surfactant in a 1:1 to 20:1 ratio.
71 71. The method of claim 66, wherein the surface-active agent is non-ionic.
72. The method of claim 66, wherein the surface-active agent has HLB value of more than 9.
73. The method of claim 66, wherein the non-ionic surfactant comprises a sucrose ester.
74. The method of claim 66, wherein the drug is intended for the treatment of a disease, the etiology of which is bacterial, fungal, viral, parasitic, inflammatory, autoimmune, allergic, hormonal, malignant and combinations thereof.
75. The method of claim 66, wherein the drug is selected from the group comprising antibacterial, antifungal, anti-inflammatory, antiallergic, nonsteroidal anti-inflammatory, retinoid, alpha hydroxy acid, beta hydroxy acid, keratolytic, antiproliferative, anticancer and anti-pigmentation drugs.
76. The method of claim 66, wherein the drug is selected from the group comprising an insecticide of an insect repellent.
77. The method of claim 66, wherein said compound is applied topically to an affected area.
78. The method of claim 66, wherein said dermatological disorder comprises dermatosis, dermatitis, bacterial Infections, fungal Infections, parasitic infections, viral infections, disorders of hair follicles and sebaceous glands, scaling papular diseases, benign tumors, malignant tumors, reactions to sunlight, bullous diseases, pigmentation disorders, disorders of cornification, pressure sores, disorders of sweating, inflammatory reactions, xerosis, ichthyosis, allergy, burn, wound, cut, and non-dermatological disorders, which respond to transdermal delivery of said active agent.
79. The method of claim 66, wherein the active agent is a figure forming agent.
80. The method of claim 66, wherein the active agent is an agent that influences hair growth.
81. The method of claim 66, wherein the active agent is a hair growth stimulating agent.
82. The method of claim 66, wherein the active agent is a hair growth inhibiting agent.
83. The method of claim 66, further comprising a sunscreen agent.
84. The method of claim 66, further comprising an inorganic sunscreen agent.
85. The method of claim 66, wherein the active agent is a combination of a skin whitening agent and a sunscreen agent.
86. The method of claim 66, wherein the active agent is a combination of a skin whitening agent and an inorganic sunscreen agent.
87. The method of claim 66, comprising an effective concentration of a penetration enhancer.
CA2502986A 2002-10-25 2003-10-24 Cosmetic and pharmaceutical foam Expired - Lifetime CA2502986C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IL152486 2002-10-25
IL15248602A IL152486A0 (en) 2002-10-25 2002-10-25 Alcohol-free cosmetic and pharmaceutical foam carrier
US42954602P 2002-11-29 2002-11-29
US60/429,546 2002-11-29
PCT/IB2003/005527 WO2004037225A2 (en) 2002-10-25 2003-10-24 Cosmetic and pharmaceutical foam

Publications (2)

Publication Number Publication Date
CA2502986A1 true CA2502986A1 (en) 2004-05-06
CA2502986C CA2502986C (en) 2011-08-23

Family

ID=32178937

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2502986A Expired - Lifetime CA2502986C (en) 2002-10-25 2003-10-24 Cosmetic and pharmaceutical foam

Country Status (12)

Country Link
US (10) US20060140984A1 (en)
EP (1) EP1556009B2 (en)
JP (1) JP2006505583A (en)
KR (1) KR101108439B1 (en)
AU (1) AU2003279493B2 (en)
BR (1) BR0314916A (en)
CA (1) CA2502986C (en)
ES (1) ES2532906T5 (en)
IL (1) IL168399A (en)
MX (1) MXPA05004278A (en)
NZ (1) NZ540166A (en)
WO (1) WO2004037225A2 (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9622947B2 (en) 2002-10-25 2017-04-18 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US9636405B2 (en) 2003-08-04 2017-05-02 Foamix Pharmaceuticals Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9662298B2 (en) 2007-08-07 2017-05-30 Foamix Pharmaceuticals Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US9675700B2 (en) 2009-10-02 2017-06-13 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US9682021B2 (en) 2006-11-14 2017-06-20 Foamix Pharmaceuticals Ltd. Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US9713643B2 (en) 2002-10-25 2017-07-25 Foamix Pharmaceuticals Ltd. Foamable carriers
US9795564B2 (en) 2007-12-07 2017-10-24 Foamix Pharmaceuticals Ltd. Oil-based foamable carriers and formulations
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US9884017B2 (en) 2009-04-28 2018-02-06 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US10092588B2 (en) 2009-07-29 2018-10-09 Foamix Pharmaceuticals Ltd. Foamable compositions, breakable foams and their uses
US10322085B2 (en) 2002-10-25 2019-06-18 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US10350166B2 (en) 2009-07-29 2019-07-16 Foamix Pharmaceuticals Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
US10821077B2 (en) 2002-10-25 2020-11-03 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof

Families Citing this family (178)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5858401A (en) * 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
US8263580B2 (en) 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US20060233721A1 (en) * 2002-10-25 2006-10-19 Foamix Ltd. Foam containing unique oil globules
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US7645803B2 (en) * 2005-05-09 2010-01-12 Foamix Ltd. Saccharide foamable compositions
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US20050271596A1 (en) * 2002-10-25 2005-12-08 Foamix Ltd. Vasoactive kit and composition and uses thereof
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US20050186142A1 (en) * 2002-10-25 2005-08-25 Foamix Ltd. Kit and composition of imidazole with enhanced bioavailability
US7820145B2 (en) * 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US20050205086A1 (en) * 2002-10-25 2005-09-22 Foamix Ltd. Retinoid immunomodulating kit and composition and uses thereof
US20080138296A1 (en) * 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US20060018937A1 (en) * 2002-10-25 2006-01-26 Foamix Ltd. Steroid kit and foamable composition and uses thereof
US20080031907A1 (en) * 2002-10-25 2008-02-07 Foamix Ltd. Cosmetic and pharmaceutical foam
MXPA05007722A (en) * 2003-01-24 2006-01-31 Connetics Australia Pty Ltd Clindamycin phosphate foam.
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
BRPI0412975A (en) * 2003-08-25 2006-10-03 Foamix Ltd penetrating foam for pharmaceutical use
US20050123484A1 (en) * 2003-10-02 2005-06-09 Collegium Pharmaceutical, Inc. Non-flammable topical anesthetic liquid aerosols
US20060188449A1 (en) * 2003-10-03 2006-08-24 Jane Hirsh Topical aerosol foams
MXPA06003743A (en) * 2003-10-03 2006-06-23 Collegium Pharmaceutical Inc Topical aerosol foams.
WO2005055921A2 (en) 2003-12-12 2005-06-23 Eran Eilat Compositions for treatment of ear disorders and methods of use thereof
US8940321B2 (en) 2003-12-12 2015-01-27 Otic Pharma Ltd. Compositions for treatment of ear disorders and methods of use thereof
US20050222169A1 (en) * 2004-01-16 2005-10-06 Nawaz Ahmad Compositions and methods of treating infections
CA2565754A1 (en) * 2004-04-28 2005-10-28 Foamix Ltd. Body cavity foams
WO2006010589A2 (en) * 2004-07-29 2006-02-02 Mipharm S.P.A. Post foaming gel mousse
WO2006029070A2 (en) * 2004-09-03 2006-03-16 Virginia Commonwealth University Prevention of ventilator associated pneumonia (vap)
US9457163B2 (en) 2004-09-03 2016-10-04 Virginia Commonwealth University Prevention of ventilator associated pneumonia (VAP)
NZ563270A (en) 2005-05-10 2010-11-26 Dermipsor Ltd Calcipotriol, polyethylene oxide topical compositions for the treatment of hyperproliferative epidermal diseases
CA2611147C (en) 2005-06-01 2013-04-09 Stiefel Research Australia Pty Ltd. Topical emulsion formulation
EP1919449A2 (en) * 2005-06-07 2008-05-14 Foamix Ltd. Antibiotic kit and composition and uses thereof
WO2007085899A2 (en) * 2005-07-06 2007-08-02 Foamix Ltd. Foamable arthropocidal composition for tropical application
WO2007085902A2 (en) * 2005-07-19 2007-08-02 Foamix Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7517852B2 (en) * 2005-07-28 2009-04-14 Biosynexus Incorporated Compositions and methods for treating bacteria
FR2890559B1 (en) * 2005-09-13 2011-06-24 Galderma Sa DERMATOLOGICAL FOAMS BASED ON METRONIDAZOLE AND EMULSIONS FOR PREPARATION
FR2890560B1 (en) * 2005-09-13 2011-06-24 Galderma Sa METRONIDAZOLE DERMATOLOGICAL FOAMS AND EMULSIONS FOR THEIR PREPARATION
DE202006004676U1 (en) * 2005-09-28 2007-02-08 Neubourg Skin Care Gmbh & Co. Kg Formulation, useful as foam skin cream and to treat e.g. dermatitis and psoriasis, comprises an aqueous emulsion, propellant gas, urea emulsion, hyaluronic acid, free fatty acid and at least two emulsions
US7576054B2 (en) * 2005-10-11 2009-08-18 Biosynexus Incorporated Compositions and methods for treating bacteria
US10010494B2 (en) 2005-10-19 2018-07-03 Menni Menashe Zinger Methods for the treatment of hyperhidrosis
US20070154402A1 (en) 2005-10-24 2007-07-05 Collegium Pharmaceutical, Inc. Topical Pharmaceutical Foam Composition
FR2893845B1 (en) * 2005-11-30 2010-10-29 Galderma Sa SPRAY COMPOSITION COMPRISING CORTICIDE AND OILY PHASE
EP1810666A1 (en) * 2006-01-19 2007-07-25 Ferring International Center S.A. Foam-Forming composition
EP1981480A1 (en) * 2006-01-19 2008-10-22 Disphar International B.V. Foam-forming composition
US7846888B2 (en) * 2006-02-07 2010-12-07 Battelle Energy Alliance, Llc Long lasting decontamination foam
US7915472B2 (en) * 2006-02-07 2011-03-29 Battelle Energy Alliance, Llc Surface decontamination compositions and methods
WO2007102243A1 (en) * 2006-03-08 2007-09-13 Nihon Nohyaku Co., Ltd. External pharmaceutical composition
US8349882B2 (en) * 2006-03-08 2013-01-08 Nihon Nohyaku Co., Ltd. Pharmaceutical composition for external use
RU2419429C2 (en) * 2006-03-08 2011-05-27 Нихон Нохияку Ко.,Лтд. Pharmaceutical composition for external application
US20070224143A1 (en) * 2006-03-21 2007-09-27 Kamedis Ltd. Cosmetic and pharmaceutical foam carrier
PL2206494T3 (en) 2006-03-31 2016-06-30 Stiefel Res Australia Pty Ltd Foamable suspension gel
CN101431892B (en) * 2006-05-02 2013-03-27 日本曹达株式会社 Liquid composition and preparation method thereof, exterior parasite remover for mammal and birds
DE102006031758A1 (en) * 2006-07-04 2008-01-10 Kilic, Cuma Composition, useful e.g. for the reduction of the penetration of body fluids into urethra, comprises at least two different hydrophobic compound such as vegetable oil, where the composition lock the urethra over the cross-section
SI2494959T1 (en) 2006-07-05 2015-04-30 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
MX2009000507A (en) * 2006-07-14 2009-06-12 Stiefel Res Australia Pty Ltd Fatty acid pharmaceutical foam.
WO2008045696A2 (en) * 2006-10-10 2008-04-17 Laclede, Inc. Methods and compositions for the treatment of vaginal diseases employing peroxide-producing enzymes and peroxidases
FR2909554B1 (en) * 2006-12-08 2013-11-01 Biorecept Lab ANTI-WRINKLE COSMETIC COMPOSITION COMPRISING HYALURONIC ACID
EP1938801A1 (en) * 2006-12-22 2008-07-02 Biofrontera Bioscience GmbH Nanoemulsion
US20100041704A1 (en) * 2007-01-12 2010-02-18 Aberg A K Gunnar Dermal compositions of substituted amides and the use thereof as medication for pain and pruritus
BRPI0808795A2 (en) * 2007-03-14 2014-08-12 Unilever Nv AIRCRAFT PRODUCT, AIRCRAFT PRODUCT, AIRCRAFT PRODUCTION PROCESS
CA2687080C (en) * 2007-05-11 2016-06-28 Convatec Technologies Inc. Ostomy appliance
DE202007007455U1 (en) * 2007-05-25 2008-10-09 Schwan-Stabilo Cosmetics Gmbh & Co. Kg Pigment-based polymer-based ink
US8617100B2 (en) 2007-09-04 2013-12-31 Foamix Ltd. Device for delivery of a foamable composition
JP5345937B2 (en) * 2007-09-05 2013-11-20 株式会社ポーラファルマ Antifungal composition
CN101808637B (en) * 2007-09-05 2013-07-24 宝丽制药股份有限公司 Pharmaceutical composition
JP5453093B2 (en) * 2007-09-05 2014-03-26 株式会社ポーラファルマ Antifungal pharmaceutical composition
EP2042154A1 (en) * 2007-09-28 2009-04-01 Koninklijke Coöperatie Cosun U.A. Cosmetic mousse
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2010041141A2 (en) 2008-10-07 2010-04-15 Foamix Ltd. Oil-based foamable carriers and formulations
EP2242476A2 (en) 2008-01-14 2010-10-27 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
US20090185995A1 (en) * 2008-01-18 2009-07-23 Stacy Vochecowicz Lubricious, non-tacky personal lubricant
US8652443B2 (en) 2008-02-14 2014-02-18 Precision Dermatology, Inc. Foamable microemulsion compositions for topical administration
US20090312428A1 (en) 2008-06-13 2009-12-17 Fernando Figueredo Biocide Compositions Comprising Quaternary Ammonium and Urea and Methods for Their Use
AU2009305748A1 (en) * 2008-10-15 2010-04-22 Quinnova Pharmaceuticals, Inc. Salicylic acid composition
RU2011120054A (en) * 2008-10-21 2012-11-27 Новодермикс Интернэшнл Лимитед COMPOSITIONS FOR TREATMENT OF EPITELIAL TISSUE
US9532717B2 (en) * 2008-10-28 2017-01-03 The Procter & Gamble Company Method for diagnosing vulvovaginal disorders
EP2379082B1 (en) * 2008-12-17 2016-02-10 Ei, Inc. Acne treatment powder foundation
PL2210588T3 (en) 2008-12-23 2011-09-30 Intendis Gmbh Foamable composition essentially free of pharmaceutically active ingredients for the treatment of human skin
WO2010072958A2 (en) * 2008-12-23 2010-07-01 Galderma S.A. Topical pharmaceutical composition containing a water-sensitive active principle
US20120238535A1 (en) * 2009-02-23 2012-09-20 Smith Jan G Topical formulation of low level clobetasol propionate for treating disorders of the skin and mucous membranes
AU2010217190B2 (en) 2009-02-25 2012-10-25 Mayne Pharma Llc Topical foam composition
IL197464A0 (en) 2009-03-08 2009-12-24 Trima Israel Pharmaceutical Pr Foamable topical composition
FR2943914A1 (en) * 2009-04-06 2010-10-08 Fabre Pierre Dermo Cosmetique MOISTURE BOTTLE COMPRISING A PHARMACEUTICAL COMPOSITION
US10130610B2 (en) 2009-04-09 2018-11-20 Pola Pharma Inc. Antimycotic pharmaceutical composition
EP2416758B8 (en) 2009-04-09 2017-10-18 Pola Pharma Inc. Antimycotic pharmaceutical composition
DE102009028156A1 (en) * 2009-07-31 2011-02-03 Evonik Stockhausen Gmbh Foamable O / W emulsion
CN102481286B (en) 2009-08-25 2014-02-26 宝丽制药股份有限公司 Antimycotic pharmaceutical composition
WO2011038120A1 (en) * 2009-09-25 2011-03-31 Pharmasol Corporation Surface coatings for skin
US20140121188A1 (en) * 2009-10-02 2014-05-01 Foamix Ltd. Compositions for the improved treatment of acne and related disorders
US8716203B2 (en) * 2009-10-18 2014-05-06 Eli D Ehrenpreis Water-soluble colonoscopy lubricant
US8419948B2 (en) * 2009-11-22 2013-04-16 United Laboratories International, Llc Wastewater treatment
NZ600358A (en) 2009-11-23 2014-05-30 Cipla Ltd Topical foam composition
EP2524225B1 (en) * 2010-01-17 2017-04-19 The Procter and Gamble Company Biomarker-based methods for identifying and formulating compositions that improve skin quality and reduce the visible signs of aging in skin
CA2828086C (en) * 2010-03-10 2018-07-31 Nuvo Research Inc. Foamable formulation
DE202010004750U1 (en) * 2010-04-09 2011-10-11 Biofrontera Bioscience Gmbh Pharmaceutical and / or cosmetic composition for the treatment of the skin
US20120022178A1 (en) * 2010-06-17 2012-01-26 Diversified Glogal Technologies, Llc Methods of embedding foam with additives
US8978936B2 (en) 2010-07-12 2015-03-17 Foamix Pharmaceuticals Ltd. Apparatus and method for releasing a unit dose of content from a container
WO2012035468A2 (en) 2010-09-14 2012-03-22 Trima - Israel Pharmaceutical Products Maabarot Ltd. Foamable topical composition
US9358209B2 (en) * 2010-10-26 2016-06-07 Exeltis Usa Dermatology, Inc. Econazole composition and methods of treatment therewith
JP5430601B2 (en) * 2011-04-01 2014-03-05 マルホ株式会社 Non-aerosol foam composition
HUE055562T2 (en) 2011-11-23 2021-11-29 Therapeuticsmd Inc Natural combination hormone replacement formulations and therapies
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
GB201122235D0 (en) 2011-12-23 2012-02-01 Givaudan Sa Composition
US9480651B2 (en) 2012-03-30 2016-11-01 Sancilio & Company, Inc. Omega-3 fatty acid ester compositions unitary pharmaceutical dosage forms
US10898458B2 (en) 2012-03-30 2021-01-26 Micelle Biopharma, Inc. Self-micellizing fatty acids and fatty acid ester compositions and their use in the treatment of disease states
US20160228397A1 (en) 2012-03-30 2016-08-11 Sancilio & Company, Inc. Omega-3 fatty acid ester compositions
EP3072510B1 (en) 2012-03-30 2019-05-08 Micelle BioPharma, Inc. Omega-3 fatty acid ester compositions
RU2505301C2 (en) * 2012-05-05 2014-01-27 Федеральное государственное бюджетное учреждение науки Институт нефтехимии и катализа Российской академии наук Agent for hair growth stimulation
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
FR2994386B1 (en) * 2012-08-07 2016-06-24 Thorel Jean-Noel INHIBITION OF ADHESION OF PATHOGENIC MICROORGANISMS BY SUCROSE AND / OR SORBITAN ESTER IN THE COSMETIC TREATMENT OF SKIN ATOPIA
RU2494746C1 (en) * 2012-08-13 2013-10-10 Федеральное бюджетное учреждение науки "Казанский научно-исследовательский институт эпидемиологии и микробиологии" Роспотребнадзора Antibacterial composition containing water-soluble low-molecular chitosan
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9499772B2 (en) 2013-03-13 2016-11-22 Battelle Energy Alliance, Llc Methods of decontaminating surfaces and related compositions
BR102013007969A2 (en) * 2013-04-03 2014-11-11 Isp Do Brasil Ltda COSMETIC COMPOSITIONS AND USE OF CYCLODEXTRIN
US10111956B2 (en) 2013-06-03 2018-10-30 Tolmar, Inc. Corticosteroid compositions
JP2015000871A (en) * 2013-06-18 2015-01-05 ロレアル Foam aerosol cosmetic composition
KR102083282B1 (en) * 2013-07-31 2020-03-02 (주)아모레퍼시픽 Cosmetic composition of wash-off pack with cleansing function
JP5671118B1 (en) * 2013-10-09 2015-02-18 近代化学株式会社 Foamable composition for repelling harmful animals
CN106029056B (en) 2014-02-14 2020-04-10 明申医药公司 Sprayable compositions comprising zinc oxide and a fluoroolefin propellant
KR102271753B1 (en) 2014-02-14 2021-06-30 미션 파머컬 캄파니 Spray delivery device
JP2017508762A (en) 2014-03-28 2017-03-30 ガルデルマ・リサーチ・アンド・デヴェロップメント Sootless chemical mousse containing benzoyl peroxide
EP3145489A1 (en) 2014-05-22 2017-03-29 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
JP6537788B2 (en) * 2014-06-25 2019-07-03 ロレアル Composition in the form of a nanoemulsion or microemulsion or having a lamellar structure
KR101686986B1 (en) 2014-07-28 2016-12-16 에스케이케미칼주식회사 Immediate-release and sustained-release pharmaceutical compositon comprising leuprolide
CA2959414C (en) 2014-09-05 2023-03-14 Symbiomix Therapeutics, Llc Secnidazole for use in the treatment of bacterial vaginosis
JP2016113406A (en) * 2014-12-16 2016-06-23 ロレアル Aerosol type oxidizing composition
WO2016109344A1 (en) * 2014-12-30 2016-07-07 3M Innovative Properties Company Bactericidal composition
JP6579766B2 (en) * 2015-03-13 2019-09-25 東洋エアゾール工業株式会社 Aerosol product for forming cold gel composition for human body
WO2016153946A1 (en) 2015-03-24 2016-09-29 The Procter & Gamble Company Foam compositions, aerosol products, and methods of using the same to improve sensory benefits to the skin
WO2016194734A1 (en) * 2015-05-29 2016-12-08 花王株式会社 Aerosol cosmetic
WO2016196653A1 (en) 2015-06-01 2016-12-08 Symbiomix Therapeutics, Llc Novel nitroimidazole formulations and uses thereof
WO2016201491A1 (en) * 2015-06-19 2016-12-22 International Scientific Pty Ltd Methods for in situ separation of mixtures
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
TWI618714B (en) * 2015-08-27 2018-03-21 中央研究院 Sialyltransferase inhibitors and uses thereof
FR3041535B1 (en) 2015-09-29 2019-01-25 Galderma Research & Development NON-RINSE CHEMICAL FOAM CONTAINING TRIFAROTENE AND USE THEREOF IN THE TREATMENT OF ICHTYOSE
FR3041538B1 (en) 2015-09-29 2018-11-30 Galderma Research & Development NON-RINSE CHEMICAL FOAM CONTAINING CLOBETASOL PROPIONATE AND USE THEREOF IN THE TREATMENT OF PSORIASIS
FR3041541B1 (en) 2015-09-29 2018-11-30 Galderma Research & Development NON-RINSE CHEMICAL FOAM COMPRISING IVERMECTIN
FR3041537B1 (en) 2015-09-29 2018-11-30 Galderma Research & Development BRIMONIDINE CONTAINING CHEMICAL FOAM WITHOUT RINSE AND USE THEREOF FOR TREATING ROSACEA.
FR3041536B1 (en) 2015-09-29 2018-11-30 Galderma Research & Development NON-RINSEED CHEMICAL FOAM CONTAINING TRIFAROTENE AND USE THEREOF IN THE TREATMENT OF ACNE
FR3041539B1 (en) 2015-09-29 2018-10-26 Galderma Research & Development SELF-FOAMING CLEANING COMPOSITION CONTAINING CLOBETASOL PROPIONATE AND USE THEREOF IN THE TREATMENT OF PSORIASIS
DE102015221568A1 (en) 2015-11-04 2017-05-04 Beiersdorf Ag Cosmetic foam of an emulsion containing glycerol and alcohol
US10413488B2 (en) * 2015-12-02 2019-09-17 L'oreal Aerosol oil foam compositions comprising a triglyceride-based oil and surfactant
BR112018070199A2 (en) 2016-04-01 2019-01-29 Therapeuticsmd Inc pharmaceutical composition of steroid hormone
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
CN105961414A (en) * 2016-06-27 2016-09-28 山东美罗福农业科技股份有限公司 Water-based plant-source pesticide with diosgenin and method for preparing water-based plant-source pesticide
TW202247855A (en) 2016-09-13 2022-12-16 美商愛力根公司 Non-protein clostridial toxin compositions
KR101899025B1 (en) * 2016-10-31 2018-09-14 진성현 Cosmetic composition and manufacturing method for the same
BR112019011953A2 (en) 2016-12-12 2019-10-29 Contract Pharmaceuticals Ltd pyrethroid spray formulations and methods of use thereof
US20230285288A1 (en) * 2017-04-04 2023-09-14 Miguel Berkstrom Nanoparticle compositions comprising cannabinoids
WO2019133882A1 (en) * 2017-12-29 2019-07-04 Scioderm, Inc. Methods of treating pyogenic granulomas
PL3773501T3 (en) * 2018-03-29 2024-03-11 The Materia Company Limited Intravaginal formulation
GB201813876D0 (en) 2018-08-24 2018-10-10 Antibiotx As Treatment
CA3118172A1 (en) 2018-11-02 2020-05-07 UNION therapeutics A/S Halogenated salicylanilides for treating the symptoms of dermatitis
WO2020089467A1 (en) 2018-11-02 2020-05-07 UNION therapeutics A/S Dosage regimen
FR3090357B1 (en) * 2018-12-20 2022-10-07 Oreal Foam aerosol device containing a composition rich in fatty substances
WO2020185955A1 (en) * 2019-03-11 2020-09-17 Bryan Hill Method and system for treating vulvodynia
WO2020188575A1 (en) * 2019-03-19 2020-09-24 Sol-Gel Technologies Ltd. Treatment of rosacea with topical combination compositions
WO2020223093A1 (en) 2019-04-30 2020-11-05 Bayer Healthcare Llc Topical analgesic gel compositions
JP7465066B2 (en) 2019-06-17 2024-04-10 小林製薬株式会社 Emulsion stabilizer
FR3103105B1 (en) * 2019-11-15 2021-11-26 Dermowave composition in the form of a rinsable oily solution to fight against lice
BR112022013127A2 (en) * 2019-12-30 2022-09-06 Rodan & Fields Llc COMPOSITION, TOPICAL FORMULATION, METHOD TO INDUCE SKIN BARRIER REPAIR AND USE
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
US10857151B1 (en) 2020-02-21 2020-12-08 Villya LLC Treatment of female genital schistosomiasis
CN112190687B (en) * 2020-11-19 2022-06-10 温州医科大学附属第一医院 Medicine for reducing skin wound scar and application thereof
CN112675356A (en) * 2020-12-23 2021-04-20 湖南工业大学 Long-term-preservation hemostatic composition, preparation method thereof and preparation method of long-term-preservation antibacterial hemostatic mixture
FR3129080A1 (en) * 2021-11-15 2023-05-19 Farevacare EMULSIFIABLE CONCENTRATED COSMETIC COMPOSITION TO DILUTE

Family Cites Families (1165)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US513714A (en) * 1894-01-30 Card-holder
US1159250A (en) 1914-05-01 1915-11-02 Frank Moulton Vaginal irrigator.
US1666684A (en) 1926-01-15 1928-04-17 Carstens Mfg Co H Vaginal douche
US1924972A (en) 1929-04-15 1933-08-29 Carl J Beckert Stabilized egg product
US2085733A (en) 1935-07-15 1937-07-06 John C Bird Shaving cream
US2390921A (en) 1943-03-23 1945-12-11 Ethel Hudson Clark Applicator for facial creams
US2524590A (en) 1946-04-22 1950-10-03 Carsten F Boe Emulsion containing a liquefied propellant gas under pressure and method of spraying same
US2586287A (en) * 1948-12-11 1952-02-19 Colagte Palmolive Peet Company Aluminum sulfamate antiperspirant preparation
US2617754A (en) 1949-08-29 1952-11-11 Procter & Gamble Cosmetic cream
US3062715A (en) 1953-11-18 1962-11-06 George S Pfaus Vaginal tablet
US2767712A (en) 1954-03-01 1956-10-23 Neil S Waterman Medicinal applicator
GB808104A (en) 1955-01-04 1959-01-28 Udylite Res Corp Electrodeposition of copper from aqueous alkaline cyanide solutions
GB808105A (en) 1956-06-15 1959-01-28 Ici Ltd New pharmaceutical compositions
US3092555A (en) 1958-04-21 1963-06-04 Roy H Horn Relatively collapsible aerosol foam compositions
US3144386A (en) 1958-05-09 1964-08-11 Merck & Co Inc Mastitis aerosol foam
US2968628A (en) * 1958-10-17 1961-01-17 Shulton Inc Propellant composition
US3178352A (en) 1959-02-27 1965-04-13 Erickson Roy Shaving method and composition therefor
US3141821A (en) 1959-03-17 1964-07-21 Lehn & Fink Products Corp Synergistic combination of alkyl sulfonates, alkylaryl sulfonates and topical antibacterial agents for local antisepsis
US3004894A (en) 1959-04-07 1961-10-17 Upjohn Co Therapeutic composition comprising tetracycline and a dioxolane
GB922930A (en) 1959-09-21 1963-04-03 Sunnen Joseph Spermicidal composition and method of making same
US3142420A (en) 1959-11-09 1964-07-28 Neotechnic Eng Ltd Metering dispenser for aerosol with fluid pressure operated piston
US3092255A (en) 1960-02-05 1963-06-04 Robert F Hohman Sorting apparatus
US3067784A (en) 1960-04-14 1962-12-11 Esta Medical Lab Inc Adapter connecting aerosol container valve stem to dispenser for filling said dispenser
NL270627A (en) 1960-10-26
US3154075A (en) * 1960-11-02 1964-10-27 Norwich Pharma Co Vaginal applicator
GB998490A (en) 1961-06-03 1965-07-14 Albert Fritz Albach A foam projector
DE1926796U (en) 1961-10-12 1965-11-11 Heidolph Elektro K G FAN.
NL128174C (en) 1962-02-28
US3261695A (en) 1962-12-24 1966-07-19 Gen Foods Corp Process for preparing dehydrated foods
US3330730A (en) 1962-08-03 1967-07-11 Colgate Palmolive Co Pressurized emulsion quick breaking foam compositions
US3252859A (en) 1962-10-24 1966-05-24 Masti Kure Company Inc Colloidal silica-oil composition and method of using same
US3244589A (en) 1962-10-26 1966-04-05 Sunnen Alkyl phenoxy polyethoxy ether spermicidal aerosol
US3298919A (en) * 1962-12-26 1967-01-17 Dow Corning Shaving cream containing polysiloxanes
US3383280A (en) 1963-01-09 1968-05-14 Miles Lab Dermatological abradant stick-type applicator
FR1355607A (en) 1963-01-22 1964-03-20 Improvements to cannula probes and their applications
US3149543A (en) 1963-03-04 1964-09-22 Ingersoll Rand Co Non-lubricated piston
GB1026831A (en) 1963-05-31 1966-04-20 Mediline Ag Preparations for use in feminine hygiene
US3824303A (en) 1963-07-24 1974-07-16 Yardley Of London Inc Collapsible foam pre-electric shave lotion containing diester lubricants
GB1081949A (en) 1963-08-12 1967-09-06 Avon Prod Inc Improvements in cosmetic mask
US3333333A (en) 1963-08-14 1967-08-01 Rca Corp Method of making magnetic material with pattern of embedded non-magnetic material
US3236457A (en) * 1963-08-21 1966-02-22 John R Kennedy Composite spray container assembly
US3263867A (en) 1963-12-26 1966-08-02 Valve Corp Of America Metering button-type aerosol actuator
US3395214A (en) 1964-01-09 1968-07-30 Scholl Mfg Co Inc Antiperspirant composition providing a readily collapsible sprayable foam
US3278093A (en) 1964-01-13 1966-10-11 Valve Corp Of America Metering and non-metering aerosol actuator button
GB1052724A (en) * 1964-04-27
US3303970A (en) * 1964-07-14 1967-02-14 Jerome Marrow Device for simultaneously dispensing from plural sources
US3395215A (en) 1964-10-15 1968-07-30 Colgate Palmolive Co Pressurized lotion composition
US3384541A (en) 1964-10-28 1968-05-21 William G. Clark Spermicidal vaginal pharmaceutical concentrate for producing nonaqueous foam with aerosol propellants
US3263869A (en) 1964-11-03 1966-08-02 Calmar Inc Liquid dispenser with overcap
US3342845A (en) 1964-11-05 1967-09-19 Upjohn Co Terphenyl triisocyanates
US3419658A (en) 1965-01-25 1968-12-31 Du Pont Nonaqueous aerosol foams containing mineral oil
US3346451A (en) 1965-01-27 1967-10-10 S E Massengill Company Concentrated liquid lactic acid douche preparation containing aromatics
US3301444A (en) * 1965-08-12 1967-01-31 Oel Inc Aerosol metering valve
US3456052A (en) 1965-09-28 1969-07-15 Garrett Lab Inc Aerosol composition containing butoxymonoether of a polyoxyalkylene glycol
GB1121358A (en) 1965-10-21 1968-07-24 Bristol Myers Co Aerosol manufacture
US3849569A (en) 1965-12-02 1974-11-19 Glaxo Lab Ltd Composition containing procaine penicillin
BE692228A (en) 1966-01-10 1967-07-05
US3401849A (en) 1966-05-24 1968-09-17 Robert L. Weber Low force metering valve
US3886084A (en) 1966-09-29 1975-05-27 Champion Int Corp Microencapsulation system
US3377004A (en) 1966-10-03 1968-04-09 Gen Mills Inc Metered dispensing container
GB1201918A (en) 1966-12-21 1970-08-12 Bespak Industries Ltd Improvements in or relating to valves for pressurised dispensers
US3527559A (en) 1967-01-05 1970-09-08 Standard Pharmacal Corp Dense aqueous aerosol foam depilatory compositions containing a mixture of alkaline metal and alkali metal thioglycolates and a fatty alcohol-alkylene oxide wax emulsifying agent
US3366494A (en) * 1967-02-15 1968-01-30 Du Pont Pressurized aerosol food emulsions
US3561262A (en) * 1967-10-26 1971-02-09 Magnaflux Corp Water soluble developer
US3540448A (en) 1968-01-17 1970-11-17 Joseph Sunnen Rechargeable applicator for dispensing substances in a foam condition
DE1926796A1 (en) 1968-05-27 1970-03-19 Dudiuyt Jean Paul Aerosol compsn. and container
US3563098A (en) * 1968-06-28 1971-02-16 Rex Chainbelt Inc Automatic quick release mechanism
US3559890A (en) * 1968-09-03 1971-02-02 William R Brooks Foam dispenser
US3878118A (en) 1968-09-06 1975-04-15 Wilkinson Sword Ltd Self-heating chemical compositions
US3667461A (en) 1968-11-05 1972-06-06 Paul A Zamarra Disposable syringe
CA975500A (en) 1969-02-06 1975-09-30 Joseph G. Spitzer Structures such as applicator pads for cleaning and other purposes, propellant compositions for forming the same, and process
US3866800A (en) * 1969-02-12 1975-02-18 Alberto Culver Co Non-pressurized package containing self-heating products
US3966090A (en) 1969-02-17 1976-06-29 Dart Industries Inc. Package for dispensing an antiseptic composition
US4001391A (en) * 1969-04-18 1977-01-04 Plough, Inc. Means for depositing aerosol sprays in buttery form
US3819524A (en) 1969-06-17 1974-06-25 Colgate Palmolive Co Cosmetic composition for thermal dispensing
US3577518A (en) 1969-07-18 1971-05-04 Nat Patent Dev Corp Hydrophilic hairspray and hair setting preparations
US3787566A (en) * 1969-07-29 1974-01-22 Holliston Labor Inc Disinfecting aerosol compositions
BE759520A (en) 1969-11-28 1971-04-30 Aspro Nicholas Ltd ASPIRIN COMPOSITIONS
GB1353381A (en) 1971-02-04 1974-05-15 Wilkinson Sword Ltd Substituted p-menthanes and compositions containing them
GB1351761A (en) 1971-02-04 1974-05-01 Wilkinson Sword Ltd Substituted p-menthane carboxamides and compositions containing them
GB1351762A (en) 1971-02-14 1974-05-01 Wilkinson Sword Ltd Tobacco and tobacco-containing manufactures
CA958338A (en) 1971-03-08 1974-11-26 Chung T. Shin Antiperspirant powder aerosol compositions containing aluminum chloride and water soluble aluminum compounds and methods of preparation
US3770648A (en) 1971-07-12 1973-11-06 Bristol Myers Co Anhydrous aerosol foam
BE788788A (en) 1971-09-13 1973-03-13 Treuhandvereinigung Ag PRODUCT FOR PRESERVING, PROMOTING AND RESTORING HAIR AND METHOD OF MANUFACTURING THIS PRODUCT
US3912667A (en) 1971-09-13 1975-10-14 Spitzer Joseph G Structures such as applicator pads for cleaning and other purposes, propellant compositions for forming the same and process
SE358308B (en) 1971-11-26 1973-07-30 Pharmacia Ab
US3997467A (en) 1971-11-26 1976-12-14 Pharmacia Aktiebolag Foam forming composition
CH1917171A4 (en) 1971-12-30 1975-04-30
JPS5715147B2 (en) * 1972-03-09 1982-03-29
US3963833A (en) 1972-06-02 1976-06-15 Colgate-Palmolive Company Antiperspirant composition and method containing a dihydro-benzofuran and an astringent metal salt
US3841525A (en) 1972-06-14 1974-10-15 N Siegel Aerosol spray device with cam activator
US3849580A (en) 1972-09-05 1974-11-19 American Home Prod Aerosol dispensing system for anhydrous edible fat compositions
US3751562A (en) 1972-09-22 1973-08-07 Princeton Biomedix Medicated gelled oils
US3970584A (en) 1973-02-14 1976-07-20 S. C. Johnson & Son, Inc. Aerosol package containing a foam-forming emulsion and propellent system
US4439416A (en) 1973-03-23 1984-03-27 Colgate-Palmolive Company Self-heating shaving composition
GB1423179A (en) 1973-05-16 1976-01-28 Wilkinson Sword Ltd Pressurised shaving foam dispensers
YU36328B (en) * 1973-07-18 1983-06-30 Elastin Werk Ag Method of manufacturing red foils for packing sausages
US4110426A (en) * 1973-07-24 1978-08-29 Colgate-Palmolive Company Method of treating skin and hair with a self-heated cosmetic
US3865275A (en) * 1973-07-30 1975-02-11 Raymond Lee Organization Inc Apparatus for operating an aerosol can
US3929985A (en) * 1974-01-18 1975-12-30 Richardson Merrell Inc Anhydrous candicidin foam compositions
DE2501548A1 (en) 1974-01-25 1975-07-31 Procter & Gamble ORAL TREATMENT PRODUCTS
GB1457671A (en) 1974-01-31 1976-12-08 Wilkinson Sword Ltd Flavour
US3923970A (en) 1974-03-29 1975-12-02 Carter Wallace Stable aerosol shaving foams containing mineral oil
US3962150A (en) 1974-04-10 1976-06-08 Richardson-Merrell Inc. Foam producing cleansing compositions
US3953591A (en) 1974-04-29 1976-04-27 The Procter & Gamble Company Fatty acid, polysiloxane and water-soluble polymer containing skin conditioning emulsion
US3966632A (en) 1974-06-06 1976-06-29 G. D. Searle & Co. Vegetable oil emulsion
US4145411A (en) 1974-09-05 1979-03-20 Colgate-Palmolive Company Pressurized foaming shaving composition
JPS5729213B2 (en) 1974-11-12 1982-06-21
US4052513A (en) 1974-12-13 1977-10-04 Plough, Inc. Stable topical anesthetic compositions
US3952916A (en) 1975-01-06 1976-04-27 Warner-Lambert Company Automatic dispenser for periodically actuating an aerosol container
US4019657A (en) 1975-03-03 1977-04-26 Spitzer Joseph G Aerosol containers for foaming and delivering aerosols
US3970219A (en) 1975-03-03 1976-07-20 Spitzer Joseph G Aerosol containers for foaming and delivering aerosols and process
US4018396A (en) 1975-05-05 1977-04-19 Bechtel International Corporation Embedded housing for ore crusher
US3993224A (en) 1975-09-08 1976-11-23 Aerosol Investments, Ltd. Spout for two-component resin dispenser
DE2608226A1 (en) 1976-02-28 1977-09-08 Haarmann & Reimer Gmbh AGENTS WITH PHYSIOLOGICAL COOLING EFFECT
US4100426A (en) 1976-03-10 1978-07-11 Square D Company Load controlling means
IL49491A (en) 1976-04-29 1979-09-30 Rosenberg Peretz Quickly-attachable connector for plastic pipes
US4102995A (en) 1976-05-13 1978-07-25 Westwood Pharmaceuticals Inc. Tar gel formulation
JPS531113A (en) 1976-06-24 1978-01-07 Nippon Steel Corp Heating of slab for producing hot rolled plate with little skit mark
US4124149A (en) 1976-07-19 1978-11-07 Spitzer Joseph G Aerosol container with position-sensitive shut-off valve
CA1089368A (en) 1976-08-02 1980-11-11 Daniel C. Geary Polyethoxylated fatty alcohol in antiperspirant sticks
IL52045A (en) 1976-08-25 1979-12-30 Mundipharma Ag Sprayable germicidal foam compositions
US4310510A (en) * 1976-12-27 1982-01-12 Sherman Kenneth N Self administrable anti-fertility composition
US4252787A (en) * 1976-12-27 1981-02-24 Cambridge Research And Development Group Anti-fertility composition and method
US4083974A (en) 1977-03-07 1978-04-11 The Upjohn Company Topical steroidal anti-inflammatory preparations containing polyoxypropylene 15 stearyl ether
JPS5744429Y2 (en) 1977-04-14 1982-10-01
IT1114950B (en) 1977-12-30 1986-02-03 Porro Marcella COMPOSITIONS FOR ACNE TREATMENT AND THERAPY
US4386104A (en) 1977-04-19 1983-05-31 Nazzaro Porro Marcella Process for the treatment of acne
GB2004746B (en) 1977-10-03 1982-03-10 Scherico Ltd Stable hopical anaesthetic compositions
JPS5639815Y2 (en) 1977-11-25 1981-09-17
SE7713618L (en) 1977-12-01 1979-06-02 Astra Laekemedel Ab LOCAL ANESTHETIC MIXTURE
US4160827A (en) 1978-02-06 1979-07-10 The Upjohn Company Metronidazole phosphate and salts
US4229432A (en) 1978-04-19 1980-10-21 Bristol-Myers Company Antiperspirant stick composition
US4603812A (en) 1978-06-27 1986-08-05 The Dow Chemical Company Foam-generating pump sprayer
US4178373A (en) 1978-08-21 1979-12-11 William H. Rorer, Inc. Coal tar gel composition
US4214000A (en) 1978-10-30 1980-07-22 Johnson & Johnson Zinc salt of all-trans-retinoic acid for the treatment of acne
JPS5569682U (en) 1978-11-08 1980-05-13
JPS5569682A (en) * 1978-11-20 1980-05-26 Toyo Aerosol Kogyo Kk Foam shrinkable composition
US4213979A (en) 1978-12-18 1980-07-22 Plough, Inc. Stable sprayable hydrocortisone product
US4954487A (en) 1979-01-08 1990-09-04 The Procter & Gamble Company Penetrating topical pharmaceutical compositions
US4439441A (en) 1979-01-11 1984-03-27 Syntex (U.S.A.) Inc. Contraceptive compositions and methods employing 1-substituted imidazole derivatives
US4226344A (en) 1979-02-06 1980-10-07 Booth, Inc. Constant flow valve actuator
CH639913A5 (en) 1979-03-16 1983-12-15 Aerosol Service Ag Container for receiving and delivering a liquid substance
US4230701A (en) 1979-03-21 1980-10-28 Hoffmann-La Roche Inc. Administration of biologically active vitamin D3 and vitamin D2 materials
US4335120A (en) 1979-03-21 1982-06-15 Hoffmann-La Roche Inc. Administration of biologically active vitamin D3 and vitamin D2 materials
US4278206A (en) * 1979-04-13 1981-07-14 Ae Development Corporation Non-pressurized dispensing system
US4241048A (en) 1979-05-01 1980-12-23 Bristol-Myers Company Suspension composition of benzocaine
JPS55153712A (en) 1979-05-18 1980-11-29 Kao Corp Insulin pharmaceutical preparation and its production
US4268499A (en) 1979-06-07 1981-05-19 Dow Corning Corporation Antiperspirant emulsion compositions
US4241149A (en) 1979-07-20 1980-12-23 Temple University Canal clathrate complex solid electrolyte cell
DE2931469A1 (en) 1979-08-02 1981-02-26 Bayer Ag SURFACE SEALED MOLDED BODIES MADE OF CELLED POLYURETHANE ELASTOMERS AND METHOD FOR THE PRODUCTION THEREOF
US4271149A (en) 1979-09-21 1981-06-02 West Agro-Chemical, Inc. Germicidal iodine compositions with enhanced iodine stability
US4299826A (en) 1979-10-12 1981-11-10 The Procter & Gamble Company Anti-acne composition
EP0032309A3 (en) 1980-01-10 1981-08-05 Imperial Chemical Industries Plc Production of catalyst component, catalyst and use thereof
US4309995A (en) * 1980-01-28 1982-01-12 Sacco Susan M Vaginal irrigation apparatus
JPS56135416A (en) * 1980-03-27 1981-10-22 Mitsubishi Chem Ind Ltd Pharmaceutical preparation for skin
SE8004580L (en) 1980-06-19 1981-12-20 Draco Ab PHARMACEUTICAL PREPARATION
US4338211A (en) 1980-06-30 1982-07-06 The Procter & Gamble Company Liquid surfactant skin cleanser with lather boosters
US4508705A (en) 1980-07-02 1985-04-02 Lever Brothers Company Skin treatment composition
US4323582A (en) 1980-07-21 1982-04-06 Siegel Norman H Method of treating animals and humans for internal and external parasites
JPS601113Y2 (en) 1980-07-22 1985-01-12 三菱電機株式会社 Round lighting equipment packaging
JPS5914282B2 (en) 1980-07-31 1984-04-04 株式会社神戸製鋼所 Tube expansion drawing method
US4329990A (en) 1980-08-07 1982-05-18 Sneider Vincent R Expanding swab applicator
US4325939A (en) 1980-09-22 1982-04-20 Richardson-Vicks Inc. Zinc derivatives and their use in dental compositions
US4305936A (en) 1980-10-09 1981-12-15 Dermik Laboratories Topical corticosteroid formulations
US4292250A (en) 1980-11-17 1981-09-29 Wisconsin Alumni Research Foundation Vitamin D derivatives
EP0052404B1 (en) 1980-11-19 1987-05-27 THE PROCTER & GAMBLE COMPANY Non-yellowing topical pharmaceutical composition
JPS57501845A (en) 1980-11-27 1982-10-14
DE3147726A1 (en) 1980-12-03 1982-06-24 Leo Pharmaceutical Products Ltd. A/S (Loevens kemiske Fabrik Produktionsaktieselskab), 2750 Ballerup ANTIBIOTIC COMPLEXES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENTS THAT CONTAIN THESE COMPOUNDS
US4352808A (en) 1980-12-12 1982-10-05 Schering Corporation 3-Aralkyloxy-2,3-dihydro-2-(imidazolylmethyl)benzo(b)thiophenes and related derivatives, their use as antimicrobials and pharmaceutical formulations useful therefore
US4323694A (en) 1981-04-13 1982-04-06 Finetex, Inc. Benzoic acid esters
US4522948A (en) 1981-04-24 1985-06-11 Syntex (U.S.A.) Inc. Spermicidal substituted 1-(cycloalkyl)alkylimidazoles
US4393066A (en) 1981-06-05 1983-07-12 Garrett David M Method for treatment of herpetic lesions
US4607101A (en) 1981-08-27 1986-08-19 Jaye-Boern Laboratories, Inc. Method of treating acne vulgaris with a composition containing carbamide peroxide
US4877805A (en) 1985-07-26 1989-10-31 Kligman Albert M Methods for treatment of sundamaged human skin with retinoids
US4469674A (en) 1981-09-03 1984-09-04 Richardson-Vicks Inc. Stable oral compositions containing zinc and fluoride compounds
US4440320A (en) 1981-11-30 1984-04-03 Wernicke Steven A Foam dispensing apparatus
LU83876A1 (en) * 1982-01-15 1983-09-02 Oreal COSMETIC COMPOSITION FOR TREATMENT OF KERATINIC FIBERS AND METHOD FOR TREATING THE SAME
LU83949A1 (en) 1982-02-16 1983-09-02 Oreal COMPOSITION FOR THE TREATMENT OF KERATINIC MATERIALS CONTAINING AT LEAST ONE CATIONIC POLYMER AND AT LEAST ONE ANIONIC LATEX
US5087618A (en) * 1982-05-18 1992-02-11 University Of Florida Redox carriers for brain-specific drug delivery
JPS5939815A (en) 1982-08-30 1984-03-05 Shiseido Co Ltd Double-layer foundation
US4529605A (en) 1983-01-12 1985-07-16 Una E. Lynch Bathing oil composition
US4661340A (en) † 1983-06-06 1987-04-28 Interkemia Vegyipari Gazdasagi Tarsasag Quail egg based stabilized foam compositions for cosmetic purposes
GB8315787D0 (en) * 1983-06-08 1983-07-13 Briggs J H Coolant spray
US4552872A (en) 1983-06-21 1985-11-12 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing corticosteroids
GB8330969D0 (en) * 1983-11-21 1983-12-29 Wellcome Found Promoting healing
GB8402748D0 (en) 1984-02-02 1984-03-07 Dunlop Ltd Intravaginal device
US4985459A (en) * 1984-02-08 1991-01-15 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US4912124A (en) 1984-02-23 1990-03-27 Ortho Pharmaceutical Corporation Antifungal dermatological solution
NZ207341A (en) 1984-03-01 1988-02-29 Harvey Alex Ind Ltd Device containing chemical impregnants for insertion into a body cavity of an animal
US4628063A (en) 1984-03-08 1986-12-09 Dana P. Brigham Antiviral pharmaceutical preparations and methods for their use
US4574052A (en) 1984-05-31 1986-03-04 Richardson-Vicks Inc. Crackling aerosol foam
GB8416638D0 (en) 1984-06-29 1984-08-01 Beecham Group Plc Topical treatment and composition
ATE37209T1 (en) 1984-08-06 1988-09-15 Ciba Geigy Ag PROCESS FOR SIZING PAPER WITH ANIONIC, HYDROPHOBIC SIZES AND CATIONIC RETENTION AGENTS.
US4595526A (en) 1984-09-28 1986-06-17 Colgate-Palmolive Company High foaming nonionic surfacant based liquid detergent
SE443914B (en) 1984-10-01 1986-03-17 Torkel Ingemar Fischer MEANS OF A SENSITIVITY TEST
IE58110B1 (en) 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
CA1261276A (en) 1984-11-09 1989-09-26 Mark B. Grote Shampoo compositions
US4701320A (en) 1984-11-29 1987-10-20 Lederle (Japan), Ltd. Composition stably containing minocycline for treating periodontal diseases
US4627973A (en) 1984-12-14 1986-12-09 Charles Of The Ritz Group Ltd. Skin mousse
AU5078885A (en) 1984-12-20 1986-06-26 Warner-Lambert Company Non-irritant detergent
US4673569A (en) 1985-02-12 1987-06-16 Faberge Incorporated Mousse hair composition
GB2172298B (en) * 1985-03-01 1988-11-23 Procter & Gamble Mild detergent mousse
US5002680A (en) 1985-03-01 1991-03-26 The Procter & Gamble Company Mild skin cleansing aerosol mousse with skin feel and moisturization benefits
US4639367A (en) 1985-03-18 1987-01-27 Product Resources International, Inc. Aerosol foam
US4752465A (en) 1985-09-20 1988-06-21 Product Resources International, Inc. Aerosol foam
AU5549486A (en) 1985-03-18 1986-10-13 Product Resources International, Inc. Exothermic stable foam compositions
US5094853A (en) 1985-04-26 1992-03-10 S. C. Johnson & Son, Inc. Method of preparing a water-soluble stable arthropodicidally-active foam matrix
US4965063A (en) 1985-05-24 1990-10-23 Irene Casey Cleaner and disinfectant with dye
DE3521713A1 (en) * 1985-06-18 1986-12-18 Henkel KGaA, 4000 Düsseldorf OIL-IN-WATER EMULSIONS WITH IMPROVED VISCOSITY BEHAVIOR
US4672078A (en) 1985-07-03 1987-06-09 Schering-Plough Corporation Urea stabilized with a lactone in various pharmaceutical and cosmetic preparations
GB8519426D0 (en) 1985-08-01 1985-09-04 Ici Plc Composition for personal care products
US4806262A (en) * 1985-08-14 1989-02-21 The Procter & Gamble Company Nonlathering cleansing mousse with skin conditioning benefits
EP0213827A3 (en) † 1985-08-14 1988-04-06 The Procter & Gamble Company Nonfoaming cleansing mousse with skin conditioning benefits
AU6175586A (en) 1985-09-11 1987-03-12 Chesebrough-Pond's Inc. Petroleum jelly, mild detergent anhydrous base compositions
FR2591331A1 (en) 1985-12-10 1987-06-12 Drevet Jean Baptiste Device for dispensing metered portions of a product contained in a pressurised receptacle
US4837378A (en) 1986-01-15 1989-06-06 Curatek Pharmaceuticals, Inc. Topical metronidazole formulations and therapeutic uses thereof
GB8607570D0 (en) * 1986-03-26 1986-04-30 Euro Celtique Sa Vaginal pharmaceutical preparation
JPS62241701A (en) 1986-04-11 1987-10-22 Maeda Kogyo Kk Quick releasing device for hub for bicycle
CA1291036C (en) 1986-04-23 1991-10-22 Edwin I. Stoltz Nasal administration of drugs
DE3614515A1 (en) 1986-04-29 1987-11-05 Pfeiffer Erich Gmbh & Co Kg DISCHARGE DEVICE FOR MEDIA
FR2598392B1 (en) 1986-05-09 1988-08-26 Oreal PACKAGING FOR TWO PRESSURIZED CONTAINERS
PH25150A (en) 1986-06-05 1991-03-13 Ciba Geigy Ag Novel pharmaceutical preparation for topical application
US4770634A (en) 1986-06-11 1988-09-13 Pellico Michael A Method for treating teeth with foamable fluoride compositions
JPS62299423A (en) 1986-06-18 1987-12-26 Mazda Motor Corp Air-conditioner for vehicle
US4837019A (en) 1986-08-11 1989-06-06 Charles Of The Ritz Group Ltd. Skin treatment composition and method for treating burned skin
US4906453A (en) 1986-08-12 1990-03-06 Jumpeer Nails, Inc. Mousse product
DE3628531A1 (en) * 1986-08-22 1988-02-25 Merz & Co Gmbh & Co FOAMABLE CREAMS
AU597734B2 (en) 1986-09-05 1990-06-07 Upjohn Company, The Sebum-dissolving nonaqueous minoxidil formulation
WO1988001863A1 (en) 1986-09-12 1988-03-24 The Upjohn Company Foams for delivery of minoxidil
JPH0778019B2 (en) * 1986-11-08 1995-08-23 久光製薬株式会社 Foamed anti-inflammatory analgesic preparation
EP0270316A3 (en) 1986-12-04 1989-12-06 Pfizer Inc. Topical compositions comprising 1-substituted imidazoles and nsaids for treatment of acne
US4822613A (en) 1986-12-15 1989-04-18 S. C. Johnson & Son, Inc. Water-soluble foamable insecticidally-active compositions
US4822614A (en) 1986-12-19 1989-04-18 S. C. Johnson & Son, Inc. Bioactive film-forming composition for control of crawling insects and the like
US5389677B1 (en) 1986-12-23 1997-07-15 Tristrata Inc Method of treating wrinkles using glycalic acid
US4863900A (en) 1987-01-15 1989-09-05 The Research Foundation Of State University Of New York Method for reducing viral transmission with poly-L-histidine
JPS63119420U (en) 1987-01-30 1988-08-02
DE3704907A1 (en) 1987-02-17 1988-08-25 Bayer Ag TOPICALLY APPLICABLE PREPARATIONS OF GYRASE INHIBITORS IN COMBINATION WITH CORTICOSTEROIDS
US4828837A (en) 1987-03-30 1989-05-09 Liposome Technology, Inc. Non-crystalline minoxidil composition, its production and application
US4933330A (en) 1987-04-01 1990-06-12 Dak-Laboratoriet Benzoic acid derivatives and use thereof
LU86839A1 (en) 1987-04-10 1988-12-13 Oreal DETERGENT AND FOAMING COSMETIC COMPOSITION, DELAYING RE-LUBRICATION OF HAIR
EP0311657A4 (en) 1987-04-21 1991-09-18 Chattan Nominees Pty. Ltd. Vaginal douche
FR2615173B1 (en) 1987-05-13 1989-08-18 Valois DOSING VALVE FOR LIQUID LOADED WITH A LIQUID OR LIQUEFIED GAS PROPELLER, FOR USE IN THE REVERSE POSITION
US4867967A (en) 1987-06-04 1989-09-19 Crutcher Wilbert L Method for the treatment of pseudofolliculitis barbae
US4780309A (en) 1987-06-16 1988-10-25 Warner-Lambert Company Edible aerosol foam compositions and method of preparing same
US4849117A (en) 1987-06-17 1989-07-18 Sanitek Products, Inc. Concentrated composition for forming an aqueous foam
US4885282A (en) 1987-07-02 1989-12-05 Thornfeldt Carl R Treatment of hyperhidrosis, ichthyosis and wrinkling
US4898246A (en) * 1987-07-06 1990-02-06 Total Walther Feuerschutz Gmbh Quick release valve for sprinkler head
US5196405A (en) 1987-07-08 1993-03-23 Norman H. Oskman Compositions and methods of treating hemorrhoids and wounds
US4847068A (en) * 1987-08-06 1989-07-11 Johnson & Johnson Consumer Products, Inc. Skin care compositions
US4913893A (en) 1987-08-28 1990-04-03 Clairol Incorporated Aerosol hair setting composition containing an alginate
CA1273576A (en) 1987-09-16 1990-09-04 Patrick A. Beauchamp Topical treatment for diseased skin disorders
US4981677A (en) * 1987-09-23 1991-01-01 L'oreal Petrolatum-containing aerosol foam concentrate
ES2017587T3 (en) * 1987-09-23 1994-10-16 Oreal TREATMENT COMPOSITION OF SKIN IN THE FORM OF AEROSOL FOAM CONTAINING VASELINE.
US4784842A (en) 1987-09-25 1988-11-15 Jean London Therapeutic composition for treatment of cuts, burns and abrasions
US4772427A (en) 1987-12-01 1988-09-20 Colgate-Palmolive Co. Post-foaming gel shower product
US5143717A (en) 1987-12-30 1992-09-01 Code Blue Medical Corporation Burn foam and delivery system
DE68901043D1 (en) 1988-01-14 1992-04-30 Akzo Nv AQUEOUS PHARMACEUTICAL PREPARATION.
US5536743A (en) 1988-01-15 1996-07-16 Curatek Pharmaceuticals Limited Partnership Intravaginal treatment of vaginal infections with buffered metronidazole compositions
JP2643217B2 (en) 1988-01-22 1997-08-20 エーザイ株式会社 Aqueous liquid of fat-soluble substance
US5719197A (en) * 1988-03-04 1998-02-17 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US4897262A (en) * 1988-03-22 1990-01-30 Playtex Jhirmack, Inc. Non-aerosol hair spray composition
DE3811081A1 (en) * 1988-03-30 1989-10-12 Schering Ag USE OF TOPIC APPLICABLE PREPARATIONS FOR THE TREATMENT OF AGING SKIN
LU87187A1 (en) 1988-03-31 1989-10-26 Oreal COMBINATION OF PYRIMIDINE DERIVATIVES AND SALICYLIC ACID DERIVATIVES FOR INDUCING AND STIMULATING HAIR GROWTH AND REDUCING HAIR LOSS
US4992478A (en) * 1988-04-04 1991-02-12 Warner-Lambert Company Antiinflammatory skin moisturizing composition and method of preparing same
US4873078A (en) 1988-04-22 1989-10-10 Plough, Inc. High-gloss, high-shine lipstick
GB8811409D0 (en) 1988-05-13 1988-06-15 Unilever Plc Cosmetic composition
US5378730A (en) * 1988-06-09 1995-01-03 Alza Corporation Permeation enhancer comprising ethanol and monoglycerides
US4827378A (en) 1988-06-15 1989-05-02 Rockwell International Corporation Jack coaxial connector EMI shielding apparatus
US5217707A (en) 1988-06-16 1993-06-08 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. Pharmaceutical composition and process for the preparation thereof
US4879083A (en) 1988-06-17 1989-11-07 Macmillan Bloedel Limited Chemically treated wood particle board
US4902281A (en) * 1988-08-16 1990-02-20 Corus Medical Corporation Fibrinogen dispensing kit
US4950420A (en) 1988-08-31 1990-08-21 Nalco Chemical Company Antifoam/defoamer composition
US4855294A (en) 1988-09-06 1989-08-08 Theratech, Inc. Method for reducing skin irritation associated with drug/penetration enhancer compositions
GB8821129D0 (en) * 1988-09-09 1988-10-12 Unilever Plc Cosmetic composition
JPH02191223A (en) 1988-10-04 1990-07-27 Otsuka Pharmaceut Co Ltd Iron-supplying preparation
US5135915A (en) 1988-10-14 1992-08-04 Genentech, Inc. Method for the treatment of grafts prior to transplantation using TGF-.beta.
US5186857A (en) 1988-11-14 1993-02-16 Imaginative Research Associates, Inc. Self-foaming oil compositions and process for making and using same
GB8828013D0 (en) * 1988-12-01 1989-01-05 Unilever Plc Topical composition
US4970067A (en) 1988-12-12 1990-11-13 Helene Curtis, Inc. Method and composition to condition hair and impart semi-permanent hair set retention properties
US5262407A (en) 1988-12-16 1993-11-16 L'oreal Use of salicylic derivatives for the treatment of skin aging
FR2640942A1 (en) 1988-12-23 1990-06-29 Suchard Sa Jacobs Container of the aerosol type for delivering, in the form of a foam, metered quantities of product, particularly of food product
DE68913693T3 (en) 1988-12-27 2004-01-22 Osaka Shipbuilding Co., Ltd. Aerosol composition.
JP2960445B2 (en) 1988-12-28 1999-10-06 株式会社大阪造船所 Aerosol composition
FR2641185B1 (en) 1988-12-29 1991-04-05 Oreal SHAVING COMPOSITION FOR THE SKIN BASED ON ACYLOXYALKYL FUNCTIONAL POLYORGANOSILOXANES AND METHOD FOR IMPLEMENTING SAME
JP2741230B2 (en) 1989-01-11 1998-04-15 株式会社コーセー Foam anhydrous cosmetics
LU87449A1 (en) 1989-02-09 1990-09-19 Oreal PROCESS FOR THE MANUFACTURE OF FOAMS FOR USE IN THE COSMETIC AND PHARMACEUTICAL AREAS AND FOAMS OBTAINED BY THIS PROCESS
US4919934A (en) 1989-03-02 1990-04-24 Richardson-Vicks Inc. Cosmetic sticks
US4996193A (en) 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
US5019375A (en) 1989-03-14 1991-05-28 The Procter & Gamble Company Low residue antiperspirant creams
DK0414920T3 (en) 1989-03-17 1997-12-15 Taisho Pharmaceutical Co Ltd Aerosol preparations for external use
US5221696A (en) 1989-03-29 1993-06-22 Alcon Laboratories, Inc. Use of monoacyl phosphoglycerides to enhance the corneal penetration of ophthalmic drugs
DE69020211T2 (en) 1989-04-05 1995-11-02 Kao Corp Cosmetic double emulsion composition.
US5071648A (en) 1989-04-06 1991-12-10 Merocel Corporation Polymeric broad-spectrum antimicrobial materials
US5204093A (en) 1989-04-06 1993-04-20 Victor Steven A Shaving cream composition for the treatment of acne vulgaris and pseudofolliculitis barbae and method of producing and using same
US5618798A (en) 1989-04-20 1997-04-08 Bar-Shalom; Daniel Use of sucralfate to treat baldness
GB8909559D0 (en) * 1989-04-26 1989-06-14 Smith Kline French Lab Pharmaceutical compositions
US4874794A (en) 1989-04-28 1989-10-17 Lidak Biopharmaceuticals Inflammatory disease treatment
US5322683A (en) 1989-05-01 1994-06-21 Leonard Mackles Anhydrous aerosol foam
US5002540A (en) 1989-05-22 1991-03-26 Warren Kirschbaum Intravaginal device and method for delivering a medicament
GB8911853D0 (en) 1989-05-23 1989-07-12 Ici Plc Co2 blown integral skin foams
CA1337279C (en) 1989-06-06 1995-10-10 Robert J. Borgman Intravaginal treatment of vaginal infections with buffered metronidazole compositions
US5208031A (en) 1989-06-06 1993-05-04 Kelly Patrick D Sexual lubricants containing zinc as an anti-viral agent
US5122519A (en) 1989-06-27 1992-06-16 American Cyanamid Company Stable, cosmetically acceptable topical gel formulation and method of treatment for acne
MX21452A (en) 1989-07-07 1994-01-31 Ciba Geigy Ag PHARMACEUTICAL PREPARATIONS THAT ARE TOPICALLY ADMINISTERED.
US5560859A (en) 1989-07-26 1996-10-01 Pfizer Inc. Post foaming gel shaving composition
US4981367A (en) * 1989-07-28 1991-01-01 Stranco, Inc. Portable mixing apparatus
ATE124860T1 (en) 1989-07-28 1995-07-15 Hisamitsu Pharmaceutical Co FOAM AEROSOL COMPOSITION.
JPH0383914A (en) 1989-08-18 1991-04-09 W R Grace & Co Drug carrier
US5219877A (en) 1989-09-25 1993-06-15 Bristol-Myers Squibb Company Lauryl alcohol as skin penetration enhancer for topical imidazole agents
IL95952A0 (en) † 1989-10-19 1991-07-18 Sterling Drug Inc Aerosol composition for topical medicament
US5439670A (en) 1989-11-28 1995-08-08 Riker Laboratories, Inc. Medicinal aerosol formulations
US5508033A (en) 1989-12-06 1996-04-16 Societe D'engrais Composes Mineraux Et Amendments Utilization of algae extract for the preparation of pharmaceutical, cosmetic, food or agricultural compositions
US5295984A (en) 1989-12-07 1994-03-22 Ultrafem, Inc. Vaginal discharge collection device and intravaginal drug delivery system
DE69034134T2 (en) 1989-12-07 2004-09-09 Instead, Inc., Missoula METHOD FOR COLLECTING VAGINAL EMISSIONS
US5422361A (en) 1989-12-20 1995-06-06 Schering Corporation Stable cream and lotion bases for lipophilic drug compositions
US4966779A (en) 1989-12-21 1990-10-30 Basf Corporation Stable, water miscible emulsion comprising a fat-soluble vitamin
US5733572A (en) 1989-12-22 1998-03-31 Imarx Pharmaceutical Corp. Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
US4963351A (en) 1989-12-26 1990-10-16 Bhn Associates Shaving aid
US5100917A (en) 1989-12-29 1992-03-31 Merrell Dow Pharmaceuticals Inc. Novel a-nor-steroid-3-carboxylic acid derivatives
US5104645A (en) 1990-02-02 1992-04-14 The Proctor & Gamble Company Antidandruff shampoo compositions
SE9000485D0 (en) * 1990-02-09 1990-02-09 Pharmacia Ab FOAMABLE COMPOSITION FOR PHARMACEUTICAL USE, USE THEREOF AND METHOD OF TREATMENT
US5164367A (en) 1990-03-26 1992-11-17 Procyte Corporation Method of using copper(ii) containing compounds to accelerate wound healing
US5130121A (en) 1990-04-17 1992-07-14 Isp Investments Inc. Skin care compositions containing discrete microdroplets of an oil in water stabilized by in situ polymerization of water-soluble vinyl monomer
US5007556A (en) 1990-04-18 1991-04-16 Block Drug Company, Inc. Metering dispenser
US5156765A (en) 1990-05-15 1992-10-20 Fox Valley Systems, Inc. Aerosol foam marking compositions
US5112359A (en) 1990-06-04 1992-05-12 Clairol, Inc. Hair colorants
JP3649341B2 (en) * 1990-06-15 2005-05-18 株式会社資生堂 COMPOSITE AND COMPOSITE COMPOSITION, EMULSION COMPOSITION, AND EMULSION COMPOSITION
JPH0451958A (en) 1990-06-18 1992-02-20 Mitsubishi Materials Corp Treating agent for circulation type toilet filth
US5034220A (en) * 1990-06-20 1991-07-23 Gaf Chemicals Corporation Non-aerosol shaving gel
US5336692A (en) 1990-06-28 1994-08-09 Medicis Pharmaceutical Corporation Ointment base and method of use
IT1243379B (en) 1990-07-27 1994-06-10 Giuliani Spa PHARMACEUTICAL COMPOSITION SUITABLE FOR RECTAL ADMINISTRATION OF ACTIVE PRINCIPLES WHICH EXPLICATE A MEDICATION ACTION AT THE LEVEL OF THE COLON, PREVALENTLY TOPICAL
US5108556A (en) 1990-09-14 1992-04-28 Minnesota Mining And Manufacturing Company Process for preparing tertiary perfluoroamines
US5091111A (en) * 1990-09-19 1992-02-25 S. C. Johnson & Son, Inc. Aqueous emulsion and aersol delivery system using same
US5114718A (en) 1990-09-20 1992-05-19 The Procter & Gamble Company Sustained release compositions for treating periodontol disease
GB9021546D0 (en) 1990-10-04 1990-11-21 Beecham Group Plc Novel composition
FR2668927B1 (en) 1990-11-09 1993-01-08 Oreal COSMETIC ANHYDROUS COMPOSITION IN AEROSOL FORM FOR THE FORMATION OF A FOAM.
DE9016291U1 (en) 1990-11-30 1991-03-28 Kali-Chemie Pharma Gmbh, 3000 Hannover, De
US5073371A (en) 1990-11-30 1991-12-17 Richardson-Vicks, Inc. Leave-on facial emulsion compositions
WO1992011839A1 (en) 1991-01-08 1992-07-23 Leonard Mackles Anhydrous aerosol
AU1411992A (en) 1991-01-15 1992-08-27 Robert A Bok A composition containing a tetracycline and use for inhibiting angiogenesis
US5227163A (en) 1991-01-18 1993-07-13 Clilco, Ltd. Lice-repellant compositions
DE4102506C2 (en) 1991-01-29 1999-11-25 Pfeiffer Erich Gmbh & Co Kg Discharge device for media
AU1184392A (en) 1991-02-05 1992-09-07 Jurgen Buil Fire extinguishing and protection agent
US5948682A (en) 1991-02-22 1999-09-07 Sembiosys Genetics Inc. Preparation of heterologous proteins on oil bodies
US5650554A (en) 1991-02-22 1997-07-22 Sembiosys Genetics Inc. Oil-body proteins as carriers of high-value peptides in plants
US6753167B2 (en) 1991-02-22 2004-06-22 Sembiosys Genetics Inc. Preparation of heterologous proteins on oil bodies
US5658956A (en) 1991-03-01 1997-08-19 Warner-Lambert Company Bioadhesive-wound healing compositions and methods for preparing and using same
US5648380A (en) 1991-03-01 1997-07-15 Warner-Lambert Company Anti-inflammatory wound healing compositions and methods for preparing and using same
US5663208A (en) 1991-03-01 1997-09-02 Warner-Lambert Company Antifungal wound healing compositions and methods for preparing and using same
IT1247138B (en) 1991-03-06 1994-12-12 Dompe Farmaceutici Spa HYDROPHILE PHARMACEUTICAL COMPOSITION CONTAINING KETOPROFENE LYSINE SALT FOR TOPICAL USE.
JPH04282311A (en) * 1991-03-08 1992-10-07 Koike Kagaku Kk Aerosol-type foamable wound-disinfectant
US5279819A (en) * 1991-03-18 1994-01-18 The Gillette Company Shaving compositions
JPH06509559A (en) * 1991-03-19 1994-10-27 セラピューティック　パッチ　リサーチ　エヌ．ブイ． Amino alcohol derivative compositions and methods as membrane permeation enhancers
US5389676A (en) * 1991-03-22 1995-02-14 E. B. Michaels Research Associates, Inc. Viscous surfactant emulsion compositions
AU658608B2 (en) 1991-03-25 1995-04-27 Astellas Pharma Europe B.V. Topical preparation containing a suspension of solid lipid particles
US5167950A (en) 1991-03-28 1992-12-01 S. C. Johnson & Son High alcohol content aerosol antimicrobial mousse
DE4110973A1 (en) 1991-04-05 1992-10-08 Haarmann & Reimer Gmbh MEDIUM WITH A PHYSIOLOGICAL COOLING EFFECT AND EFFECTIVE COMPOUNDS SUITABLE FOR THIS MEDIUM
JP3100416B2 (en) 1991-04-11 2000-10-16 オカモト株式会社 Moose-like lubricant
HU209605B (en) * 1991-04-15 1994-09-28 Chinoin Gyogyszer Es Vegyeszet Process for production of wather-free transdermal preparation
IT1247529B (en) 1991-04-24 1994-12-17 Poli Ind Chimica Spa PHARMACEUTICAL COMPOSITIONS IN FOAM FORM FOR INTRAVAGINAL, SKIN AND ORAL ADMINISTRATION
US5204090A (en) 1991-05-30 1993-04-20 Bristol Myers Squibb Waterproof high-SPF sunscreen compositions
US5164357A (en) 1991-06-05 1992-11-17 Appleton Papers Inc. Thermally-responsive record material
FR2677544B1 (en) 1991-06-14 1993-09-24 Oreal COSMETIC COMPOSITION CONTAINING A MIXTURE OF NANOPIGMENTS OF METAL OXIDES AND MELANIC PIGMENTS.
DE4210165A1 (en) 1991-07-30 1993-02-04 Schering Ag TRANSDERMAL THERAPEUTIC SYSTEMS
GB9118028D0 (en) 1991-08-21 1991-10-09 Secr Defence Brit Improved transdrmal formulations
DE4127630A1 (en) 1991-08-21 1993-02-25 Bruno Jesswein TWO-COMPONENT PRESSURE CAN, IN PARTICULAR FOR 2K FOAM
JP2969398B2 (en) 1991-09-12 1999-11-02 花王株式会社 Anhydrous foam cleaning agent
US5643600A (en) 1991-09-17 1997-07-01 Micro-Pak, Inc. Lipid vesicles containing avocado oil unsaponifiables
DE69228373T2 (en) 1991-09-27 1999-06-17 Nof Corp COSMETIC AND EMULSION
GB2260079B (en) 1991-10-01 1995-08-09 American Cyanamid Co Pharmaceutical composition containing felbinac
US5230897A (en) 1991-10-31 1993-07-27 G. D. Searle & Co. Transdermal pentamidine
US5236707A (en) 1991-11-08 1993-08-17 Dallas Biotherapeutics, Inc. Stabilization of human interferon
CA2122272A1 (en) 1991-11-22 1993-05-27 Susan C. Wivell Combined personal cleansing and moisturizing compositions
DE4140474C2 (en) 1991-12-09 1995-07-13 Schuelke & Mayr Gmbh Skincare additive
US5294365A (en) 1991-12-12 1994-03-15 Basf Corporation Hydroxypolyethers as low-foam surfactants
IT1253711B (en) 1991-12-17 1995-08-23 Alfa Wassermann Spa VAGINAL PHARMACEUTICAL FORMULATIONS CONTAINING RIFAXIMIN AND THEIR USE IN THE TREATMENT OF VAGINAL INFECTIONS
US5252246A (en) 1992-01-10 1993-10-12 Allergan, Inc. Nonirritating nonionic surfactant compositions
EP0552612A3 (en) 1992-01-22 1993-10-20 Hoffmann La Roche Methods for determining and isolating compounds which bind directly to nucleosolic proteins
JP3146052B2 (en) 1992-01-31 2001-03-12 プレスコ株式会社 Aerosol massage agent
US5318774A (en) 1992-02-28 1994-06-07 Richardson-Vicks Inc. Composition and method for imparting an artificial tan to human skin
RU2148647C1 (en) 1992-04-02 2000-05-10 Сембайозис Дженетикс Инк. Method of expression of interesting dna sequence in seed cell, dna-structure, expression cassette, isolated regulatory site of transcription and method of alternation of specific metabolism in seeds
US5344051A (en) 1992-04-27 1994-09-06 Insta-Foam Products, Inc. Two-component foam dispensing apparatus
ZA932947B (en) * 1992-04-28 1993-10-27 Schering Plough Healthcare Applicator for semisolid medications
US5409706A (en) 1992-05-04 1995-04-25 Imaginative Research Associates, Inc. Anhydrous foaming composition containing low concentrations of detergents and high levels of glycerin and emollients such as oils and esters
US5254334A (en) 1992-05-04 1993-10-19 Imaginative Research Associates, Inc. Anhydrous foaming composition containing low concentrations of detergents and high levels of glycerin amd emollients such as oils and esters
IL105595A0 (en) 1992-05-15 1993-09-22 Akzo Nv Applicator for introducing a cream-type substance into a woman's vagina
DE69314025T2 (en) 1992-05-18 1998-04-16 Procter & Gamble COMPOSITIONS WITH COOLING EFFECT
CA2095739A1 (en) † 1992-05-27 1993-11-28 Michael J. Mcnutt Charge skimming and variable integration time in focal plane arrays
US5389305A (en) 1992-06-03 1995-02-14 Colgate Palmolive Co. High foaming nonionic surfactant base liquid detergent
JPH08501529A (en) 1992-06-11 1996-02-20 セラテック・インコーポレイテッド Use of glycerin to alleviate skin-penetrating drug administration
US5346135A (en) 1992-06-16 1994-09-13 Vincent Edward C Spraying apparatus for blending liquids in a gaseous spray system
US5300286A (en) 1992-07-14 1994-04-05 Dow Corning Corporation Silicone emulsion for personal care application
AU4673993A (en) 1992-07-28 1994-02-14 Procter & Gamble Company, The Pharmaceutical composition for topical use containing a crosslinked cationic polymer and an alkoxylated ether
NO933239D0 (en) * 1992-09-10 1993-09-10 Mcneil Ppc Inc Bioerodible device for administering active ingredients
JPH08501553A (en) 1992-09-14 1996-02-20 スミス・ウォルター・ピー Skin conditioning composition, its application and manufacture
JPH06100414A (en) 1992-09-18 1994-04-12 Osaka Aerosol Ind Corp Composition for aerosol
US6096756A (en) 1992-09-21 2000-08-01 Albert Einstein College Of Medicine Of Yeshiva University Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists
US5413775A (en) 1992-09-29 1995-05-09 Amerchol Corporation Hairsprays and acrylic polymer compositions for use therein
IT1255895B (en) * 1992-10-20 1995-11-17 Laura Chiodini PHARMACEUTICAL COMPOSITIONS CONTAINING A CALCITONIN
AU5541594A (en) 1992-10-21 1994-05-09 Gynetech Laboratories, Inc. Vaginal sponge delivery system
ES2114993T3 (en) 1992-10-31 1998-06-16 Goldschmidt Ag Th COSMETIC OR PHARMACEUTICAL PREPARATIONS.
DE4238860A1 (en) 1992-11-19 1994-05-26 Medicon Gmbh Skin protection products for the protection of human skin
US5308643A (en) 1992-11-30 1994-05-03 Osipow Lloyd I Self-lather generating shaving compositions
JP3328344B2 (en) 1992-12-22 2002-09-24 タイホー工業株式会社 Method of controlling foaming state retention time of foaming type cleaning polishes
JPH06263630A (en) 1993-03-10 1994-09-20 Lion Corp Vitamin as-solubilizing eye drop
DE4309900C1 (en) * 1993-03-26 1994-06-30 Goldschmidt Ag Th Process for the preparation of amphoteric surfactants
JPH06279228A (en) 1993-03-30 1994-10-04 Kao Corp Foaming composition
US5326557A (en) * 1993-04-06 1994-07-05 Dow Corning Corporation Moisturizing compositions containing organosilicon compounds
US5807571A (en) 1993-05-06 1998-09-15 Lts Lohmann Therapie-Systeme Gmbh Transdermal therapeutic systems for administering indole serotonin agonists
US5576016A (en) 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
PT698393E (en) 1993-05-19 2002-10-31 Hisamitsu Pharmaceutical Co SOLUBILIZATION AGENT AND PREPARATION FOR EXTERNAL USE CONTAINING THE SAME
CA2161431A1 (en) 1993-05-21 1994-12-08 Barry A. Salka Mild shampoo composition
JP3161869B2 (en) 1993-05-24 2001-04-25 株式会社ダイゾー Water-in-oil aerosol composition and process for producing the same
US5635469A (en) 1993-06-10 1997-06-03 The Procter & Gamble Company Foaming cleansing products
US5447725A (en) 1993-06-11 1995-09-05 The Procter & Gamble Company Methods for aiding periodontal tissue regeneration
US5384308A (en) * 1993-06-14 1995-01-24 Henkin; R. I. Composition and method for enhancing wound healing
US5744155A (en) 1993-08-13 1998-04-28 Friedman; Doron Bioadhesive emulsion preparations for enhanced drug delivery
US5398846A (en) 1993-08-20 1995-03-21 S. C. Johnson & Son, Inc. Assembly for simultaneous dispensing of multiple fluids
US6596260B1 (en) 1993-08-27 2003-07-22 Novartis Corporation Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol
FR2709666B1 (en) 1993-09-07 1995-10-13 Oreal Cosmetic or dermatological composition consisting of an oil-in-water emulsion based on oily globules provided with a lamellar liquid crystal coating.
JP2978043B2 (en) 1993-09-16 1999-11-15 高砂香料工業株式会社 (2S) -3-{(1R, 2S, 5R)-[5-methyl-2- (1-methylethyl) cyclohexyl] oxy} -1,2-propanediol, its production method and use
US5766632A (en) 1993-10-01 1998-06-16 Legere Pharmaceuticals, Ltd. Method of using lectins for contraception
FR2710854B1 (en) * 1993-10-08 1995-12-01 Oreal Oil-in-water emulsion usable for obtaining a cream.
US5578315A (en) 1993-12-01 1996-11-26 Rutgers, The State University Of New Jersey Mucosal adhesive device for long-acting delivery of pharmaceutical combinations in oral cavity
FR2713486B1 (en) 1993-12-14 1996-02-09 Scophysa New compositions for foams, in particular rectal foams, and foams thus obtained.
DE69426727D1 (en) 1993-12-23 2001-03-29 Procter & Gamble ANTIMICROBIAL COMPOSITIONS FOR WIPES
US5527822A (en) 1993-12-29 1996-06-18 Forest Laboratories, Inc. Method of treatment of traumatic brain injury
DE9422052U1 (en) 1994-01-04 1997-10-30 Wuerth Adolf Gmbh & Co Kg Filling device for filling a refillable dispensing container and refillable dispensing container
JP3530564B2 (en) 1994-02-03 2004-05-24 株式会社ノエビア Aerosol foam cosmetics
DE4405127A1 (en) 1994-02-18 1995-08-31 Henkel Kgaa Hair treatment products
US5514367A (en) 1994-02-28 1996-05-07 Estee Lauder, Inc. Skin tanning compositions and methods for their preparation and use
US5925669A (en) 1994-03-22 1999-07-20 Molecular/Structural Bio Technologies, Inc. Carrier compositions for anti-neoplastic drugs
US5658749A (en) 1994-04-05 1997-08-19 Corning Clinical Laboratories, Inc. Method for processing mycobacteria
IL109230A (en) 1994-04-05 1998-08-16 Agis Ind 1983 Ltd Anti-fungal composition containing bifonazole and fluocinonide
US5429815A (en) 1994-04-11 1995-07-04 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Stable single-phase self-foaming cleanser
FR2719467B1 (en) 1994-05-05 1996-05-31 Oreal Use of flavonoids to preserve and / or strengthen the mechanical properties of the hair and method of protecting hair using these compounds.
ES2079320B1 (en) * 1994-05-17 1996-10-16 Cusi Lab OPHTHALMIC DISSOLUTION BASED ON A DICLOFENACO AND TOBRAMYCIN AND ITS APPLICATIONS.
US5902574A (en) 1994-05-23 1999-05-11 The Gillette Company Shaving preparation for improved shaving comfort
US5545401A (en) 1994-06-02 1996-08-13 Shanbrom; Edward Antiviral, spermicidal vaginal gel and foam containing low molecular weight povidone-iodine
FR2720635B1 (en) * 1994-06-03 1996-07-26 Oreal Sunscreen cosmetic compositions and uses.
US6221381B1 (en) 1994-06-28 2001-04-24 The University Of British Columbia Enhancing milk production by adding to feed a nonionic surfactant coated on a carrier
MA23592A1 (en) 1994-06-30 1995-12-31 Procter & Gamble COMPOSITIONS FOR BODY CARE CONTAINING THERMOPLASTIC ELASTOMERIC GRAFT COPOLYMERS
US5679324A (en) * 1994-07-08 1997-10-21 The Procter & Gamble Co. Aerosol foamable fragrance composition
FR2722431B1 (en) 1994-07-12 1996-09-13 Lir France Sa DOUBLE DISPENSER FOR FLUID PRODUCTS
US5869529A (en) * 1994-07-20 1999-02-09 Agis Industries (1983) Ltd. Topical preparation for the prevention and treatment of lesions and sores associated with a herpes virus
US5444092A (en) 1994-07-20 1995-08-22 Collins; Jerry Method and composition for treating psoriasis
JP3173330B2 (en) 1994-07-20 2001-06-04 トヨタ自動車株式会社 Slip control device for vehicle lock-up clutch
GB9414699D0 (en) 1994-07-21 1994-09-07 Slagel David Aqueous foamable composition
US5512555A (en) 1994-07-21 1996-04-30 Merck & Co., Inc. Method of treating sweat-related conditions using finasteride, epristeride and a cholestan-3-one
JP3241542B2 (en) 1994-07-29 2001-12-25 高砂香料工業株式会社 Method for purifying (-)-n-isopulegol and citrus-based fragrance composition containing (-)-n-isopulegol obtained by the method
DE4428096A1 (en) 1994-08-09 1996-02-15 Wella Ag Two-chamber container
US5656586A (en) 1994-08-19 1997-08-12 Rhone-Poulenc Inc. Amphoteric surfactants having multiple hydrophobic and hydrophilic groups
US5547989A (en) 1994-08-19 1996-08-20 Schering-Plough Healthcare Products, Inc. Compositions for treating corns and calluses
EP0777464A1 (en) 1994-08-26 1997-06-11 The Procter & Gamble Company Personal cleansing compositions
JP3558393B2 (en) 1994-08-29 2004-08-25 株式会社ダイゾー Foamable aerosol composition
US5976555A (en) 1994-09-07 1999-11-02 Johnson & Johnson Consumer Products, Inc. Topical oil-in-water emulsions containing retinoids
JP3604177B2 (en) 1994-09-14 2004-12-22 日東電工株式会社 Transdermal formulation
US5500211A (en) 1994-09-22 1996-03-19 The Gillette Company Soap-free self-foaming shave gel composition
US5905092A (en) 1994-09-27 1999-05-18 Virotex Corporation Reel/Frame Topical antibiotic composition providing optimal moisture environment for rapid wound healing that reduces skin contraction
US5955414A (en) 1994-10-05 1999-09-21 S. C. Johnson & Son, Inc. Cleaning foam having fluorinated stain repellent and low flammability
US5540853A (en) 1994-10-20 1996-07-30 The Procter & Gamble Company Personal treatment compositions and/or cosmetic compositions containing enduring perfume
AU3855695A (en) 1994-11-08 1996-05-31 Mochida Pharmaceutical Co., Ltd. External preparation for skin protection
US5567420A (en) 1994-11-16 1996-10-22 Mceleney; John Lotion which is temporarily colored upon application
US5788664A (en) 1994-11-30 1998-08-04 Scalise; Gaspare Suppository applicator
GB9424562D0 (en) * 1994-12-06 1995-01-25 Giltech Ltd Product
US5641480A (en) * 1994-12-08 1997-06-24 Lever Brothers Company, Division Of Conopco, Inc. Hair care compositions comprising heteroatom containing alkyl aldonamide compounds
JP3355257B2 (en) 1994-12-09 2002-12-09 太陽化学株式会社 Cosmetics
US5529770A (en) 1994-12-09 1996-06-25 West Agro, Inc. Viscous liquid conditioning topical germicides
DE4444238A1 (en) 1994-12-13 1996-06-20 Beiersdorf Ag Cosmetic or dermatological drug combinations of cinnamic acid derivatives and flavone glycosides
FR2728166A1 (en) 1994-12-19 1996-06-21 Oreal TOPICAL COMPOSITION CONTAINING AN ANTAGONIST OF SUBSTANCE P
US6455076B1 (en) 1994-12-21 2002-09-24 Gary S. Hahn Formulations and methods for reducing skin irritation
WO1996019921A1 (en) 1994-12-23 1996-07-04 Commonwealth Scientific And Industrial Research Organisation Iodine biocidal material
DE4446891A1 (en) 1994-12-27 1996-07-04 Falk Pharma Gmbh Stable aqueous budesonide solution
US5616136A (en) * 1995-01-09 1997-04-01 Med-Safe Systems, Inc. Quick release needle removal apparatus
US5534261A (en) 1995-01-17 1996-07-09 University Of Southern California Retinoid-based compositions and method for preventing adhesion formation using the same
FR2729855A1 (en) * 1995-01-26 1996-08-02 Oreal USE OF A CGRP ANTAGONIST IN A COSMETIC, PHARMACEUTICAL OR DERMATOLOGICAL COMPOSITION AND COMPOSITION OBTAINED
US5523078A (en) 1995-02-03 1996-06-04 Michael E. Baylin Method of preparing and composition for treatment of hair and scalp
US5587149A (en) 1995-02-06 1996-12-24 R.P. Scherer Corporation Topical application emulsions
FR2730930B1 (en) 1995-02-27 1997-04-04 Oreal USE OF NO-SYNTHASE INHIBITORS TO REDUCE THE IRRITANT SKIN EFFECT OF PRODUCTS USED IN THE COSMETIC OR PHARMACEUTICAL FIELD
FR2730932B1 (en) 1995-02-27 1997-04-04 Oreal TRANSPARENT NANOEMULSION BASED ON FLUID NON-IONIC AMPHIPHILIC LIPIDS AND USE IN COSMETICS OR DERMOPHARMACY
GB9504265D0 (en) 1995-03-03 1995-04-19 Medeva Plc Corticosteroid-containing pharmaceutical composition
US5558872A (en) 1995-03-07 1996-09-24 Healthpoint Medical Limited Partnership Gelled mineral oil skin protectant
US5618850A (en) 1995-03-09 1997-04-08 Focal, Inc. Hydroxy-acid cosmetics
US5783202A (en) 1995-03-14 1998-07-21 Soltec Research Pty. Ltd. Pediculicidal mousse composition for killing head lice
WO1996029996A1 (en) 1995-03-29 1996-10-03 Shionogi & Co., Ltd. Gelatin capsule with adjusted water activity
JPH08277209A (en) 1995-04-07 1996-10-22 Taisho Pharmaceut Co Ltd Revitalizing hair tonic
US5585104A (en) 1995-04-12 1996-12-17 The Procter & Gamble Company Cleansing emulsions
EP0738510A3 (en) 1995-04-20 2005-12-21 L'oreal Use of a HMG-CoA reductase inhibitor as an anti-ageing agent and as an anti-acne agent. Composition comprising at least one HMG-CoA reductase inhibitor and at least one active substance with scaling properties.
FR2733417B1 (en) 1995-04-25 1997-06-06 Oreal FOAMING OIL-IN-WATER EMULSION BASED ON NON-IONIC SURFACTANTS, A FATTY PHASE AND A CATIONIC OR ANIONIC POLYMER CROSS-LINKED AND USE IN TOPICAL APPLICATION
GB9510856D0 (en) 1995-05-27 1995-07-19 Cussons Int Ltd Cleaning composition
UY24246A1 (en) 1995-06-06 1996-06-14 Neutrogena Corp TROPIC VEHICLES CONTAINING SOLUBILIZED AND STABILIZED AZELAIC ACID
CA2224798A1 (en) 1995-06-22 1997-01-09 Matthew T. Scholz Stable hydroalcoholic compositions
JP3542665B2 (en) 1995-07-07 2004-07-14 株式会社資生堂 Anti-aging skin external preparation, collagen cross-linking inhibition skin external preparation and anti-ultraviolet skin external preparation
FR2736824B1 (en) 1995-07-18 1997-10-10 Fabre Pierre Dermo Cosmetique MINOXIDIL HAIR COMPOSITION WITH LOW FAT SOLVENT CONTENT
US5705472A (en) * 1995-07-18 1998-01-06 Petroferm Inc. Neutral aqueous cleaning composition
DE29512760U1 (en) 1995-08-08 1995-11-16 Wella Ag Pressurized gas container for dispensing foam
TW504387B (en) 1995-09-06 2002-10-01 Kao Corp Emulsified, water-in-oil type composition and skin cosmetic preparation
US5881493A (en) 1995-09-14 1999-03-16 D. B. Smith & Co. Inc. Methods for applying foam
CN1062129C (en) 1995-09-14 2001-02-21 徐荣祥 Medicine matrix and its use
JPH0984855A (en) 1995-09-25 1997-03-31 Kyoto Yakuhin Kogyo Kk Aerosol preparation for administer medicine to rectum or vagina
JPH0999553A (en) 1995-10-09 1997-04-15 Fujitsu Ltd Ink jet head
JP3425019B2 (en) 1995-10-16 2003-07-07 カネボウ株式会社 Oily foam cleansing cosmetic
US6221823B1 (en) 1995-10-25 2001-04-24 Reckitt Benckiser Inc. Germicidal, acidic hard surface cleaning compositions
DK0870497T3 (en) 1995-12-14 2004-05-24 Taisho Pharmaceutical Co Ltd aerosol
FR2742986B1 (en) * 1995-12-29 1998-01-30 Rhone Poulenc Chimie COSMETIC COMPOSITIONS FOR THE HAIR OR THE SKIN BASED ON SULPHONATED COPOLYESTERS WITH POLYORGANOSILOXANE MOTIFS
US5716611A (en) * 1996-01-02 1998-02-10 Euro-Celtique, S.A. Emollient antimicrobial formulations containing povidone iodine
US5843411A (en) 1997-02-06 1998-12-01 Topix Pharmaceuticals Inc. Stabilization of ascorbic acid, ascorbic acid derivatives and/or extracts containing ascorbic acid for topical use
US5889028A (en) 1996-02-09 1999-03-30 Mayo Foundation For Medical Education And Research Colonic delivery of nicotine to treat inflammatory bowel disease
US5846983A (en) 1996-02-09 1998-12-08 Mayo Foundation For Medical Education And Research Colonic delivery of nicotine to treat inflammatory bowel disease
US5759524A (en) * 1996-02-09 1998-06-02 The Procter & Gamble Company Photoprotective compositions
AUPN814496A0 (en) 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
US5912007A (en) 1996-02-29 1999-06-15 Warner-Lambert Company Delivery system for the localized administration of medicaments to the upper respiratory tract and methods for preparing and using same
US6251369B1 (en) 1996-03-05 2001-06-26 Sultan Dental Products Dental fluoride foam
FR2745716B1 (en) 1996-03-07 1998-04-17 Oreal ULTRAFINE PRESSURIZABLE FOAMING OIL-IN-WATER EMULSIONS
US6251941B1 (en) 1996-04-19 2001-06-26 Sloan-Kettering Institute For Cancer Research Use of inhaled retinoids in the prevention of cancer
US5910382A (en) 1996-04-23 1999-06-08 Board Of Regents, University Of Texas Systems Cathode materials for secondary (rechargeable) lithium batteries
IT1283042B1 (en) 1996-05-21 1998-04-07 Condea Augusta Spa COSMETIC COMPOUNDS DEODORANT AND / OR ANTI-BREATHING
US5797955A (en) 1996-06-11 1998-08-25 Walters; David J. Pressure application unit for positioning vertebra
US5833961A (en) 1996-06-25 1998-11-10 Inolex Investment Corporation Polyester-based suncreen formulations
US6204285B1 (en) 1996-07-01 2001-03-20 Sepracor Inc. Methods and compositions for treating urinary incontinence using enantiomerically enriched (R,R)-glycopyrrolate
US5716621A (en) * 1996-07-03 1998-02-10 Pharmadyn, Inc. Nonocclusive drug delivery device and process for its manufacture
JP2002514163A (en) * 1996-07-10 2002-05-14 ステリス インコーポレイテッド Triclosan skin wash with improved efficacy
DE19631221C2 (en) 1996-08-02 1999-07-01 Beiersdorf Ag Foam-form sunscreen preparations containing water-soluble sunscreen filter substances and surface-active substances
AU725954B2 (en) 1996-08-15 2000-10-26 Board Of Trustees Of Southern Illinois University, The Enhancement of antimicrobial peptide activity by metal ions
US5833963A (en) 1996-08-20 1998-11-10 Bristol-Myers Squibb Company Non-tacky and quick-drying aqueous-based antiperspirant compositions
US5837270A (en) 1996-08-26 1998-11-17 Burgess; Nelson Leon Topical anti-acne composition
EP0829259A1 (en) 1996-09-04 1998-03-18 Warner-Lambert Company Foam/gel with microbeads and/or fine particles
US6271295B1 (en) 1996-09-05 2001-08-07 General Electric Company Emulsions of silicones with non-aqueous hydroxylic solvents
US5952392A (en) 1996-09-17 1999-09-14 Avanir Pharmaceuticals Long-chain alcohols, alkanes, fatty acids and amides in the treatment of burns and viral inhibition
US7060253B1 (en) 1996-09-20 2006-06-13 Mundschenk David D Topical formulations and delivery systems
FR2754451B1 (en) 1996-10-14 1998-11-06 Oreal SELF-FOAMING CREAM
WO1998017282A1 (en) 1996-10-23 1998-04-30 Vertex Pharmaceuticals Incorporated Methods of using sucrose octasulfate to treat or prevent enveloped virus infection
US6093408A (en) * 1996-10-25 2000-07-25 The Procter & Gamble Company Skin care compositions
IT1287114B1 (en) 1996-10-31 1998-08-04 Recordati Chem Pharm ANTI-HERPETIC PHARMACEUTICAL COMPOSITIONS FOR TOPICAL APPLICATORS, CONTAINING ACICLOVIR
EP0941044A1 (en) 1996-11-04 1999-09-15 The Procter & Gamble Company Hair mousse composition comprising silicone emulsion
BR9713348A (en) * 1996-11-12 2000-08-08 Dov Tamarkin Method for treating dermatological disorders
FR2755854B1 (en) 1996-11-15 1998-12-24 Oreal NANOEMULSION BASED ON NON-IONIC AND CATIONIC AMPHIPHILIC LIPIDS AND USES
EP0889719B1 (en) * 1996-11-16 2003-04-02 Wella Aktiengesellschaft Agents for dying and decolorizing fibers
US5906992A (en) 1996-11-21 1999-05-25 Colgate Palmolive Company Foam cleaning compositions
AUPO379596A0 (en) 1996-11-22 1996-12-19 Soltec Research Pty Ltd Percutaneous delivery system
US5951544A (en) 1996-12-04 1999-09-14 Laser Industries Ltd. Handpiece assembly for laser apparatus
US5759579A (en) 1996-12-05 1998-06-02 American Home Products Corporation Pharmaceutical suspension systems
US5695551A (en) 1996-12-09 1997-12-09 Dow Corning Corporation Water repellent composition
US5856452A (en) * 1996-12-16 1999-01-05 Sembiosys Genetics Inc. Oil bodies and associated proteins as affinity matrices
US5672634A (en) 1996-12-23 1997-09-30 Isp Investments Inc. Crosslinked PVP-I2 foam product
US5879469A (en) 1997-01-06 1999-03-09 Deeay Technologies Ltd. Dishwashing method and detergent composition therefor
US6582711B1 (en) 1997-01-09 2003-06-24 3M Innovative Properties Company Hydroalcoholic compositions thickened using polymers
SE520811C2 (en) † 1997-01-17 2003-08-26 Ponsus Ab Skin protection preparations containing lipophilic and hydrophilic components, method of preparation and use thereof
IN186803B (en) * 1997-02-05 2001-11-10 Panacea Biotec Ltd
ES2133090B1 (en) 1997-02-21 2000-04-01 Uriach & Cia Sa J NEW APPLICATOR FOR THE ADMINISTRATION OF SEMI-SOLID MEDICATIONS.
WO1998034604A1 (en) 1997-02-11 1998-08-13 Bernard Salafsky ANTI-PARASITIC ACTION OF N,N-DIETHYL-m-TOLUAMIDE (DEET) AND FORMULATIONS THAT PROLONG ITS ACTIVITY IN THE SKIN
IL131477A0 (en) 1997-02-24 2001-01-28 Michael A Kamm Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
JP3050289B2 (en) 1997-02-26 2000-06-12 日本電気株式会社 Output impedance adjustment circuit of output buffer circuit
FR2760637B1 (en) 1997-03-11 1999-05-28 Fabre Pierre Dermo Cosmetique COAL TAR EXTRACT WITH REDUCED AROMATIC HYDROCARBON CONTENT, PROCESS FOR OBTAINING AND DERMO-COSMETIC PREPARATIONS
US5922331A (en) * 1997-03-26 1999-07-13 Chanel, Inc. Skin cream composition
US5951989A (en) 1997-04-07 1999-09-14 Heymann; Warren R. Method for the treatment of dry skin
USH2043H1 (en) 1997-05-23 2002-08-06 The Procter & Gamble Company Skin care compositions
US6183762B1 (en) * 1997-05-27 2001-02-06 Sembiosys Genetics Inc. Oil body based personal care products
JP3869861B2 (en) 1997-05-27 2007-01-17 セムバイオシス ジェネティクス インコーポレイテッド Oil body usage
US6599513B2 (en) 1997-05-27 2003-07-29 Sembiosys Genetics Inc. Products for topical applications comprising oil bodies
US6372234B1 (en) 1997-05-27 2002-04-16 Sembiosys Genetics Inc. Products for topical applications comprising oil bodies
US6217887B1 (en) 1997-06-04 2001-04-17 The Procter & Gamble Company Leave-on antimicrobial compositions which provide improved immediate germ reduction
JP3113610B2 (en) 1997-06-04 2000-12-04 東洋ガスメーター株式会社 Mounting fixture for transmission equipment for gas meters
EP0884045A1 (en) 1997-06-06 1998-12-16 Pfizer Products Inc. Self-tanning dihydroxyacetone formulations having improved stability and providing enhanced delivery
US20050276836A1 (en) 1997-06-11 2005-12-15 Michelle Wilson Coated vaginal devices for vaginal delivery of therapeutically effective and/or health-promoting agents
EP0993827A4 (en) 1997-06-13 2006-07-05 Taisho Pharmaceutical Co Ltd Aerosols
JPH11111A (en) 1997-06-13 1999-01-06 Kagoshima Pref Gov Feed for fish breeding
FR2765799B1 (en) 1997-07-08 1999-08-27 Oreal GLOSSY COMPOSITION CONTAINING AROMATIC OILS THICKENED BY A POLYSACCHARIDE ALKYLETHER
EP1014916B2 (en) * 1997-08-18 2011-06-15 Neubourg Skin Care GmbH & Co. KG Foaming skin cream, uses thereof and a method for producing the same
JP3553767B2 (en) 1997-08-22 2004-08-11 三洋電機株式会社 Transfer assistance device
SE9703226D0 (en) 1997-09-08 1997-09-08 Astra Ab New pharmaceutical composition
US5885581A (en) 1997-09-11 1999-03-23 Merz, Incorporated Composition and method for improvement of the appearance of scars
US5939376A (en) 1997-09-25 1999-08-17 Colgate Palmolive Company Liquid cleaning compositions containing an organic ester foam control agent
US6241971B1 (en) 1997-09-25 2001-06-05 The Procter & Gamble Company Hair styling compositions comprising mineral salt, lipophilic material, and low levels of surfactant
US6214318B1 (en) 1997-10-02 2001-04-10 Oms Holdings Llc Aerosol ointment compositions for topical use
FR2769299B1 (en) 1997-10-03 1999-12-31 Oreal BI-PRODUCTS PACKAGING AND DISTRIBUTION SET
US6075056A (en) 1997-10-03 2000-06-13 Penederm, Inc. Antifungal/steroid topical compositions
AUPO983897A0 (en) 1997-10-17 1997-11-06 Soltec Research Pty Ltd Topical antifungal composition
US5961957A (en) 1997-10-20 1999-10-05 Mcanalley; Bill H. Foam compositions
US5911981A (en) 1997-10-24 1999-06-15 R.I.T.A. Corporation Surfactant blends for generating a stable wet foam
US5865347A (en) * 1997-10-27 1999-02-02 William T. Wilkinson Multi-chamber dispenser for flowable materials
CA2306837C (en) 1997-10-28 2007-05-08 Asivi, Llc. Treatment of female sexual dysfunction
US5877216A (en) 1997-10-28 1999-03-02 Vivus, Incorporated Treatment of female sexual dysfunction
JP3450680B2 (en) 1997-10-28 2003-09-29 高砂香料工業株式会社 Method for producing para-menthane-3,8-diol
CN1172674C (en) 1997-11-10 2004-10-27 赛勒吉药物股份有限公司 Penetration enhancing and irritation reducing systems
DE29720316U1 (en) 1997-11-17 1998-01-29 Andris Raimund Gmbh & Co Kg Two-chamber dispenser
US5849042A (en) 1997-11-19 1998-12-15 Bristol-Myers Squibb Hair dye compositions containing 2,3 dialkyl-4-aminophenol and a 2-alkyl-1-naphthol
US5871720A (en) * 1997-11-20 1999-02-16 Colgate-Palmolive Company Cosmetic compositions with DBS and functionalized silicones
EP1049486A4 (en) 1997-12-05 2006-01-04 Lilly Co Eli Glp-1 formulations
TWI225793B (en) 1997-12-25 2005-01-01 Ajinomoto Kk Cosmetic composition
DE19802206A1 (en) 1998-01-22 1999-07-29 Beiersdorf Ag Stable cosmetic or dermatological composition with low viscosity
FR2774595A1 (en) 1998-02-06 1999-08-13 Rech D Innovation Et De Dev Ce EMULSION FOR TRANSDERMAL STEROID ADMINISTRATION
DE19805918A1 (en) 1998-02-13 1999-08-19 Beiersdorf Ag Lipidreduced preparations
US6110966A (en) 1998-02-20 2000-08-29 Medi-Cell Laboratories, Inc. Triple action complex
DE19807774A1 (en) * 1998-02-24 1999-08-26 Beiersdorf Ag Use of flavone, flavanone or flavonoid compound for protection of ascorbic acid or ascorbyl compound against oxidation, especially in cosmetic and dermatological preparations,
JP3514105B2 (en) 1998-02-27 2004-03-31 ティアック株式会社 Recording medium recording / reproducing device
NZ500769A (en) 1998-03-04 2001-04-27 Teijin Ltd Activated dihydroxy- and hydroxyvitamin D3 emulsion-type lotions for treating psoriasis
US6121210A (en) 1998-03-12 2000-09-19 Dap Products Inc. Foamable silicone oil compositions and methods of use thereof
US5990100A (en) 1998-03-24 1999-11-23 Panda Pharmaceuticals, L.L.C. Composition and method for treatment of psoriasis
AUPP310798A0 (en) 1998-04-22 1998-05-14 Soltec Research Pty Ltd Vehicle system for a composition comprising a piperidinopyrimidine derivative
US5919830A (en) 1998-04-30 1999-07-06 Gopalkrishnan; Sridhar Stable non-aqueous blends for personal care compositions
US6649175B1 (en) 1998-05-04 2003-11-18 Schering-Plough Healthcare Products, Inc. Skin barrier composition
GB9810949D0 (en) 1998-05-22 1998-07-22 Hewlett Healthcare Limited Formulation
FR2779637B1 (en) 1998-06-15 2000-09-01 Oreal PHOTOPROTECTIVE COSMETIC COMPOSITIONS CONTAINING A METAL OXIDE NANOPIGMENT AND AN ACRYLIC TERPOLYMER AND USE OF SUCH COMPOSITIONS FOR PROTECTING KERATINIC MATERIALS FROM ULTRAVIOLET RADIATION
US6706290B1 (en) 1998-07-06 2004-03-16 Olvai E. Kajander Methods for eradication of nanobacteria
FR2780879B1 (en) * 1998-07-09 2002-09-20 Oreal PHOTOPROTECTOR COSMETIC COMPOSITION CONTAINING AN ANIONIC SURFACTANT, COMPOUND FILTERING ULTRAVIOLET RADIATION AND CATIONIC OR ZPHITTERIONIC AMPHIPHILIC COMPOUND AND USE THEREOF
US6146664A (en) 1998-07-10 2000-11-14 Shaklee Corporation Stable topical ascorbic acid compositions
US6124362A (en) 1998-07-17 2000-09-26 The Procter & Gamble Company Method for regulating hair growth
US6071541A (en) 1998-07-31 2000-06-06 Murad; Howard Pharmaceutical compositions and methods for managing skin conditions
DE19835239A1 (en) 1998-08-04 2000-02-24 Johnson & Johnson Gmbh Foaming oil preparation and its use
JP4017758B2 (en) 1998-08-04 2007-12-05 高砂香料工業株式会社 Cooling agent composition
GB9817817D0 (en) 1998-08-14 1998-10-14 Unilever Plc Cosmetic composition
NZ509618A (en) 1998-08-20 2003-09-26 3M Innovative Properties Co A patch-in-a-bottle that provides a fluid composition, which is applied to a surface and subsequently dries to form a covering, such as a patch
JP3712868B2 (en) 1998-09-02 2005-11-02 株式会社カネボウ化粧品 Aerosol composition
AUPP583198A0 (en) 1998-09-11 1998-10-01 Soltec Research Pty Ltd Mousse composition
US8263580B2 (en) 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
US6087310A (en) 1998-09-23 2000-07-11 Castrol Limited Skin cleaning compositions and uses comprising a polymer latex emulsion
CA2345641A1 (en) 1998-09-28 2000-04-06 Merck & Co., Inc. A method for treating inflammatory diseases by administering a thrombin inhibitor
US6914057B1 (en) 1998-09-28 2005-07-05 The Research Foundation Of State University Of New York Inhibitor of cataract formation
US6607716B1 (en) 1998-09-29 2003-08-19 Tech Labs, Inc. Pediculicidal compositions, a kit, and methods of use
RU2134052C1 (en) * 1998-10-07 1999-08-10 Нерушай Сергей Алексеевич Method and apparatus for aerosol application of perfumery liquids
US6287546B1 (en) 1998-10-09 2001-09-11 Colgate-Palmolive Company Shampoos with stabilizers
JP3876081B2 (en) 1998-10-22 2007-01-31 東洋エアゾール工業株式会社 Aerosol composition for foam formation
US6110477A (en) 1998-10-30 2000-08-29 Topix Pharmaceuticals Inc. Stabilization of ascorbic acid, ascorbic acid derivatives and/or extracts containing ascorbic acid for topical use
US7521068B2 (en) 1998-11-12 2009-04-21 Elan Pharma International Ltd. Dry powder aerosols of nanoparticulate drugs
US5980904A (en) 1998-11-18 1999-11-09 Amway Corporation Skin whitening composition containing bearberry extract and a reducing agent
US6344218B1 (en) * 1998-11-23 2002-02-05 The Procter & Gamble Company Skin deodorizing and santizing compositions
DE19855097A1 (en) 1998-11-28 2000-05-31 Wella Ag Pigment-containing, foamable gel
US20010006654A1 (en) 1998-12-09 2001-07-05 L'oreal Compositions and methods for treating hair and skin using aqueous delivery systems
US6486207B2 (en) 1998-12-10 2002-11-26 Nexmed (Holdings), Inc. Compositions and methods for amelioration of human female sexual dysfunction
US6087317A (en) 1998-12-10 2000-07-11 Dow Corning Corporation Particle size stable silicone emulsions
US6262128B1 (en) 1998-12-16 2001-07-17 3M Innovative Properties Company Aqueous foaming compositions, foam compositions, and preparation of foam compositions
FR2787325B1 (en) * 1998-12-17 2001-01-26 Oreal NANOEMULSION BASED ON OXYETHYLENE OR NON-OXYETHYLENE SORBITAN FATTY ESTERS, AND ITS USES IN THE COSMETIC, DERMATOLOGICAL AND / OR OPHTHALMOLOGICAL FIELDS
FR2787728B1 (en) 1998-12-23 2001-01-26 Oreal NANOEMULSION BASED ON FATTY ESTERS OF PHOSPHORIC ACID, AND ITS USES IN THE COSMETIC, DERMATOLOGICAL, PHARMACEUTICAL AND / OR OPHTHALMOLOGICAL FIELDS
JP2000191429A (en) 1998-12-28 2000-07-11 Kao Corp Foamable cosmetic
JP4557113B2 (en) 1998-12-28 2010-10-06 大正製薬株式会社 Topical preparation
FR2787703B1 (en) 1998-12-29 2001-01-26 Oreal NANOEMULSION BASED ON ETHOXYL FATHER ETHERS OR ETHOXYL FATTY ESTERS, AND ITS USES IN THE COSMETIC, DERMATOLOGICAL AND / OR OPHTHALMOLOGICAL FIELDS
FR2788007B1 (en) * 1999-01-05 2001-02-09 Oreal NANOEMULSION BASED ON BLOCK COPOLYMERS OF ETHYLENE OXIDE AND PROPYLENE OXIDE, AND ITS USES IN THE COSMETIC, DERMATOLOGICAL AND / OR OPHTHALMOLOGICAL FIELDS
US6486168B1 (en) 1999-01-08 2002-11-26 3M Innovative Properties Company Formulations and methods for treatment of mucosal associated conditions with an immune response modifier
US6270781B1 (en) 1999-01-08 2001-08-07 Maxim Pharmaceuticals, Inc. Method and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors
FR2789371B1 (en) 1999-02-05 2001-04-27 Sofab DISTRIBUTOR OF CHEMICALLY UNSTABLE PRODUCTS
EP1025836A1 (en) 1999-02-08 2000-08-09 F. Hoffmann-La Roche Ag Cosmetic light screening composition
TWI262930B (en) 1999-02-10 2006-10-01 Mitsui Chemicals Inc High-durability flexible polyurethane cold molded foam and process for producing the same
US6423329B1 (en) 1999-02-12 2002-07-23 The Procter & Gamble Company Skin sanitizing compositions
US6224888B1 (en) 1999-02-12 2001-05-01 The Procter & Gamble Company Cosmetic compositions
JP3641152B2 (en) 1999-02-17 2005-04-20 株式会社ヤクルト本社 Topical skin preparation
US7374779B2 (en) 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US6761903B2 (en) 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
ATE253405T1 (en) 1999-02-26 2003-11-15 Wella Ag DEVICE FOR MIXING, FROTHING AND DISPENSING LIQUIDS FROM SEPARATE COMPRESSED GAS CONTAINER
IL129102A0 (en) 1999-03-22 2000-02-17 J P M E D Ltd An emulsion
ES2272209T3 (en) 1999-03-31 2007-05-01 Firmenich Sa USE OF CUBEBOL AS AROMATIZING INGREDIENT.
US6383471B1 (en) 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
US6264964B1 (en) * 1999-04-14 2001-07-24 Conopco, Inc. Foaming cosmetic products
WO2000062776A1 (en) 1999-04-16 2000-10-26 Fujisawa Pharmaceutical Co., Ltd. Antifungal compositions
US6284802B1 (en) 1999-04-19 2001-09-04 The Procter & Gamble Company Methods for regulating the condition of mammalian keratinous tissue
US6433003B1 (en) 1999-04-23 2002-08-13 Arthur M. Bobrove Method for treating hyperhidrosis in mammals
MXPA01010676A (en) 1999-04-23 2003-08-20 Leo Pharm Prod Ltd Pharmaceutical composition.
GB9909711D0 (en) 1999-04-27 1999-06-23 Unilever Plc Mousse forming hair treatment composition
FR2793479B1 (en) 1999-05-10 2001-06-29 Lir France Sa DOUBLE DISPENSER FOR FLUID OR PASTY PRODUCTS
AU4841700A (en) 1999-05-12 2000-11-21 Nitromed, Inc. Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
US6168576B1 (en) * 1999-05-24 2001-01-02 Irene N. Reynolds Device for dispensing vaginal medication
US6395300B1 (en) 1999-05-27 2002-05-28 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
US6518228B1 (en) 1999-05-27 2003-02-11 Clairol Incorporated Ultra-mild, clear, aqueous, foamable skin cleanser
AU5067000A (en) 1999-05-28 2000-12-18 Unilever Plc Foamable shower oil composition
JP2000351726A (en) 1999-06-08 2000-12-19 Lion Corp Aerosol preparation
JP2000354623A (en) 1999-06-14 2000-12-26 Shiigeru Kk Deodorant and deodorizing spray
US6113888A (en) 1999-06-15 2000-09-05 Neutrogena Corporation Self-tanning mousse
GB9913951D0 (en) 1999-06-15 1999-08-18 Unilever Plc Mousse-forming shampoo compositions
KR100352088B1 (en) 1999-06-21 2002-09-12 한미약품공업 주식회사 Dermal emulsion composition comprising minoxidil
US6190365B1 (en) * 1999-06-21 2001-02-20 Chun Lim Abbott Vaginal douche applicator and method of vaginal deodorization using the same
US6524594B1 (en) 1999-06-23 2003-02-25 Johnson & Johnson Consumer Companies, Inc. Foaming oil gel compositions
NL1012419C2 (en) 1999-06-23 2000-12-28 Airspray Nv Aerosol for dispensing a liquid.
JP2001002526A (en) 1999-06-23 2001-01-09 Koike Kagaku Kk Foam aerosol composition
US6551604B1 (en) 1999-06-28 2003-04-22 The Procter & Gamble Company Skin care compositions
WO2001001949A1 (en) 1999-07-01 2001-01-11 Johnson And Johnson Consumer Companies, Inc. Cleansing compositions
US6762158B2 (en) * 1999-07-01 2004-07-13 Johnson & Johnson Consumer Companies, Inc. Personal care compositions comprising liquid ester mixtures
FR2795643B1 (en) 1999-07-02 2004-06-11 Oreal FIRMING COSMETIC COMPOSITION INCLUDING AT LEAST ONE HYDROXYSTILBENE IN ASSOCIATION WITH ASCORBIC ACID
JP4058199B2 (en) 1999-07-06 2008-03-05 ポーラ化成工業株式会社 Warm feeling pack
CA2313955A1 (en) 1999-07-15 2001-01-15 Playtex Products, Inc. Sunscreen aerosol composition
US6548074B1 (en) 1999-07-22 2003-04-15 Elizabeth Arden Co., Division Of Conopco, Inc. Silicone elastomer emulsions stabilized with pentylene glycol
FR2796925B1 (en) 1999-07-29 2001-10-05 Valois Sa DISPENSER WITH ARTICULATED DISPENSING HEAD
AU7389300A (en) 1999-08-02 2001-02-19 First Horizon Pharmaceutical Corporation Methods of administration of glycopyrrolate compositions
US6303552B1 (en) 1999-08-04 2001-10-16 Napier International Technologies, Inc. Aerosol paint stripper compositions
DE19938757A1 (en) * 1999-08-16 2001-02-22 Beiersdorf Ag Cosmetic or dermatological preparations of the oil-in-water type
WO2001013956A2 (en) 1999-08-26 2001-03-01 Ganeden Biotech, Inc. Use of emu oil a carrier for antifungal, antibacterial, and antiviral medications
US6777591B1 (en) 1999-08-27 2004-08-17 Sembiosys Genetics Inc. Legume-like storage protein promoter isolated from flax and methods of expressing proteins in plant seeds using the promoter
US6479058B1 (en) 1999-09-02 2002-11-12 Mccadden Michael E. Composition for the topical treatment of poison ivy and other forms of contact dermatitis
US6308863B1 (en) 1999-09-02 2001-10-30 Owens-Brockway Plastic Products Inc. Dual chamber package for pressurized products
JP4394775B2 (en) 1999-09-03 2010-01-06 株式会社ダイゾー Water-in-oil foam aerosol composition and method for producing the same
JP4045475B2 (en) 1999-09-06 2008-02-13 東洋紡績株式会社 Nucleic acid / protein purification equipment
US6986883B2 (en) 1999-09-09 2006-01-17 Discus Dental, Inc. Increased peroxide content tooth bleaching gel
AU3887301A (en) 1999-09-20 2001-04-24 Procter & Gamble Company, The Article for the delivery of foam products
US6437006B1 (en) 1999-09-27 2002-08-20 American Cyanamid Company Pharmaceutical carrier formulation
US6528086B2 (en) * 1999-09-28 2003-03-04 Zars, Inc. Methods and apparatus for drug delivery involving phase changing formulations
FR2798849B1 (en) 1999-09-29 2001-11-23 Oreal COMPOSITION FOR WASHING KERATIN MATERIALS, BASED ON A DETERGENT SURFACE-ACTIVE AGENT, A DIALKYL DIALLYL AMMONIUM HOMOPOLYMER AND AN ACRYLIC TERPOLYMER
US6790435B1 (en) 1999-10-01 2004-09-14 Unilever Home & Personal Care Usa Division Of Conopco, Inc. Antiperspirant compositions comprising microemulsions
US6667045B2 (en) 1999-10-01 2003-12-23 Joseph Scott Dahle Topical applications for skin treatment
FR2799369B1 (en) 1999-10-08 2001-12-21 Oreal COMBINATION OF ESCINE AND DEXTRAN SULFATE AND THE USE THEREOF
US6186367B1 (en) * 1999-10-19 2001-02-13 Valley Design Inc. Metered liquid squeeze dispenser
FR2799963B1 (en) 1999-10-22 2002-07-19 Oreal EMULSIONS CONTAINING AT LEAST ONE INSOLUBLE ORGANIC UV FILTER AND A NON-FILTERING ORGANOMODIFIED SILICONE
US6080394A (en) 1999-11-08 2000-06-27 Dow Corning Corporation Polar solvent-in-oil emulsions and multiple emulsions
US20030077301A1 (en) 1999-12-16 2003-04-24 Maibach Howard I. Topical pharmaceutical composition for the treatment of inflammatory dermatoses
UA66796C2 (en) 1999-12-27 2004-06-15 Univ Nat Pharmaceutical Composition "profesol foamy" for treating radiation lesions of skin
IL133969A0 (en) 2000-01-10 2001-04-30 Thixo Ltd Thixotropic compositions containing unsaturated oils and food products containing the same
US6967023B1 (en) 2000-01-10 2005-11-22 Foamix, Ltd. Pharmaceutical and cosmetic carrier or composition for topical application
US6528033B1 (en) 2000-01-18 2003-03-04 Valence Technology, Inc. Method of making lithium-containing materials
US7001690B2 (en) 2000-01-18 2006-02-21 Valence Technology, Inc. Lithium-based active materials and preparation thereof
FR2804015B1 (en) * 2000-01-21 2005-12-23 Oreal NANEMULSION CONTAINING AMPHIPHILIC LIPIDS AND NONIONIC POLYMER AND USES THEREOF
FR2804016B1 (en) 2000-01-21 2006-07-28 Oreal NANEMULSION CONTAINING AMPHIPHILIC LIPIDS AND PEG ESTER AND USES THEREOF
US20020006435A1 (en) 2000-01-27 2002-01-17 Samuels Paul J. Transdermal anesthetic and vasodilator composition and methods for topical administration
FR2804666B1 (en) 2000-02-04 2002-06-14 Oreal DISPENSER FOR STORING AT LEAST TWO COMPONENTS AND SELECTIVE DISPENSING EITHER OF A SINGLE CONSTITUENT, EITHER OF THEIR MIXTURE, AND METHOD FOR THE IMPLEMENTATION THEREOF
US6780443B1 (en) 2000-02-04 2004-08-24 Takasago International Corporation Sensate composition imparting initial sensation upon contact
NL1014389C2 (en) 2000-02-15 2001-08-16 Dija Zeist Bv Tanning preparation for the skin.
US20040161447A1 (en) 2000-02-17 2004-08-19 Leonard Paul Liquid foam producing compositions and dispensing system therefor
JP2003524259A (en) 2000-02-22 2003-08-12 メタカルタ インコーポレイテッド Spatial coding and display of information
DE60105362T2 (en) 2000-02-22 2005-02-17 Color Access, Inc. AQUEOUS COSMETIC GEL
DE10008837A1 (en) 2000-02-25 2001-08-30 Henkel Kgaa Dental cleaner containing propellant gas
DE10008896A1 (en) 2000-02-25 2001-08-30 Beiersdorf Ag Improving the solubility and compatibility of benzotriazole UV filters in oils, e.g. in cosmetics or dermatological compositions, by addition of dialkylnaphthalates
US6664287B2 (en) 2000-03-15 2003-12-16 Bethesda Pharmaceuticals, Inc. Antioxidants
IL135222A (en) 2000-03-22 2005-06-19 Univ Ben Gurion Compositions containing molecular iodine
DE20006099U1 (en) * 2000-04-01 2000-07-06 Megaplast Gmbh & Co Kg Dosing pump dispenser with at least two dosing pumps
US6649571B1 (en) 2000-04-04 2003-11-18 Masi Technologies, L.L.C. Method of generating gas bubbles in oleaginous liquids
FR2807322B1 (en) 2000-04-10 2004-02-20 Oreal COMPOSITION, ESPECIALLY COSMETIC, COMPRISING ASCORBIC ACID IN ASSOCIATION WITH AN ASCORBIC ACID DERIVATIVE
US7758888B2 (en) 2000-04-21 2010-07-20 Sol-Gel Technologies Ltd. Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
JP2002012513A (en) 2000-04-24 2002-01-15 Kanebo Ltd Urea-containing whipped cosmetic
EP1282830A1 (en) * 2000-05-03 2003-02-12 Magellan Corporation Low signal-to-noise ratio positioning system
US6358541B1 (en) 2000-05-03 2002-03-19 David S. Goodman Topical preparation for the treatment of hair loss
US6410036B1 (en) 2000-05-04 2002-06-25 E-L Management Corp. Eutectic mixtures in cosmetic compositions
AU2001257534A1 (en) 2000-05-05 2001-11-20 R.P. Scherer Technologies, Inc. Oil-in-water emulsion formulation containing hydroquinone and retinol
US6433024B1 (en) 2000-05-08 2002-08-13 Karl F. Popp Topical anti-acne composition
JP3911161B2 (en) 2000-05-08 2007-05-09 ファイザー・プロダクツ・インク Spray composition for skin protection
FR2808685B1 (en) 2000-05-12 2004-10-08 Sanofi Synthelabo PHARMACEUTICAL COMPOSITIONS FOR TRANSDERMAL DELIVERY OF ANTI-INFLAMMATORY AGENTS
JP2001326952A (en) 2000-05-15 2001-11-22 Nec Corp Broadcast confirmation system, method and device for broadcast confirmation, and recording medium with broadcast confirmation program recorded thereon
FR2809010B1 (en) 2000-05-22 2002-07-12 Oreal NANOEMULSION BASED ON ANIONIC POLYMERS, AND ITS USES IN PARTICULAR IN THE COSMETIC, DERMATOLOGICAL, PHARMACEUTICAL AND / OR OPHTHALMOLOGICAL FIELDS
JP4653282B2 (en) * 2000-05-23 2011-03-16 昭和薬品化工株式会社 Minocycline-containing composition
DE10028638A1 (en) 2000-06-09 2001-12-20 Schuelke & Mayr Gmbh Storage-stable composition useful in cosmetic and pharmaceutical compositions comprises combination of glycerol monoalkyl ether with antioxidant
WO2001095728A1 (en) 2000-06-13 2001-12-20 Fd Management, Inc. Cosmetic composition for stressed skin under extreme conditions
US6818204B2 (en) 2000-06-23 2004-11-16 Combe Incorporated Stable foam for use in disposable wipe
US20020164381A1 (en) * 2000-06-30 2002-11-07 Medicis Pharmaceutical Corporation Mitocidal compositions and methods
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
CA2313659A1 (en) 2000-07-06 2002-01-06 Barry J. Barclay B complex vitamin compositions that protect against cellular damage caused by ultraviolet light
DE10033414B4 (en) 2000-07-08 2004-02-19 Wella Aktiengesellschaft Clear, two-phase, foam-forming aerosol hair care product
FR2811564B1 (en) 2000-07-13 2002-12-27 Oreal NANOEMULSION CONTAINING NON-IONIC POLYMERS, AND ITS USES IN PARTICULAR IN THE COSMETIC, DERMATOLOGICAL, PHARMACEUTICAL AND / OR OPHTHALMOLOGICAL FIELDS
US6468989B1 (en) 2000-07-13 2002-10-22 Dow Pharmaceutical Sciences Gel compositions containing metronidazole
DE10035930A1 (en) * 2000-07-21 2002-01-31 Clariant Gmbh fine emulsions
US20020035070A1 (en) 2000-07-26 2002-03-21 The Procter & Gamble Company Method of regulating hair growth using metal complexes of oxidized carbohydrates
FR2812191B1 (en) 2000-07-28 2003-10-17 Oreal USE OF PROSTAGLANDIN E2 RECEPTOR AGONISTS (EP-3) TO ATTENUATE, DECREASE OR STOP HAIR AND HAIR GROWTH IN COSMETIC PREPARATIONS
JP4166931B2 (en) 2000-08-02 2008-10-15 ポーラ化成工業株式会社 Fever foam cosmetic
US20040198706A1 (en) 2003-03-11 2004-10-07 Carrara Dario Norberto R. Methods and formulations for transdermal or transmucosal application of active agents
US6514487B1 (en) 2000-08-08 2003-02-04 Teresa Leigh Barr Foam and gel oat protein complex and method of use
AU2001285201A1 (en) 2000-08-22 2002-03-04 The Procter And Gamble Company Personal care compositions containing adhesive elastomeric polymer and inorganic colloid
US6299023B1 (en) 2000-08-24 2001-10-09 Miles Arnone Device for dispensing two substances in a user selectable ratio with replaceable cartridges
AU2001286578A1 (en) 2000-08-24 2002-03-04 Tim Ioannides Topical antioxidant having vitamin c and method of combination with topical agent by user
FR2813189B1 (en) 2000-08-31 2003-02-28 Oreal COSMETIC FOAMING CREAM FOR THE TREATMENT OF OILY SKIN
WO2002022086A2 (en) 2000-09-14 2002-03-21 Quantum Energy Technologies Application of water nanoclusters to skin
ATE301988T1 (en) 2000-09-21 2005-09-15 Taisho Pharmaceutical Co Ltd SUPPOSITORIES RETAINED IN THE LOWER RECTUM
AUPR048600A0 (en) 2000-10-02 2000-10-26 Soltec Research Pty Ltd Pharmaceutical vehicle
DE10049147A1 (en) 2000-10-04 2002-04-25 Wella Ag Hair wax product with waxes, non-volatile oils and volatile, hydrophobic substances
FR2814959A1 (en) 2000-10-09 2002-04-12 Menarini France Atomiser for pharmaceutical products based on antiinflammatory agents comprises pressurized container, dosing pouch and metering valve
US6547063B1 (en) 2000-10-10 2003-04-15 The Procter & Gamble Company Article for the delivery of foam products
GB2367809A (en) 2000-10-12 2002-04-17 Bespak Plc Metering valve with collapsible chamber
US6403069B1 (en) 2000-10-20 2002-06-11 Colgate-Palmolive Company High oil clear emulsion with elastomer
FR2815616B1 (en) 2000-10-20 2003-01-24 Oreal DISTRIBUTION ASSEMBLY FOR THE EXTEMPORARY DISTRIBUTION OF TWO PRODUCTS
US20040018228A1 (en) * 2000-11-06 2004-01-29 Afmedica, Inc. Compositions and methods for reducing scar tissue formation
DE10058384B4 (en) * 2000-11-24 2004-12-16 Wella Aktiengesellschaft Cosmetic or dermatological agent in the form of a creamy permanent foam or a stably foamed cream, its use and method for producing the agent
US6299032B1 (en) 2000-11-27 2001-10-09 George W. Hamilton Disposable actuator with cap opener for aerosol cans
AU2002217896A1 (en) 2000-11-28 2002-06-11 Avon Products Inc. Foaming insect repellent compositions
US6969521B1 (en) 2000-11-28 2005-11-29 Avon Products, Inc. Aerosol insect repellent composition having low VOC content and method of applying same to the skin
US20050013853A1 (en) * 2000-11-29 2005-01-20 Irit Gil-Ad Anti-proliferative drugs
US6774100B2 (en) 2000-12-06 2004-08-10 Imaginative Research Associates, Inc. Anhydrous creams, lotions and gels
GB0030068D0 (en) 2000-12-11 2001-01-24 Lawrence Malcolm Highway vehicular traffic flow control
JP3497466B2 (en) 2000-12-12 2004-02-16 高砂香料工業株式会社 Warming composition
US20060254597A1 (en) 2000-12-14 2006-11-16 40J's Llc Method of treatment of atrophic vaginitis by topical clitoral menthol or a related cooling compound
DE10063342A1 (en) 2000-12-19 2002-06-20 Beiersdorf Ag Cosmetic or dermatological composition contains three-part emulsifier system and gas
US6749860B2 (en) 2000-12-22 2004-06-15 Kimberly-Clark Worldwide, Inc. Absorbent articles with non-aqueous compositions containing botanicals
US20040079361A1 (en) 2001-01-17 2004-04-29 Clayton Colin D. Medicinal aerosols
FR2819427B1 (en) 2001-01-18 2003-04-11 Oreal TRANSLUCENT NANOEMULSION, MANUFACTURING METHOD THEREOF AND USES THEREOF IN THE COSMETIC, DERMATOLOGICAL AND / OR OPHTHALMOLOGICAL FIELDS
US20030013692A1 (en) 2001-01-19 2003-01-16 Gullans Steven R. Methods of treating neurological disorders
MXPA03006998A (en) 2001-02-05 2004-10-15 Michael Albert Kamm A treatment of oesophageal motility disorders and gastro-oesophageal reflux disease.
DE10110336A1 (en) * 2001-03-03 2002-09-12 Clariant Gmbh Surfactant-free cosmetic, dermatological and pharmaceutical agents
WO2002069906A2 (en) 2001-03-06 2002-09-12 Cellegy Pharmaceuticals, Inc. Compounds and methods for the treatment of urogenital disorders
WO2002076414A2 (en) 2001-03-07 2002-10-03 The Procter & Gamble Company Cosmetic topical composition comprising a functional aromatic derivative bonding agent
WO2002076401A2 (en) 2001-03-26 2002-10-03 Dana-Farber Cancer Institute, Inc. Method of attenuating reactions to skin irritants
US6640805B2 (en) * 2001-03-26 2003-11-04 3M Innovative Properties Company Metering valve for a metered dose inhaler having improved flow
CN1536986B (en) 2001-03-27 2012-07-04 沃纳奇尔科特(爱尔兰)有限公司 Intravaginal drug delivery devices for administration of antimicrobial agent
MXPA03008869A (en) 2001-03-29 2004-05-24 Dial Corp Antibacterial compositions for skin care.
JP2002302419A (en) 2001-03-30 2002-10-18 Aldeep Cosmetics Japan Inc Cosmetic composition
AU2002256092C1 (en) 2001-04-05 2009-10-15 Collagenex Pharmaceuticals, Inc. Controlled delivery of tetracycline compounds and tetracycline derivatives
US6848597B2 (en) 2001-04-18 2005-02-01 James A. Vlodek Methods and apparatus for extruding foam through orifices
US20030053980A1 (en) 2001-04-30 2003-03-20 The Gillette Company Shaving compositions containing highly lubricious water soluble polymers
US6682726B2 (en) * 2001-04-30 2004-01-27 The Gillette Company Self-foaming shaving lotion
US20020187181A1 (en) 2001-05-14 2002-12-12 3M Innovative Properties Company System for delivering cosmetics and pharmaceuticals
ITMI20011019A1 (en) 2001-05-17 2002-11-17 Carlo Ghisalberti FURILIC SUBSTANCES FOR TOPICAL USE
AU2002314847A1 (en) 2001-05-31 2002-12-09 Upsher-Smith Laboratories, Inc. Dermatological compositions and methods comprising alpha-hydroxy acids or derivatives
CN1520282A (en) 2001-06-20 2004-08-11 宝洁公司 Personal care compsn. comprising polyol-in-silicone emulsion
US7270828B2 (en) 2001-06-20 2007-09-18 The Procter & Gamble Company Personal care composition comprising hydrophobic gel
FR2826292B1 (en) 2001-06-22 2004-01-23 Rhodia Chimie Sa OIL-IN-OIL EMULSIONS COMPRISING A SILICONE, DISPERSIONS OF SUCH EMULSIONS AND USE THEREOF
US6428772B1 (en) 2001-06-25 2002-08-06 Blistex Inc. Acne treatment composition with cooling effect
US6544562B2 (en) 2001-06-25 2003-04-08 Blistex Inc. Acne treatment including dual-package system
WO2003002082A1 (en) 2001-06-26 2003-01-09 The Procter & Gamble Company Pressurized anhydrous antiperspirant emulsions
CN1225386C (en) 2001-06-27 2005-11-02 钟纺化妆品株式会社 Mixer/extractor
JP2003012511A (en) 2001-06-27 2003-01-15 Rohto Pharmaceut Co Ltd Aerosol composition
US6777011B2 (en) * 2001-06-28 2004-08-17 Crosswind Industries, Inc. Multi-layer food product, system and process
US20060194773A1 (en) 2001-07-13 2006-08-31 Paratek Pharmaceuticals, Inc. Tetracyline compounds having target therapeutic activities
JP2004536839A (en) 2001-07-13 2004-12-09 ザ プロクター アンド ギャンブル カンパニー Mousse-forming compositions containing quaternary ammonium agents
DE10134786A1 (en) 2001-07-17 2003-02-06 Beiersdorf Ag Foamable preparations
EP1420783A4 (en) 2001-08-03 2009-09-30 Takeda Pharmaceutical Stable emulsion composition
DE10138495B4 (en) 2001-08-04 2004-11-11 Beiersdorf Ag Foaming preparations and their use
DK1424067T3 (en) 2001-08-08 2010-08-30 Dominguez Maria Antonia Garcia-Olmedo Injectable foam and novel pharmaceutical applications thereof
JP2005511493A (en) 2001-08-09 2005-04-28 クローダ，インコーポレイテッド Anti-irritant
JP4707279B2 (en) 2001-08-09 2011-06-22 ポーラ化成工業株式会社 Cosmetics for massage with cool-down effect
IL160275A0 (en) 2001-08-11 2004-07-25 Aventis Pharma Ltd Pressurised aerosol dispenser
US6638981B2 (en) 2001-08-17 2003-10-28 Epicept Corporation Topical compositions and methods for treating pain
US20030049218A1 (en) 2001-08-28 2003-03-13 Amit Patel Antiperspirant deodorant emulsion
ATE429947T1 (en) 2001-08-29 2009-05-15 Pharmakodex Ltd DEVICE FOR TOPICAL ADMINISTRATION
US6709663B2 (en) 2001-08-31 2004-03-23 Healthpoint, Ltd. Multivesicular emulsion drug delivery systems
US6479060B1 (en) 2001-09-04 2002-11-12 Healthpoint, Ltd. Elegant hydrogenated castor oil ointments
FR2829693B1 (en) 2001-09-20 2004-02-27 Oreal FOAMING COSMETIC CREAM
DE10147820A1 (en) 2001-09-27 2003-04-10 Beiersdorf Ag Self-foaming, foam-like, post-foaming or foamable cosmetic or dermatological preparations containing waxes or lipids which are solid and / or semi-solid at room temperature
US7931533B2 (en) 2001-09-28 2011-04-26 Igt Game development architecture that decouples the game logic from the graphics logics
US20030185839A1 (en) 2001-10-05 2003-10-02 Podolsky Daniel K. Methods and compositions for treating dermal lesions
US6649574B2 (en) 2001-10-10 2003-11-18 Exxonmobil Research And Engineering Company Biodegradable non-toxic gear oil
ATE420619T1 (en) 2001-10-26 2009-01-15 Taiyo Kagaku Kk OILY FOAMABLE AEROSOL COMPOSITION
US20030082120A1 (en) 2001-10-26 2003-05-01 Milstein Harold J. Method for reducing systemic effects of aging, effects of aging on the skin, and incidence of skin damage from sun exposure using antibiotics of the tetracycline family
US7255869B2 (en) 2001-10-30 2007-08-14 The Procter & Gamble Company Anhydrous cosmetic compositions containing polyols
DE10154324A1 (en) 2001-11-06 2003-08-07 Merz Pharma Gmbh & Co Kgaa Topically applicable compositions with external active substance depot formation, their production and their use
DE10155956A1 (en) 2001-11-09 2003-05-22 Beiersdorf Ag Self-foaming, foam-like, post-foaming or foamable cosmetic or dermatological preparations
JP2005513007A (en) 2001-11-13 2005-05-12 ザ プロクター アンド ギャンブル カンパニー Compositions containing enzymes stabilized by specific osmoprotectants and methods of using said compositions in personal care
DE10155792A1 (en) 2001-11-14 2003-05-22 Beiersdorf Ag Self-foaming, foam-like, post-foaming or foamable cosmetic or dermatological preparations containing siloxane elastomers
US6955816B2 (en) 2001-11-16 2005-10-18 Klysz Beatrice M Anti-aging skin care composition and uses thereof
DE10159002A1 (en) 2001-11-30 2003-06-18 Clariant Gmbh Use of multi-phase foaming agents from foam dispensers
FR2833246B1 (en) 2001-12-06 2005-06-24 Beatrice France Touteau DEVICE FOR SIMULTANEOUSLY ACTING TWO AEROSOLS CONTAINING TWO PRODUCTS TO BE MIXED AT THE TIME OF USE
US6531118B1 (en) 2001-12-11 2003-03-11 Avon Products, Inc. Topical compositions with a reversible photochromic ingredient
MXPA04006017A (en) 2001-12-20 2005-06-08 Femmepharma Inc Vaginal delivery of drugs.
SE0104421D0 (en) 2001-12-21 2001-12-21 Ponsus Pharma Ab New composition
US6765001B2 (en) 2001-12-21 2004-07-20 Medicis Pharmaceutical Corporation Compositions and methods for enhancing corticosteroid delivery
US20030118515A1 (en) 2001-12-21 2003-06-26 Robert Jew Cosmetic composition containing carbon dioxide
US20030129259A1 (en) 2001-12-28 2003-07-10 Avon Products, Inc. Topical lightening compostitions and methods of use
JP4549625B2 (en) 2002-01-05 2010-09-22 株式會社アモーレパシフィック Finely emulsified particles containing ginseng saponin metabolites as active ingredients, a method for producing the same, and a cosmetic composition for preventing skin aging containing the same
US7192601B2 (en) 2002-01-18 2007-03-20 Walker Edward B Antimicrobial and sporicidal composition
US6992049B2 (en) 2002-01-31 2006-01-31 Exxonmobil Research And Engineering Company Lubricating oil compositions
NZ517094A (en) 2002-02-08 2005-03-24 Advanced Animal Technology Ltd Improvements in and relating to substance delivery device
US20050255065A1 (en) 2002-02-14 2005-11-17 Quimversion, S.L. Aluminium and hexamethylenetetramine complex and the applications thereof
US6589216B1 (en) 2002-02-20 2003-07-08 Abbott Research Group, Inc. Vaginal douches, vaginal douche applicators and methods of vaginal douching
US6682511B2 (en) 2002-02-21 2004-01-27 Robert Wallace Besoyan Brief protector
US6691898B2 (en) 2002-02-27 2004-02-17 Fomo Products, Inc. Push button foam dispensing device
US7635463B2 (en) * 2002-02-27 2009-12-22 Pharmain Corporation Compositions for delivery of therapeutics and other materials
WO2003075851A2 (en) 2002-03-06 2003-09-18 Cellegy Pharmaceuticals, Inc. Compositions and methods for the treatment of anorectal disorders
US20050281766A1 (en) 2002-03-11 2005-12-22 Avon Products, Inc. Method of improving the aesthetic appearance of epithelia
US6736860B2 (en) 2002-03-12 2004-05-18 Unilever Home & Personal Care Usa Division Of Conopco, Inc. Gradual permanent coloring of hair using dye intermediates dissolved in alkaline water with fatty alcohol
CA2422244A1 (en) 2002-03-14 2003-09-14 Homax Products, Inc. Aerosol systems and methods for mixing and dispensing two-part materials
KR20050008659A (en) 2002-03-19 2005-01-21 에어스프레이 인터내쇼날 비.브이. Dispensing unit
US20030180347A1 (en) 2002-03-19 2003-09-25 W.F. Young, Incorporated Patch for the delivery of topical agents
JP4322124B2 (en) 2002-03-28 2009-08-26 伯東株式会社 Method for stabilizing bubbles in foam-containing cosmetics
AU2003230927A1 (en) 2002-04-12 2003-10-27 Dreamwell, Ltd. Cassette bedding system
US8192749B2 (en) 2003-04-16 2012-06-05 Galderma Laboratories Inc. Methods of simultaneously treating ocular rosacea and acne rosacea
US8846039B2 (en) 2002-04-26 2014-09-30 Asan Laboratories Company (Cayman), Limited Method for ameliorating pruritus
US6875438B2 (en) 2002-04-27 2005-04-05 Aventis Pharma Deutschland Gmbh Preparations for topical administration of substances having antiandrogenic activity
CA2384922C (en) 2002-05-03 2008-09-02 Purepharm Inc. Topical glycopyrrolate product for the reduction of sweating
JP2005526114A (en) 2002-05-06 2005-09-02 コッラジェネックス ファーマシューチカルス インコーポレイテッド Method for simultaneous treatment of mucositis and fungal infection
WO2003094873A1 (en) 2002-05-10 2003-11-20 Unilever Plc Hair conditioning compositions
US6783027B2 (en) 2002-05-15 2004-08-31 The Procter & Gamble Company Metered-dose underarm product and package
US20030215472A1 (en) 2002-05-16 2003-11-20 Bonda Craig A Methods and compositions employing a dialkyl amide
JP2005533766A (en) 2002-05-20 2005-11-10 コッラジェネックス ファーマシューチカルス インコーポレイテッド How to treat allergic reactions
JP4050094B2 (en) 2002-05-28 2008-02-20 株式会社三谷バルブ Metering valve mechanism and aerosol products
US6723309B1 (en) 2002-06-10 2004-04-20 Jeffrey Alan Deane Hair cleansing conditioner
US7763587B2 (en) 2002-06-13 2010-07-27 L'oreal S.A. Derivative of glucose and of vitamin F, compositions comprising it, uses and preparation process
FR2840903B1 (en) 2002-06-13 2005-01-28 Oreal GLUCOSE AND VITAMIN F DERIVATIVE, COMPOSITIONS COMPRISING THE SAME, AND USES FOR IMPROVING THE CONDITION OF HAIR AND HAIR
US7163669B2 (en) 2002-06-19 2007-01-16 J.M. Huber Corporation Cosmetic compositions comprising calcium silicates
US7455195B2 (en) 2002-06-26 2008-11-25 Daizo Co., Ltd. Container for discharging plural contents, a dispenser using the container, and a process for producing the dispenser
JP2004026605A (en) 2002-06-27 2004-01-29 Asahi Fiber Glass Co Ltd Greige goods for glass fiber yarn and glass fiber yarn made using this
US20040002550A1 (en) * 2002-06-28 2004-01-01 Mercurio Anthony Fred Post foaming compositions
US6785629B2 (en) 2002-07-02 2004-08-31 Agilent Technologies, Inc. Accuracy determination in bit line voltage measurements
JP3833972B2 (en) 2002-07-08 2006-10-18 古河電気工業株式会社 Wire harness assembly system
DE10233330B4 (en) 2002-07-22 2007-04-26 Sasol Germany Gmbh Microemulsion containing UV photoprotective filter and / or anti-dandruff agent
US7137536B2 (en) 2002-07-22 2006-11-21 Seaquist Perfect Dispensing Foreign, Inc. Inverted aerosol dispenser
US6897195B2 (en) 2002-07-24 2005-05-24 Nanjing Zhongshi Chemical Co. Composition of menthol and menthyl lactate, its preparation method and its applications as a cooling agent
US20020182162A1 (en) 2002-08-07 2002-12-05 Mohsen Shahinpoor Nitric oxide (NO) donor+cGMP-PDE5 inhibitor as a topical drug for enhanced hair growth
US20040025862A1 (en) * 2002-08-09 2004-02-12 W.C. Bradley Company Vented burner shield for use with a gas burner element
FR2843373B1 (en) 2002-08-12 2005-03-04 Jean Augustin DEVICE FOR PACKAGING AND APPLYING A PRODUCT IN FLUID FORM
US7939170B2 (en) 2002-08-15 2011-05-10 The Rockefeller University Water soluble metal and semiconductor nanoparticle complexes
EP1545516B1 (en) 2002-08-26 2008-09-03 S.L.A. Pharma AG Topical formulation comprising at least 10% of metronidazole in white petrolatum and its use in the anal and rectal region
US6770607B2 (en) 2002-09-12 2004-08-03 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Viscoelastic cleansing gel with micellar surfactant solutions
US7906473B2 (en) 2002-09-13 2011-03-15 Bissell Homecare, Inc. Manual spray cleaner
GB0221697D0 (en) 2002-09-18 2002-10-30 Unilever Plc Novel compouds and their uses
US6968982B1 (en) 2002-09-18 2005-11-29 Burns Caleb E S Multiple-mist dispenser
US7179481B2 (en) 2002-09-19 2007-02-20 Kimberly-Clark Worldwide, Inc. Vaginal health products
US6949037B2 (en) 2002-09-27 2005-09-27 Richard A. Enos Quick-release fastener for releasably attaching lacrosse stick head to shaft
FR2845672B1 (en) 2002-10-09 2006-02-10 Airlessystems FLUID PRODUCT DISPENSER
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
EP1567113A4 (en) 2002-10-24 2006-11-08 G & R Pharmaceuticals Llc Antifungal formulations
US20120156144A1 (en) 2002-10-25 2012-06-21 Foamix Foamable Compositions, Kits and Methods for Hyperhidrosis
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US20070292355A1 (en) 2002-10-25 2007-12-20 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
MXPA05004278A (en) 2002-10-25 2005-10-05 Foamix Ltd Cosmetic and pharmaceutical foam.
US8119150B2 (en) * 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US20080031907A1 (en) 2002-10-25 2008-02-07 Foamix Ltd. Cosmetic and pharmaceutical foam
US20080206161A1 (en) 2002-10-25 2008-08-28 Dov Tamarkin Quiescent foamable compositions, steroids, kits and uses thereof
US20060193789A1 (en) 2002-10-25 2006-08-31 Foamix Ltd. Film forming foamable composition
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US20160158261A1 (en) 2002-10-25 2016-06-09 Foamix Pharmaceuticals Ltd. Antibiotic Kit and Composition and Uses Thereof
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US20070292461A1 (en) 2003-08-04 2007-12-20 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US20050186142A1 (en) 2002-10-25 2005-08-25 Foamix Ltd. Kit and composition of imidazole with enhanced bioavailability
US20060233721A1 (en) 2002-10-25 2006-10-19 Foamix Ltd. Foam containing unique oil globules
US20050205086A1 (en) 2002-10-25 2005-09-22 Foamix Ltd. Retinoid immunomodulating kit and composition and uses thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US20060018937A1 (en) 2002-10-25 2006-01-26 Foamix Ltd. Steroid kit and foamable composition and uses thereof
US20070292359A1 (en) 2002-10-25 2007-12-20 Foamix Ltd. Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
US7645803B2 (en) 2005-05-09 2010-01-12 Foamix Ltd. Saccharide foamable compositions
US20050271596A1 (en) 2002-10-25 2005-12-08 Foamix Ltd. Vasoactive kit and composition and uses thereof
US20080317679A1 (en) 2002-10-25 2008-12-25 Foamix Ltd. Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses
CN1300095C (en) 2002-10-28 2007-02-14 吉万奥丹股份有限公司 Coolant solutions and compositions comprising the sameitle
JP2004250435A (en) 2002-11-21 2004-09-09 Dai Ichi Seiyaku Co Ltd Composition for hair growth
JP4282311B2 (en) 2002-11-26 2009-06-17 三洋電機株式会社 Ice making equipment
CN1723009A (en) 2002-12-12 2006-01-18 诺伊堡皮肤护理两合公司 Stable foam cream
GB0229071D0 (en) 2002-12-13 2003-01-15 Unilever Plc Cosmetic method and composition for enhancing attractiveness
US20040191196A1 (en) 2002-12-16 2004-09-30 Dov Tamarkin Novel conjugate compounds and dermatological compositions thereof
FR2848847B1 (en) 2002-12-18 2005-10-14 Coletica COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION COMPRISING AN AQUEOUS INSOLUBLE ENZYME AND USES THEREOF
US7842791B2 (en) 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
FR2848998B1 (en) 2002-12-20 2006-04-07 Oreal DISPENSING DEVICE HAVING MEANS FOR DISTRIBUTING TWO PRODUCTS IN VARIABLE PROPORTIONS
JP2006515026A (en) 2003-01-02 2006-05-18 フェムファーマ ホールディング カンパニー， インコーポレイテッド Pharmaceutical preparations for the treatment of breast diseases and disorders
WO2004064769A2 (en) 2003-01-21 2004-08-05 Hector Herrera Methods for making and using topical delivery agents
MXPA05007722A (en) 2003-01-24 2006-01-31 Connetics Australia Pty Ltd Clindamycin phosphate foam.
US20040151756A1 (en) 2003-02-04 2004-08-05 Richards Anthony P. Edible low density high surface area drug vehicle, method of manufacturing low density high surface area drug vehicle
EP1603560A1 (en) 2003-02-06 2005-12-14 Cipla Ltd. Topical immunotherapy and compositions for use therein
EP1594454B8 (en) 2003-02-12 2016-10-12 Stiefel Research Australia Pty Ltd Film forming hydroalcoholic foam
US6841547B2 (en) 2003-02-28 2005-01-11 Albert Einstein College Of Medicine Of Yeshevia University Method for decreasing low density lipoprotein
US20040175347A1 (en) 2003-03-04 2004-09-09 The Procter & Gamble Company Regulation of mammalian keratinous tissue using hexamidine compositions
GB0305010D0 (en) 2003-03-05 2003-04-09 Unilever Plc Changing colours
US6843390B1 (en) * 2003-03-17 2005-01-18 Joe G. Bristor Multiple fluid closed system dispensing device
US7357950B2 (en) 2003-03-21 2008-04-15 Elizabeth Anne Mazzio Topical treatment for dyshidrosis (pompholyx) and dry skin disorders
WO2004084973A2 (en) 2003-03-24 2004-10-07 Becton, Dickinson And Company Invisible antimicrobial glove and hand antiseptic
US20040192754A1 (en) 2003-03-24 2004-09-30 Shapira Nathan Andrew Methods for treating idiopathic hyperhidrosis and associated conditions
DE10315936A1 (en) 2003-04-03 2004-10-28 Ing. Erich Pfeiffer Gmbh Discharge device for at least one medium
GB0308585D0 (en) 2003-04-14 2003-05-21 Pz Cussons Int Ltd Cleaning composition
WO2004093814A2 (en) 2003-04-22 2004-11-04 Pharmacia Corporation Compositions of a cyclooxygenase-2 selective inhibitor and a sodium channel blocker
WO2004093895A1 (en) 2003-04-22 2004-11-04 Pharmacia Corporation Compositions of a cyclooxygenase-2 selective inhibitor and a potassium ion channel modulator for the treatment of pain, inflammation or inflammation mediated disorders
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
DE10319771B4 (en) 2003-05-02 2005-03-17 Koenig & Bauer Ag System for inspecting a printed image
JP2004353084A (en) 2003-05-08 2004-12-16 Sanyo Electric Co Ltd Evaporator fixation member
FR2854821B1 (en) 2003-05-16 2006-12-08 Oreal ASSEMBLY FOR PACKAGING AND DISPENSING A PRODUCT, IN PARTICULAR IN THE FORM OF A SAMPLE
JP4232535B2 (en) 2003-05-20 2009-03-04 セイコーエプソン株式会社 Printer maintenance system, print control server, client, method related thereto and program related thereto
US7222802B2 (en) 2003-05-23 2007-05-29 Meadwestvaco Corporation Dual sprayer with external mixing chamber
US7648711B2 (en) 2003-05-25 2010-01-19 Yuwan Wang Dimethicone-containing sustained release injection formulation
US7186416B2 (en) 2003-05-28 2007-03-06 Stiefel Laboratories, Inc. Foamable pharmaceutical compositions and methods for treating a disorder
US20070010580A1 (en) * 2003-05-30 2007-01-11 Gianfranco De Paoli Ambrosi Formulation for chemical peeling
US20050208083A1 (en) 2003-06-04 2005-09-22 Nanobio Corporation Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof
JP4018032B2 (en) 2003-06-17 2007-12-05 高砂香料工業株式会社 Hair and body cleaning composition
EP1643990B8 (en) 2003-06-18 2007-05-09 Galderma S.A. Metronidazole-based green tinted topical pharmaceutical composition
CN100428924C (en) * 2003-06-19 2008-10-29 宝洁公司 Polyol-in-silicone emulsions
US20050042182A1 (en) 2003-08-13 2005-02-24 Moshe Arkin Topical compositions of urea
AU2004253410B2 (en) 2003-07-03 2008-08-21 Japan Science And Technology Agency Remedy for sarcoidosis and method of treating the same
US20070140999A1 (en) 2003-07-18 2007-06-21 Hill Dermaceuticals, Inc. Topical skin care composition containing refined peanut oil
EP1653932A1 (en) 2003-07-24 2006-05-10 Ranbaxy Laboratories Limited Modified release compositions for minocycline
US7226230B2 (en) 2003-07-28 2007-06-05 Raymond Liberatore Spreader
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US20080069779A1 (en) 2003-08-04 2008-03-20 Foamix Ltd. Foamable vehicle and vitamin and flavonoid pharmaceutical compositions thereof
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
EP1670435A2 (en) 2003-08-04 2006-06-21 Foamix Ltd. Foam carrier containing amphiphilic copolymeric gelling agent
BRPI0412975A (en) 2003-08-25 2006-10-03 Foamix Ltd penetrating foam for pharmaceutical use
US20060140990A1 (en) 2003-09-19 2006-06-29 Drugtech Corporation Composition for topical treatment of mixed vaginal infections
AU2004275821A1 (en) 2003-09-25 2005-04-07 Dmi Biosciences Inc. Methods and products which utilize N-acyl-L-aspartic acid
US20050084551A1 (en) 2003-09-26 2005-04-21 Jensen Claude J. Morinda citrifolia-based oral care compositions and methods
FR2860143B1 (en) 2003-09-26 2008-06-27 Oreal COSMETIC COMPOSITION COMPRISING A SEQUENCE POLYMER AND A NON-VOLATILE SILICONE OIL
KR20060113907A (en) 2003-09-29 2006-11-03 에테나 헬스케어 인코포레이티드 - high alcohol content gel-like and foaming compositions
GB2406330B (en) 2003-09-29 2005-12-07 Bespak Plc A dispensing apparatus
MXPA06003743A (en) 2003-10-03 2006-06-23 Collegium Pharmaceutical Inc Topical aerosol foams.
FR2860502B1 (en) 2003-10-07 2007-09-14 Valois Sas DOSING VALVE AND DEVICE FOR DISPENSING FLUID PRODUCT COMPRISING SUCH A VALVE
GB0323908D0 (en) 2003-10-11 2003-11-12 Nupharm Lab Ltd Pharmaceutical foam formulation
ATE416012T1 (en) 2003-10-14 2008-12-15 Showa Denko Kk AGENT FOR EXTERNAL USE ON THE SKIN COMPRISING A SALT OF AN ASCORBIC ACID DERIVATIVE, METHOD FOR STABILIZING THE AGENT FOR EXTERNAL USE ON THE SKIN
FR2860976B1 (en) 2003-10-20 2006-02-10 Ravi Shrivastava NOVEL SYNERGISTIC COMPOSITIONS FOR IMPROVING THE BIODAVAILABILITY AND EFFICIENCY OF POLYUNSATURATED FATTY ACIDS FOR THE TREATMENT OF BRAIN FUNCTIONING DISORDERS.
US7419498B2 (en) 2003-10-21 2008-09-02 Nmt Medical, Inc. Quick release knot attachment system
MXPA06004826A (en) 2003-10-31 2006-07-03 Procter & Gamble Skin care composition containing dehydroacetic acid and skin care actives.
MXPA06004593A (en) 2003-11-06 2006-06-27 Unilever Nv Improved cosmetic composition comprising vitamin b3, vitamin b6 and an organic acid.
AU2004289358B8 (en) 2003-11-06 2010-12-23 The Research Foundation Of State University Of New York Methods of treating eczema
US8157788B2 (en) 2003-11-06 2012-04-17 Paolo L. Manfredi Multi-site drug delivery platform
MXPA06005512A (en) 2003-11-17 2006-08-17 Procter & Gamble Antiperspirant composition and applicator therefor.
DE10354051A1 (en) 2003-11-17 2005-06-16 Beiersdorf Ag Dispensers containing cosmetic preparations containing aids for keeping the donor in motion
CA2546195A1 (en) 2003-11-21 2005-06-02 Pfizer Products Inc. The use of anti biotics as vaccine adjuvants
US20050115988A1 (en) 2003-12-01 2005-06-02 Brian Law Multiple liquid foamer
US20050123496A1 (en) 2003-12-08 2005-06-09 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Self foaming non-aqueous personal wash cleansers with little or no surfactant
DE10361022A1 (en) 2003-12-23 2005-07-28 Merckle Gmbh Chem.-Pharm. Fabrik Topical preparations containing dimethyl sulfoxide and dexpanthenol
PT1716162E (en) 2003-12-30 2010-11-24 Gilead Sciences Inc Phosphonates, monophosphonamidates, bisphosphonamidates for the treatment of viral diseases
IL159729A0 (en) 2004-01-06 2004-06-20 Doron I Friedman Non-aqueous composition for oral delivery of insoluble bioactive agents
EP1727522A2 (en) 2004-02-04 2006-12-06 Foamix Ltd. Cosmetic and pharmaceutical foam with solid matter
US7225518B2 (en) 2004-02-23 2007-06-05 Boston Scientific Scimed, Inc. Apparatus for crimping a stent assembly
JP4381169B2 (en) 2004-02-27 2009-12-09 花王株式会社 Hair cosmetics
PT2656859E (en) 2004-03-03 2016-02-24 Revance Therapeutics Inc Topical application and transdermal delivery of botulinum toxins
US20050206214A1 (en) 2004-03-18 2005-09-22 Bodypoint Designs, Inc. Pivoting side mount for a pelvic stabilization device
DE102004016710B4 (en) 2004-04-05 2020-11-19 Greppmayr GmbH Foot care formulation
BRPI0509708B8 (en) 2004-04-08 2021-05-25 Meda Pharma S A R L pharmaceutical foam, pimecrolimus foam composition containing hexylene glycol, optionally oleyl alcohol, dimethyl isosorbide and/or medium chain triglycerides and usage
WO2005102282A1 (en) 2004-04-19 2005-11-03 Strategic Science & Technologies, Llc Transdermal delivery of beneficial substances effected by a hostile biophysical environment
NL1026031C2 (en) 2004-04-23 2005-10-25 Airspray Nv Delivery assembly.
CA2565754A1 (en) 2004-04-28 2005-10-28 Foamix Ltd. Body cavity foams
US20050244354A1 (en) 2004-04-30 2005-11-03 Sam Speron Oxygenated personal care products
JP2005314323A (en) 2004-04-30 2005-11-10 Sato Pharmaceutical Co Ltd Hair growth formulation
US20050255048A1 (en) 2004-05-15 2005-11-17 Collegium Pharmaceutical, Inc. Sprayable formulations for the treatment of acute inflammatory skin conditions
US7083125B2 (en) 2004-05-17 2006-08-01 S.C. Johnson & Son, Inc. Detachable tube assembly
US7143909B2 (en) 2004-05-21 2006-12-05 Sonoco Development, Inc. Reconfigurable metered material dispenser
US8394394B2 (en) 2004-05-26 2013-03-12 L'oréal Mousse formulations
ITBO20040338A1 (en) 2004-05-28 2004-08-28 Progine Farmaceutici Srl VAGINAL NEBULIZATION DISPENSER
US20050268416A1 (en) 2004-06-03 2005-12-08 Sommers J E Foldable lotion applicator
JP4368250B2 (en) 2004-06-09 2009-11-18 ポーラ化成工業株式会社 Post-form dosage form of warm cosmetic
FR2871696B1 (en) 2004-06-17 2006-11-10 Galderma Sa TOPICAL COMPOSITION FOR THE TREATMENT OF PSORIASIS
FR2871698B1 (en) 2004-06-17 2008-07-04 Galderma Sa SPRAY COMPOSITION COMPRISING AN ASSOCIATION OF PHARMACEUTICAL ASSETS AND AN OILY PHASE
US8211449B2 (en) 2004-06-24 2012-07-03 Dpt Laboratories, Ltd. Pharmaceutically elegant, topical anhydrous aerosol foam
JP4355264B2 (en) 2004-06-25 2009-10-28 ポーラ化成工業株式会社 Warm feeling non-water foam cosmetic
US7207655B2 (en) 2004-06-28 2007-04-24 Eastman Kodak Company Latency stirring in fluid ejection mechanisms
US6991789B2 (en) 2004-06-29 2006-01-31 Allergas, Inc. Methods of modulating intracellular degradation rates of toxins
US20060008432A1 (en) * 2004-07-07 2006-01-12 Sebastiano Scarampi Gilsonite derived pharmaceutical delivery compositions and methods: nail applications
UA93354C2 (en) 2004-07-09 2011-02-10 Гилиад Сайенсиз, Инк. Topical antiviral formulations
US20060121073A1 (en) 2004-07-12 2006-06-08 Sandhya Goyal Topical gel formulation comprising insecticide and its preparation thereof
US7288692B2 (en) * 2004-07-14 2007-10-30 Exxonmobil Chemcial Patents Inc. Process for producing olefins
US20070225357A1 (en) 2004-07-19 2007-09-27 Pfizer Inc. Formulation for Stimulating Hair Growth
WO2006010589A2 (en) 2004-07-29 2006-02-02 Mipharm S.P.A. Post foaming gel mousse
JP4557624B2 (en) 2004-07-29 2010-10-06 株式会社吉野工業所 Quantitative dispenser
US20060029565A1 (en) 2004-08-09 2006-02-09 The Gillette Company Self-heating shave foam product
US7505696B2 (en) 2004-08-12 2009-03-17 Triaccess Technologies, Inc. Optical receiver with increased dynamic range
TWI397427B (en) 2004-08-31 2013-06-01 Stiefel Res Australia Pty Ltd Micro emulsion and sub-micron emulsion process and composition
KR100623013B1 (en) 2004-09-04 2006-09-19 김영대 Nano-emulsion, the use thereof, and preparing method thereof
ES2729826T3 (en) 2004-09-23 2019-11-06 Arc Medical Devices Inc Pharmaceutical compositions and related methods to inhibit fibrous adhesions or inflammatory disease using low sulfate fucans
HUE045022T2 (en) 2004-09-27 2019-12-30 Special Water Patents B V Methods and compositions for treatment of water
FR2875797B1 (en) 2004-09-30 2006-11-24 Oreal DISTRIBUTION ASSEMBLY FOR THE EXTENDED DISTRIBUTION OF TWO PRODUCTS
BRPI0404595A (en) 2004-10-26 2006-06-13 Natura Cosmeticos Sa oil-in-water nanoemulsion, cosmetic composition and cosmetic product comprising same, process for preparing said nanoemulsion
DE102004052986A1 (en) 2004-11-02 2006-05-04 Lindal Ventil Gmbh Device for mixing two different components
US7350673B2 (en) 2004-11-19 2008-04-01 Glynntech, Inc. Metered dose squeeze dispenser
US8080560B2 (en) 2004-12-17 2011-12-20 3M Innovative Properties Company Immune response modifier formulations containing oleic acid and methods
FR2880802B1 (en) 2005-01-14 2008-12-19 Sederma Soc Par Actions Simpli COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION CONTAINING EUGLENE EXTRACT
US20060194769A1 (en) 2005-01-25 2006-08-31 University Of Vermont And State Agricultural College Small molecules that reduce fungal growth
CA2595692A1 (en) 2005-01-28 2006-08-03 Basf Aktiengesellschaft Use of a water-in-water emulsion polymers in the form of a thickener for cosmetic preparations
US20060177392A1 (en) 2005-02-10 2006-08-10 William Walden Oil-based composition for acne
US20060193813A1 (en) 2005-02-11 2006-08-31 L'oreal Nanoemulsion containing a hydroxylated urea compound
GB0506141D0 (en) 2005-03-24 2005-05-04 Transphase Ltd A topical compostion and its uses
US20090061001A1 (en) 2005-03-24 2009-03-05 Ensign Laboratories Pty Ltd Sunscreen aerosol spray
US20060222675A1 (en) 2005-03-29 2006-10-05 Sabnis Ram W Personal care compositions with color changing indicator
WO2008020268A2 (en) 2005-04-19 2008-02-21 Foamix Ltd. Apparatus and method for releasing a measured amount of content from a container
CN101278051B (en) 2005-05-05 2011-10-05 金克克国际有限公司 Personal care compositions and methods for their use
NZ563270A (en) 2005-05-10 2010-11-26 Dermipsor Ltd Calcipotriol, polyethylene oxide topical compositions for the treatment of hyperproliferative epidermal diseases
WO2006122158A2 (en) 2005-05-10 2006-11-16 Xanthone Plus International, Llc Skin care compositions containing xanthones
CA2611147C (en) 2005-06-01 2013-04-09 Stiefel Research Australia Pty Ltd. Topical emulsion formulation
US20060272199A1 (en) 2005-06-02 2006-12-07 Bmc Manufacturing, Llc Aqueous gel candle for use with a warming device
US8211874B2 (en) 2005-06-03 2012-07-03 Galderma Laboratories Inc. Inhibition of thrombin generation
EP1919449A2 (en) 2005-06-07 2008-05-14 Foamix Ltd. Antibiotic kit and composition and uses thereof
WO2007085899A2 (en) 2005-07-06 2007-08-02 Foamix Ltd. Foamable arthropocidal composition for tropical application
US20070009607A1 (en) * 2005-07-11 2007-01-11 George Jones Antibacterial/anti-infalmmatory composition and method
US20070015738A1 (en) 2005-07-15 2007-01-18 Walker Stephen G Use of non-antibacterial tetracycline formulations for inhibiting bacterial spores from becoming infectious vegetative cells
ES2765897T3 (en) 2005-07-18 2020-06-11 Procter & Gamble Method for conditioning hair with a cream spray foam
WO2007085902A2 (en) 2005-07-19 2007-08-02 Foamix Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US20080152596A1 (en) 2005-07-19 2008-06-26 Foamix Ltd. Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
CN100531515C (en) * 2005-07-22 2009-08-19 鸿富锦精密工业（深圳）有限公司 Printing circuit board with modified power zone block
EP1745769B1 (en) 2005-07-22 2008-10-15 Wella Aktiengesellschaft Hair treatment method using dry foam as mechanical support for hair
EP1951200A2 (en) 2005-08-09 2008-08-06 Nanobio Corporation Nanoemulsion compositions having anti-inflammatory activity
CA2632183A1 (en) 2005-08-25 2007-03-01 Philip R. Houle Treatment systems for delivery of sensitizer solutions
WO2007119099A2 (en) 2005-09-12 2007-10-25 Foamix Ltd. Apparatus and method for releasing a measure of content from a plurality of containers
FR2890559B1 (en) 2005-09-13 2011-06-24 Galderma Sa DERMATOLOGICAL FOAMS BASED ON METRONIDAZOLE AND EMULSIONS FOR PREPARATION
DE202006004676U1 (en) 2005-09-28 2007-02-08 Neubourg Skin Care Gmbh & Co. Kg Formulation, useful as foam skin cream and to treat e.g. dermatitis and psoriasis, comprises an aqueous emulsion, propellant gas, urea emulsion, hyaluronic acid, free fatty acid and at least two emulsions
US20070154402A1 (en) 2005-10-24 2007-07-05 Collegium Pharmaceutical, Inc. Topical Pharmaceutical Foam Composition
US20070134174A1 (en) 2005-11-03 2007-06-14 Christopher Irwin Personal care composition
JP2007131539A (en) 2005-11-08 2007-05-31 Koike Kagaku Kk Chilling foam cosmetic
US20070148194A1 (en) 2005-11-29 2007-06-28 Amiji Mansoor M Novel nanoemulsion formulations
JP4885529B2 (en) 2005-12-08 2012-02-29 住友重機械工業株式会社 Radiation detection unit and radiation inspection apparatus
US20070160548A1 (en) 2005-12-13 2007-07-12 Playtex Products, Inc. Moisturizing sunless tanning composition
US20070142263A1 (en) 2005-12-15 2007-06-21 Stahl Katherine D Color changing cleansing composition
US20070148112A1 (en) 2005-12-28 2007-06-28 Avon Products, Inc. Foaming, color-changing topical composition and method of imparting a cosmetic effect
US20070166273A1 (en) 2006-01-19 2007-07-19 Krivulka Joseph J Skin treatment educational kit
EP1981480A1 (en) 2006-01-19 2008-10-22 Disphar International B.V. Foam-forming composition
CA2645073A1 (en) 2006-03-08 2007-09-13 Nuviance, Inc. Transdermal drug delivery compositions and topical compositions for application on the skin
US20070224143A1 (en) 2006-03-21 2007-09-27 Kamedis Ltd. Cosmetic and pharmaceutical foam carrier
KR20080098659A (en) 2006-03-22 2008-11-11 더 프록터 앤드 갬블 캄파니 Aerosol product comprising a foaming concentrate composition comprising particulate materials
US7252816B1 (en) 2006-03-29 2007-08-07 Dow Pharmaceutical Sciences Topical acne vulgairs medication with a sunscreen
PL2206494T3 (en) 2006-03-31 2016-06-30 Stiefel Res Australia Pty Ltd Foamable suspension gel
WO2008075207A2 (en) 2006-04-04 2008-06-26 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof
US20070264317A1 (en) 2006-05-15 2007-11-15 Perrigo Israel Pharmaceuticals Ltd. Imiquimod cream formulation
EP2034831A2 (en) 2006-05-31 2009-03-18 The Dial Corporation Alcohol-containing antimicrobial compositions having improved efficacy
JP4892282B2 (en) 2006-06-09 2012-03-07 アルプス電気株式会社 Lubricating composition for electrical contacts
WO2008110872A2 (en) 2006-06-23 2008-09-18 Foamix Ltd. Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses
US7826675B2 (en) * 2006-07-04 2010-11-02 Hewlett-Packard Development Company, L.P. Feature-aware image defect removal
SI2494959T1 (en) 2006-07-05 2015-04-30 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
MX2009000507A (en) * 2006-07-14 2009-06-12 Stiefel Res Australia Pty Ltd Fatty acid pharmaceutical foam.
NO343857B1 (en) 2006-07-18 2019-06-24 Meda Ab Immune Response Modifying Foam Formulations
US20080031908A1 (en) 2006-07-25 2008-02-07 L'oreal Oily cosmetic composition in aerosol form
JP2008040899A (en) 2006-08-08 2008-02-21 Fuji Xerox Co Ltd Printing controller, program, and method
WO2008032212A2 (en) 2006-09-08 2008-03-20 Foamix Ltd. Colored or colorable foamable composition and foam
ES2315123B1 (en) 2006-09-25 2009-12-30 Divasa-Farmavic, S.A. STABLE PHARMACEUTICAL COMPOSITIONS OF TETRACICLINES IN SOLUTION, PROCEDURE FOR OBTAINING AND USES.
HUP0600765A2 (en) 2006-10-06 2008-10-28 Istvan Piller Container for stable carbondioxide foam, process for producing stable carbondioxide foam and method for using of foam
US20080206155A1 (en) 2006-11-14 2008-08-28 Foamix Ltd. Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
EP2097065A2 (en) 2006-11-29 2009-09-09 Foamix Ltd. Foamable waterless compositions with modulating agents
JP2010513289A (en) 2006-12-15 2010-04-30 ザ プロクター アンド ギャンブル カンパニー Skin care composition
CA2674078C (en) 2006-12-26 2012-03-20 Femmepharma Holding Company, Inc. Topical administration of danazol
US20080292560A1 (en) 2007-01-12 2008-11-27 Dov Tamarkin Silicone in glycol pharmaceutical and cosmetic compositions with accommodating agent
WO2008087148A2 (en) 2007-01-16 2008-07-24 Oystershell N.V. Foamable composition for killing arthropods and uses thereof
US20080188446A1 (en) 2007-02-02 2008-08-07 Warner Chilcott Company Inc. Tetracycline compositions for topical administration
WO2008097850A1 (en) 2007-02-02 2008-08-14 Warner Chilcott Company, Inc. Tretracycline compositions for topical administration
PT103661B (en) 2007-02-23 2010-09-07 Hovione Farmaciencia S A MINOCYCINE PREPARATION PROCESS CRYSTALLINE
GB0703909D0 (en) 2007-02-28 2007-04-11 Neuropharm Ltd Treatment of anxiety disorders
FR2915891B1 (en) 2007-05-10 2012-05-11 Oreal FOAM COMPOSITION COMPRISING A SILICONE POLYMER
US9511016B2 (en) 2007-06-12 2016-12-06 Epicentrx, Inc. Topical composition for treating pain
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US8617100B2 (en) 2007-09-04 2013-12-31 Foamix Ltd. Device for delivery of a foamable composition
US20090130029A1 (en) 2007-11-21 2009-05-21 Foamix Ltd. Glycerol ethers vehicle and pharmaceutical compositions thereof
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2010041141A2 (en) 2008-10-07 2010-04-15 Foamix Ltd. Oil-based foamable carriers and formulations
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
WO2009087578A2 (en) 2008-01-08 2009-07-16 Foamix Ltd. Sensation modifying topical composition foam
EP2242476A2 (en) * 2008-01-14 2010-10-27 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
US8652443B2 (en) 2008-02-14 2014-02-18 Precision Dermatology, Inc. Foamable microemulsion compositions for topical administration
ES2330291B1 (en) * 2008-02-29 2010-10-18 Lipotec Sa USEFUL PEPTIDES IN THE TREATMENT OF SKIN, MUCOSAS AND / OR LEATHER HAIR AND ITS USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS.
RU2547441C2 (en) 2008-03-06 2015-04-10 Анакор Фармасьютикалз, Инк. Boron-containing small molecules as anti-inflammatory agents
US20120141384A1 (en) 2008-05-06 2012-06-07 Dov Tamarkin Antibacterial conjugated boronic acids and pharmaceutical compositions thereof
US8253882B2 (en) 2008-08-07 2012-08-28 Sharp Kabushiki Kaisha Display device
KR101616663B1 (en) 2008-08-08 2016-04-28 인터디지탈 패튼 홀딩스, 인크 Method and apparatus for reporting a buffer status
PL2210588T3 (en) 2008-12-23 2011-09-30 Intendis Gmbh Foamable composition essentially free of pharmaceutically active ingredients for the treatment of human skin
JP5213734B2 (en) 2009-01-22 2013-06-19 サンウエーブ工業株式会社 Cabinet with flap door
CA2752070C (en) 2009-02-12 2017-11-28 Precision Dermatology, Inc. Foamable benzoyl peroxide compositions for topical administration
AU2010217190B2 (en) 2009-02-25 2012-10-25 Mayne Pharma Llc Topical foam composition
US20120164087A1 (en) 2009-04-24 2012-06-28 Carter Daniel C Human Serum Albumin-Based Topical Ointment for Treatment of Acne, Psoriasis, Egfr-Induced Toxicity, Premature Skin Aging and Other Skin Conditions
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
PT104644B (en) 2009-06-26 2012-11-06 Hovione Farmaciencia S A Topical formulation containing a tetracycline and a method of treating skin infections using the same
US8255186B2 (en) 2009-07-09 2012-08-28 Air Liquide Large Industries U.S. Lp Presenting dynamic SCADA data
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011026094A2 (en) 2009-08-31 2011-03-03 Collegium Pharmaceutical, Inc. Stable aerosol topical foams comprising a hypochlorite salt
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US20140121188A1 (en) 2009-10-02 2014-05-01 Foamix Ltd. Compositions for the improved treatment of acne and related disorders
MX359879B (en) 2009-10-02 2018-10-12 Foamix Pharmaceuticals Ltd Topical tetracycline compositions.
GB2474930B (en) 2009-10-02 2012-07-04 Foamix Ltd Topical tetracycline compositions
US20140186269A1 (en) 2013-01-03 2014-07-03 Foamix Ltd. Vehicle compositions essentially free of pharmaceutically active agents for the improved treatment of acne and related disorders
US8735377B1 (en) 2010-02-04 2014-05-27 Susan Anna Sipos Methods of treating herpes zoster
US20110212035A1 (en) 2010-02-26 2011-09-01 Collegium Pharmaceutical, Inc. Emollient foams for treatment of dermatoses
WO2011115700A2 (en) 2010-03-18 2011-09-22 Precision Dermatology, Inc. Emollient foams for treatment of seborrheic dermatitis
US8592380B2 (en) 2010-03-26 2013-11-26 Precision Dermatology, Inc. Aerosol foams comprising clindamycin phosphate
WO2011133217A1 (en) 2010-04-21 2011-10-27 Pharmacline, Llc Topical drug delivery system with dual carriers
US20130053353A1 (en) 2010-05-04 2013-02-28 Foamix Ltd. Compositions, gels and foams with rheology modulators and uses
JP5865360B2 (en) 2010-06-11 2016-02-17 プレシジョン ダーマトロジー インコーポレイテッドＰｒｅｃｉｓｉｏｎ Ｄｅｒｍａｔｏｌｏｇｙ， Ｉｎｃ． Softening aerosol foam composition with high oil content
US8978936B2 (en) 2010-07-12 2015-03-17 Foamix Pharmaceuticals Ltd. Apparatus and method for releasing a unit dose of content from a container
EP2603215A4 (en) 2010-08-11 2015-08-05 Philadelphia Health & Educatio Novel d3 dopamine receptor agonists to treat dyskinesia in parkinson's disease
US20120064136A1 (en) 2010-09-10 2012-03-15 Nanobio Corporation Anti-aging and wrinkle treatment methods using nanoemulsion compositions
US8895536B2 (en) 2010-10-29 2014-11-25 Infirst Healthcare Ltd. Compositions and methods for treating chronic inflammation and inflammatory diseases
EA031630B1 (en) 2011-01-19 2019-01-31 Лэборатори Скин Кер, Инк. Topical minocycline compositions and methods of using the same
WO2013009586A1 (en) 2011-07-08 2013-01-17 The Research Foundation Of State University Of New York Topical minocycline ointment for suppression of allergic skin responses
CA2854449A1 (en) 2011-11-03 2013-05-10 Precision Dermatology, Inc. Stable dermatological aerosol foams utilizing reactive propellants
US8801680B2 (en) 2012-03-14 2014-08-12 Becton, Dickinson And Company Angled retracting sheath for safety needle
IL225239A0 (en) 2012-03-15 2013-06-27 Meir Eini Compositions for the treatment of acne and related disorders
MX2014011181A (en) 2012-03-22 2015-03-06 Prec Dermatology Inc Cyclodextrin-based microemulsions, and dermatological uses thereof.
CA2775393C (en) 2012-05-02 2014-04-29 Samy Saad Topical non-aqueous pharmaceutical formulations
CA2878462A1 (en) 2012-07-13 2014-01-16 Paratek Pharmaceuticals, Inc. Tetracycline compounds for treating neurodegenerative disorders
PT106679B (en) 2012-11-27 2015-03-25 Hovione Farmaciencia Sa TOPICAL FORMULATIONS OF TETRACYCLINES, THEIR PREPARATION AND USES
CN105050584A (en) 2013-02-28 2015-11-11 普雷西恩护肤公司 Topical formulations of corticosteroids with enhanced bioavailability
WO2014134427A1 (en) 2013-02-28 2014-09-04 Precision Dermatology, Inc. Controlling the bioavailability of active ingredients in topical formulations
WO2014151347A1 (en) 2013-03-15 2014-09-25 Revance Therapeutics, Inc. Minocycline derivatives
WO2014201541A1 (en) 2013-06-17 2014-12-24 Contract Pharmaceuticals Limited Non-aerosol foams for topical administration
EP3065717A1 (en) 2013-11-04 2016-09-14 Biopharmx, Inc. Dosage form comprising an active ingredient and a plurality of solid porous microcarriers
US20160287614A1 (en) 2013-11-20 2016-10-06 Lupin Limited Stable Pharmaceutical Formulation(s) of Tetracycline Antibiotic
PT107433B (en) 2014-01-28 2018-12-04 Hovione Farm S A PARTICLE SIZE REDUCTION AND CONTROL PROCESS
WO2015153864A2 (en) 2014-04-02 2015-10-08 Hopkins Patricia T Methods for treating inflammatory conditions

Cited By (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9713643B2 (en) 2002-10-25 2017-07-25 Foamix Pharmaceuticals Ltd. Foamable carriers
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US10322085B2 (en) 2002-10-25 2019-06-18 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US11033491B2 (en) 2002-10-25 2021-06-15 Vyne Therapeutics Inc. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US10821077B2 (en) 2002-10-25 2020-11-03 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US9622947B2 (en) 2002-10-25 2017-04-18 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US9636405B2 (en) 2003-08-04 2017-05-02 Foamix Pharmaceuticals Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9682021B2 (en) 2006-11-14 2017-06-20 Foamix Pharmaceuticals Ltd. Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US9662298B2 (en) 2007-08-07 2017-05-30 Foamix Pharmaceuticals Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US11103454B2 (en) 2007-08-07 2021-08-31 Vyne Therapeutics Inc. Wax foamable vehicle and pharmaceutical compositions thereof
US10369102B2 (en) 2007-08-07 2019-08-06 Foamix Pharmaceuticals Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US11433025B2 (en) 2007-12-07 2022-09-06 Vyne Therapeutics Inc. Oil foamable carriers and formulations
US9795564B2 (en) 2007-12-07 2017-10-24 Foamix Pharmaceuticals Ltd. Oil-based foamable carriers and formulations
US10363216B2 (en) 2009-04-28 2019-07-30 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US10588858B2 (en) 2009-04-28 2020-03-17 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US10213384B2 (en) 2009-04-28 2019-02-26 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US9884017B2 (en) 2009-04-28 2018-02-06 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US11219631B2 (en) 2009-07-29 2022-01-11 Vyne Pharmaceuticals Inc. Foamable compositions, breakable foams and their uses
US10350166B2 (en) 2009-07-29 2019-07-16 Foamix Pharmaceuticals Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US10092588B2 (en) 2009-07-29 2018-10-09 Foamix Pharmaceuticals Ltd. Foamable compositions, breakable foams and their uses
US10610599B2 (en) 2009-10-02 2020-04-07 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10835613B2 (en) 2009-10-02 2020-11-17 Foamix Pharmaceuticals Ltd. Compositions, gels and foams with rheology modulators and uses thereof
US10517882B2 (en) 2009-10-02 2019-12-31 Foamix Pharmaceuticals Ltd. Method for healing of an infected acne lesion without scarring
US9675700B2 (en) 2009-10-02 2017-06-13 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10213512B2 (en) 2009-10-02 2019-02-26 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10086080B2 (en) 2009-10-02 2018-10-02 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10821187B2 (en) 2009-10-02 2020-11-03 Foamix Pharmaceuticals Ltd. Compositions, gels and foams with rheology modulators and uses thereof
US10463742B2 (en) 2009-10-02 2019-11-05 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10322186B2 (en) 2009-10-02 2019-06-18 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10946101B2 (en) 2009-10-02 2021-03-16 Vyne Therapeutics Inc. Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US10967063B2 (en) 2009-10-02 2021-04-06 Vyne Therapeutics Inc. Surfactant-free, water-free formable composition and breakable foams and their uses
US10137200B2 (en) 2009-10-02 2018-11-27 Foamix Pharmaceuticals Ltd. Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US10849847B2 (en) 2016-09-08 2020-12-01 Foamix Pharamaceuticals Ltd. Compositions and methods for treating rosacea and acne
US11324691B2 (en) 2016-09-08 2022-05-10 Journey Medical Corporation Compositions and methods for treating rosacea and acne
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne

Also Published As

Publication number Publication date
KR20050083826A (en) 2005-08-26
IL168399A (en) 2011-12-29
EP1556009B2 (en) 2021-07-21
US8722021B2 (en) 2014-05-13
US20180214558A1 (en) 2018-08-02
KR101108439B1 (en) 2012-01-31
EP1556009A2 (en) 2005-07-27
US20140241998A1 (en) 2014-08-28
AU2003279493B2 (en) 2009-08-20
US8840869B2 (en) 2014-09-23
US20050271598A1 (en) 2005-12-08
WO2004037225A2 (en) 2004-05-06
US20160354473A1 (en) 2016-12-08
US20190307887A1 (en) 2019-10-10
BR0314916A (en) 2005-08-16
CA2502986C (en) 2011-08-23
EP1556009B1 (en) 2014-12-24
ES2532906T3 (en) 2015-04-01
US20080138293A1 (en) 2008-06-12
US20200101164A1 (en) 2020-04-02
AU2003279493A1 (en) 2004-05-13
US20060140984A1 (en) 2006-06-29
ES2532906T5 (en) 2022-03-23
US9713643B2 (en) 2017-07-25
MXPA05004278A (en) 2005-10-05
US20170274084A1 (en) 2017-09-28
NZ540166A (en) 2007-06-29
IL168399A0 (en) 2009-02-11
JP2006505583A (en) 2006-02-16
US20130183250A1 (en) 2013-07-18
WO2004037225A3 (en) 2004-12-29

Similar Documents

Publication Publication Date Title
CA2502986A1 (en) Cosmetic and pharmaceutical foam
JP2006505583A5 (en)
US20190307685A1 (en) Nonsteroidal immunomodulating kit and composition and uses thereof
Searle et al. The top 10 cosmeceuticals for facial hyperpigmentation
US20130195925A1 (en) Anti aging application and method for treating aging
US20060177392A1 (en) Oil-based composition for acne
US20050271596A1 (en) Vasoactive kit and composition and uses thereof
Glaser Anti-aging products and cosmeceuticals
EP2144590B1 (en) Skin treatment compositions and methods
US9775789B2 (en) Topical liposome compositions containing phenolic anti-inflammatory agents and their methods of preparation
US20090137534A1 (en) Skin treatment compositions and methods
MXPA06001381A (en) Foam carrier containing amphiphilic copolymeric gelling agent.
WO2005027977A2 (en) Diclofenac compositions for the treatment of skin disorders
US20160175223A1 (en) Anti-aging compositions comprising bile acid-fatty acid conjugates
Aparajita et al. Liposomes as carriers in skin ageing
JP2002506821A (en) How to treat skin irritation
EP3463278B1 (en) Use of thiophosphate derivatives as skin depigmenting agents
Bagatin et al. Tretinoin-based formulations-influence of concentration and vehicles on skin penetration
EP1594456B1 (en) Use of a composition comprising vitamin k1 oxide or a derivative thereof for the treatment and/or the prevention of mammal dermatological lesions
Bagatin et al. Hydroxy Acids
JP2002506804A (en) Skin care composition
CN117915904A (en) Topical formulation comprising benzoyl peroxide and azelaic acid and use thereof
TR2023018194A2 (en) NANOEMULSION BASED NANOCREEN FORMULATIONS CONTAINING SALICYLIC ACID, COCONUT OIL, VITAMIN C AND VITAMIN E IN COMBINED FORM
WO2022153309A1 (en) Topical composition
US20210290603A1 (en) Methods for treating acne

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20231024